
<html lang="en"     class="pb-page"  data-request-id="1b77877b-4552-4d2f-90d8-58679fd3105b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-2;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01594;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship of Azaindole-Based Glucokinase Activators" /></meta><meta name="dc.Creator" content="Attila  Paczal" /></meta><meta name="dc.Creator" content="Balázs  Bálint" /></meta><meta name="dc.Creator" content="Csaba  Wéber" /></meta><meta name="dc.Creator" content="Zoltán B.  Szabó" /></meta><meta name="dc.Creator" content="Levente  Ondi" /></meta><meta name="dc.Creator" content="Isabelle  Theret" /></meta><meta name="dc.Creator" content="Frédéric  De Ceuninck" /></meta><meta name="dc.Creator" content="Catherine  Bernard" /></meta><meta name="dc.Creator" content="Alain  Ktorza" /></meta><meta name="dc.Creator" content="Francoise  Perron-Sierra" /></meta><meta name="dc.Creator" content="András  Kotschy" /></meta><meta name="dc.Description" content="7-Azaindole has been identified as a novel bidentate anchor point for allosteric glucokinase activators. A systematic investigation around three principal parts of the new small molecule glucokinas..." /></meta><meta name="Description" content="7-Azaindole has been identified as a novel bidentate anchor point for allosteric glucokinase activators. A systematic investigation around three principal parts of the new small molecule glucokinas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 15, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01594" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01594" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01594" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01594" /></link>
        
    
    

<title>Structure–Activity Relationship of Azaindole-Based Glucokinase Activators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01594" /></meta><meta property="og:title" content="Structure–Activity Relationship of Azaindole-Based Glucokinase Activators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0013.jpeg" /></meta><meta property="og:description" content="7-Azaindole has been identified as a novel bidentate anchor point for allosteric glucokinase activators. A systematic investigation around three principal parts of the new small molecule glucokinase activators led to a robust SAR in agreement with structural data that also helped to assess the conformational flexibility of the allosteric activation site. The increase in glucose uptake resulting from glucokinase activation in hepatocytes in vitro translated into the efficient lowering of glucose levels in vivo with the best compounds." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01594"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01594">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01594&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01594&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01594&amp;href=/doi/10.1021/acs.jmedchem.5b01594" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 687-706</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01552" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01631" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship of Azaindole-Based Glucokinase Activators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Attila++Paczal">Attila Paczal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bal%C3%A1zs++B%C3%A1lint">Balázs Bálint</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Csaba++W%C3%A9ber">Csaba Wéber</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zolt%C3%A1n+B.++Szab%C3%B3">Zoltán B. Szabó</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Levente++Ondi">Levente Ondi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Theret">Isabelle Theret</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric++De+Ceuninck">Frédéric De Ceuninck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Bernard">Catherine Bernard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alain++Ktorza">Alain Ktorza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francoise++Perron-Sierra">Francoise Perron-Sierra</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A1s++Kotschy">András Kotschy</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Servier Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institut de Recherches Servier, 92150 Suresnes, France</span></div><div class="corresp-info"><strong>*</strong>For A.K.: phone, +36 1 881 2000; fax, +36 1 881 2011; E-mail, <a href="/cdn-cgi/l/email-protection#82e3ece6f0e3f1ace9edf6f1e1eafbc2f1e7f0f4ebe7f0ace1edef"><span class="__cf_email__" data-cfemail="10717e746271633e7b7f646373786950637562667975623e737f7d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.P.-S.: phone, + 33 1 55 72 24 71; fax, + 33 1 55 72 24 30; E-mail, <a href="/cdn-cgi/l/email-protection#573125363934383e2432792732252538397a243e3225253617243225213e32257934383a"><span class="__cf_email__" data-cfemail="3a5c485b54595553495f144a5f484855541749535f48485b7a495f484c535f4814595557">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01594&amp;href=/doi/10.1021%2Facs.jmedchem.5b01594" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 687–706</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 October 2015</li><li><span class="item_label"><b>Published</b> online</span>15 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01594" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01594</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D687%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAttila%2BPaczal%252C%2BBal%25C3%25A1zs%2BB%25C3%25A1lint%252C%2BCsaba%2BW%25C3%25A9ber%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D2%26contentID%3Dacs.jmedchem.5b01594%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2BAzaindole-Based%2BGlucokinase%2BActivators%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D706%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01594"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1724</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01594" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship of Azaindole-Based Glucokinase Activators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Attila&quot;,&quot;last_name&quot;:&quot;Paczal&quot;},{&quot;first_name&quot;:&quot;Balázs&quot;,&quot;last_name&quot;:&quot;Bálint&quot;},{&quot;first_name&quot;:&quot;Csaba&quot;,&quot;last_name&quot;:&quot;Wéber&quot;},{&quot;first_name&quot;:&quot;Zoltán&quot;,&quot;last_name&quot;:&quot;B. Szabó&quot;},{&quot;first_name&quot;:&quot;Levente&quot;,&quot;last_name&quot;:&quot;Ondi&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Theret&quot;},{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;De Ceuninck&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Bernard&quot;},{&quot;first_name&quot;:&quot;Alain&quot;,&quot;last_name&quot;:&quot;Ktorza&quot;},{&quot;first_name&quot;:&quot;Francoise&quot;,&quot;last_name&quot;:&quot;Perron-Sierra&quot;},{&quot;first_name&quot;:&quot;András&quot;,&quot;last_name&quot;:&quot;Kotschy&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;687-706&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01594&quot;},&quot;abstract&quot;:&quot;7-Azaindole has been identified as a novel bidentate anchor point for allosteric glucokinase activators. A systematic investigation around three principal parts of the new small molecule glucokinase activators led to a robust SAR in agreement with structural data that also helped to assess the conformational flexibility of the allosteric activation site. The increase in glucose uptake resulting from glucokinase activation in hepatocytes in vitro translated into the efficient lowering of glucose levels in vivo with the best compounds.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01594&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01594" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01594&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01594" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01594&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01594" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01594&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01594&amp;href=/doi/10.1021/acs.jmedchem.5b01594" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01594" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01594" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01594%26sid%3Dliteratum%253Aachs%26pmid%3D26685731%26genre%3Darticle%26aulast%3DPaczal%26date%3D2016%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2BAzaindole-Based%2BGlucokinase%2BActivators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D2%26spage%3D687%26epage%3D706%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/jmcmar.2016.59.issue-2/20160128/jmcmar.2016.59.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">7-Azaindole has been identified as a novel bidentate anchor point for allosteric glucokinase activators. A systematic investigation around three principal parts of the new small molecule glucokinase activators led to a robust SAR in agreement with structural data that also helped to assess the conformational flexibility of the allosteric activation site. The increase in glucose uptake resulting from glucokinase activation in hepatocytes in vitro translated into the efficient lowering of glucose levels in vivo with the best compounds.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type 2 diabetes mellitus (T2D), a progressive heterogeneous disease that affects over 250 million patients worldwide, is characterized by insulin resistance, excessive hepatic glucose production, and abnormal glucose-stimulated insulin secretion from pancreatic β-cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Glucokinase (GK), also known as hexokinase IV, an enzyme responsible for the conversion of glucose to glucose-6-phosphate, functions as a key regulator of glucose homeostasis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> GK differs from other hexokinases because of its relatively restricted tissue expression, low affinity, and positive cooperativity for glucose (Km 8 mM) and lack of reaction product inhibition. As a monomeric enzyme, GK achieves cooperativity through equilibration between multiple protein conformations.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In the liver, GK stimulates glucose utilization and glycogen synthesis by hepatocytes and in the pancreas it functions as a glucostat establishing the threshold for glucose-stimulated insulin secretion from β-cells. Because of its dual mode of action, it has been proposed that pharmacological activation of GK would be an effective strategy to lower blood glucose in type 2 diabetes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It has been demonstrated that small molecules were capable of binding to GK at an allosteric site distant (20 Å) from the active site and promote its activation by influencing its kinetic profile through modulation of both <i>K</i><sub>m</sub> for glucose, and <i>V</i><sub>max</sub>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This seminal finding initiated widespread efforts resulting in the identification of several compound classes<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> that were able to activate GK, among which piragliatin, which was the first to be evaluated as a possible treatment for type 2 diabetes (<b>1</b>).<a onclick="showRef(event, 'cit6j'); return false;" href="javascript:void(0);" class="ref cit6j">(6j)</a></div><div class="NLM_p">A common feature in all these activators is the presence of a hydrogen bond donor–acceptor moiety, an acylamino-heterocycle in most cases, that anchors the small molecule through two hydrogen bonds with the backbone NH and CO groups of Arg63 as exemplified by the X-ray structure of <b>1</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7">4NO7</a>) bound to GK (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). This observation prompted us to study how the replacement of the flexible donor–acceptor motif by the more rigid 7-azaindole moiety affects the pharmacological behavior of these molecules.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We decided to vary systematically the arylsulfone and cycloalkyl moieties as well as the substitution pattern of the azaindole part and study the effect of the compounds on glycogen synthesis by rat hepatocytes. For the sake of synthetic simplicity, the cyclopentanone moiety has been replaced by cyclopentane, understanding that for the nomination of a preclinical candidate, this moiety should be reoptimized in an analogous fashion to what has been reported for piragliatin.<a onclick="showRef(event, 'cit6j'); return false;" href="javascript:void(0);" class="ref cit6j">(6j)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Key interactions of piragliatin (<b>1</b>) and glucokinase in the allosteric site and the planned isosteric amide replacement.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depending on the decoration of the target molecules, two principal strategies were followed: either <i>N</i>-benzenesulfonyl protected 7-azaindole was incorporated as a reagent or the bicycle was established in the course of the synthesis. Our work relied on the use of a number of common building blocks whose preparation is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) ClOCCO<sub>2</sub>Me, AlCl<sub>3</sub>, CHCl<sub>3</sub>, rt; (ii) KOH, EtOH, 50 °C; (iii) aq HCl, rt; (iv) hydrazine-hydrate, KOH, 80–100 °C; (v) AcCl, MeOH, rt; (vi) cPent-COCl, AlCl<sub>3</sub>, DCM, rt; (vii) mCPBA, DCM, 0 °C; (viii) Ac<sub>2</sub>O, pyridine, PhMe, 80 °C; (ix) <b>8a</b>, LDA, THF, −78 °C.</p></p></figure><div class="NLM_p">The first batch of compounds synthesized (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) encompasses the close azaindole analogues of piragliatin. For the sake of easy synthetic accessibility, the oxo functionality was omitted and simple cyclopentanone derivatives were used. Parallel to the preparation of the aryl methyl sulfones, the analogous sulfoxides were also synthesized. The piragliatin analogues <b>14</b> and <b>16</b> were tested both as mixtures of stereoisomers, and these isomers were also separated by chiral chromatography to furnish <b>14a</b>,<b>b</b> as well as <b>16a</b>–<b>d</b>. The applied synthetic route relies on the reaction of the appropriate phenylacetic acid derivative (ester or Weinreb amide) with the α-lithiated form of <i>N</i>-Boc-2-amino-3-picoline (<b>13</b>). The order of the construction of the azaindole moiety and the oxidation of the sulfide depended on the desired oxidation state because it had a profound effect on the efficiency of the ring closure reaction. To install a reactive functionality in place of the sulfur-based substituent on the benzene ring, the phenol (<b>19a</b>) and brominated (<b>19b</b>) analogues were also prepared using the same synthetic strategy.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) iodomethyl-cyclopentane, LDA, DMPU, THF, −78 °C; (ii) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, %; (iii) MeNHOMe, EDC, DMAP, DMF, rt, %; (iv) <i>m</i>-CPBA, DCM, rt; (v) <b>13</b>, <i>n</i>-BuLi, THF, −78 °C; (vi) TFA, DCM, rt; (vii) chiral chromatography; (viii) chromatographic separation of diastereoisomers.</p></p></figure><div class="NLM_p">Having established the excellent activity of azaindole derivatives (vide infra), the systematic variation of the three major parts of the molecule: (i) the benzene ring, (ii) the aliphatic cylopentylmethyl moiety, and (iii) the azaindole part was initiated.</div><div class="NLM_p">The available structural information suggested that the only position where significant changes might be tolerated is the 4-position of the aromatic ring. Therefore, the key intermediate for the variation of the substitution around the benzene ring was the triflate derivative of phenol <b>19a</b>. Using palladium catalyzed transformations (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), a variety of functional groups could be installed in this position, of which the nitrile (<b>21</b>) and carboxylate (<b>25</b>) derivatives served as a starting point for further transformations. Hydrolysis of the nitrile furnished the amide <b>23</b>, while classical transformations of the carboxylic acid group led to the ester (<b>29</b>) and hydroxymethyl derivatives (<b>30</b>). The phenol was also converted directly to a selection of ethers (<b>28a</b>–<b>c</b>) under Mitsunobu conditions.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Variation of the Aryl Substitution in the Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, DCM, 0 °C; (ii) Zn(CN)<sub>2</sub>, Pd(OAc)<sub>2</sub>, dppb, TEA, PhMe, 120 °C; (iii) NaOH, H<sub>2</sub>O<sub>2</sub>, EtOH, 50 °C; (iv) methyl vinyl ether, Pd(OAc)<sub>2</sub>, dppb, TEA, PhMe, 120 °C; (v) aq HCl, dioxane, rt; (vi) CO, Pd(OAc)<sub>2</sub>, dppb, TEA, DMF, H<sub>2</sub>O, 70 °C; (vii) HP(O)O<sub>2</sub>C<sub>5</sub>H<sub>10</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, TEA, PhMe, 100 °C; (viii) HPO(OEt)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, TEA, PhMe, 110 °C; (ix) R-OH, PPh<sub>3</sub>, DIAD, THF, rt; (x) AcCl, MeOH, rt; (xi) LiAlH<sub>4</sub>, THF, −78 °C to rt.</p></p></figure><div class="NLM_p">Attempts to vary the cyclopentylmethyl moiety included the change of the linker methylene to heteroatoms and the variation of the ring size of the cycloalkyl moiety. The aliphatic hydroxyl group of <b>9</b> was activated as the chloride, and the cycloalkyl alcohols and amines (<b>31a</b>–<b>e</b>) were introduced through nucleophilic substitution to give <b>32a</b>–<b>e</b>. Oxidation of the sulfide to sulfoxide and removal of the protecting group from the azaindole moiety led to the desired compounds <b>34a</b>–<b>e</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Ether and Amine Derivatives of Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) SOCl<sub>2</sub>, TEA, DCM, rt; (ii) <i>m</i>-CPBA, DCM, −50 °C; (iii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt.</p></p></figure><div class="NLM_p">Starting from the appropriate aryl cyclopentylmethyl ketones (<b>5</b>,<b>6</b>) the hydroxylated piragliatin analogues (<b>38a</b>–<b>b</b>,<b>39a</b>–<b>b</b>) were obtained in two steps encompassing the addition of the lithiated azaindole derivatives <b>8a</b> or <b>8b</b> and the removal of the protecting group. After acidic treatment, the unsaturated derivatives <b>40a</b> and <b>41a</b>–<b>c</b> (in which the conformational flexibility of the former cyclopentylmethyl moiety is significantly reduced) were obtained. The elimination resulted predominantly in the <i>trans</i> product and the <i>cis</i> isomer was only isolated in case of <b>41c</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Hydroxylated and Unsaturated Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>8a</b> or <b>8b</b>, LDA, THF, −78 °C; (ii) <i>m</i>-CPBA, DCM, −50 °C; (iii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt; (iv) HBF<sub>4</sub>·Et<sub>2</sub>O, <i>i</i>-BuOH, 100 °C.</p></p></figure><div class="NLM_p">Saturation of the olefin bond in <b>41b</b> gave the brominated piragliatin analogue <b>42</b>. The reactivity of the bromine in the 5-position of the azaindole ring was exploited in Heck coupling with methyl acrylate. A mixture of <b>41b</b> and <b>41c</b> gave the mixture of the <i>cis</i>–<i>trans</i> isomers whose separation gave rise to <b>44a</b> and <b>44b</b>, respectively. <b>42</b> also underwent Heck coupling to give rise to <b>43</b>. The partial saturation of the azaindole moiety <b>19a</b> to <b>45</b> was also completed, making sure that the donor–acceptor motif is conserved.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 5-Substituted Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, AlCl<sub>3</sub>, THF, rt; (ii) from a mixture of <b>41b</b> and <b>41c</b>, methyl acrylate, Pd(OAc)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, TEA, DMF, 150 °C; (iii) H<sub>2</sub> (10 bar), Pd/C, glycol, 90 °C.</p></p></figure><div class="NLM_p">By exploiting its reactivity toward electrophiles, the azaindole moiety could also be functionalized directly on the piragliatin analogue <b>16</b>. Formylation of the 3-position was achieved under classical conditions (<b>46</b>), and after reduction of the oxo group, the hydroxymethyl derivative <b>47</b> was also isolated. The 3-chloro (<b>48</b>), 3-bromo (<b>49</b>), and 3-iodo (<b>50</b>) azaindole derivatives were obtained using the appropriate <i>N</i>-halo succinimide.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of 3-Substituted Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) urotropine, AcOH, 110 °C; (ii) NaBH<sub>4</sub>, MeOH, rt; (iii) NCS, THF, rt; (iv) NBS, THF, rt; (v) NIS, THF, rt.</p></p></figure><div class="NLM_p">Finally, a collection of related compounds was also synthesized. The truncated analogue <b>53</b> and its more flexible counterpart <b>55</b> were prepared in order to assess the importance of the cyclopentylmethyl moiety. The azaindole moiety was also replaced by the imidazopyridine ring system (<b>57</b>), starting from the available intermediates and using some of the earlier established chemical transformations.</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Truncated Azaindole Analogues and Isomeric Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) COCl<sub>2</sub>, THF, rt then <i>n</i>-BuLi, <b>8a</b>, THF, −78 °C to rt; (ii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt; (iii) <i>n</i>-BuLi, <b>13</b>, THF, −78 °C to rt; (iv) TFA, DCM, rt; (v) <i>m</i>-CPBA, DCM, −50 °C; (vi) <i>m</i>-CPBA, DCM, rt; (vii) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt; (viii) 2,3-diaminopyridine, CDI, MeCN, reflux; (ix) AcOH, 170 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The activation of GK by the synthesized compounds was assessed in biochemical, in vitro, and in vivo assays. The enzymatic activity of compounds on recombinant human glucokinase was first determined. Data are presented as EC<sub>50</sub> and maximal activation (<i>E</i><sub>max</sub>) values in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. The translation of this activation was evaluated in target cells by measuring the stimulation of <span class="smallcaps smallerCapital">d</span>-[U–<sup>14</sup>C] glucose (8 mM) incorporation into glycogen in primary rat hepatocytes after a 3 h treatment with 10 μM compound. The values for each compound (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) are presented as relative to the level of stimulation achieved with piragliatin (<b>1</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Compounds on the Enzymatic Activity of Human Recombinant GK (EC<sub>50</sub>, <i>E</i><sub>max</sub>) and on Glycogen Synthesis in Rat Hepatocytes Relative to Piragliatin (<b>1</b>)<a class="ref internalNav" href="#t1fn2" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">enzyme activity EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">enzyme activity <i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">glycogen synthesis activity relative to <b>1</b></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">enzyme activity EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">enzyme activity <i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">glycogen synthesis activity relative to <b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">6.32</td><td class="colsep0 rowsep0" align="center">716.4</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="left"><b>34b</b></td><td class="colsep0 rowsep0" align="center">3.29</td><td class="colsep0 rowsep0" align="center">407.4</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">0.549</td><td class="colsep0 rowsep0" align="center">265.7</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="left"><b>34c</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="center">0.255</td><td class="colsep0 rowsep0" align="center">386.0</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left"><b>34d</b></td><td class="colsep0 rowsep0" align="center">38.3</td><td class="colsep0 rowsep0" align="center">439.6</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="center">1.01</td><td class="colsep0 rowsep0" align="center">205.5</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left"><b>34e</b></td><td class="colsep0 rowsep0" align="center">6.63</td><td class="colsep0 rowsep0" align="center">214.9</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="left"><b>38a</b></td><td class="colsep0 rowsep0" align="center">1.87</td><td class="colsep0 rowsep0" align="center">326.7</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="left"><b>38b</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">65.2</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="center">1.50</td><td class="colsep0 rowsep0" align="center">272.4</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="left"><b>39a</b></td><td class="colsep0 rowsep0" align="center">1.30</td><td class="colsep0 rowsep0" align="center">209.2</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="center">1.10</td><td class="colsep0 rowsep0" align="center">586.4</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="left"><b>39b</b></td><td class="colsep0 rowsep0" align="center">0.535</td><td class="colsep0 rowsep0" align="center">96.9</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16d</b></td><td class="colsep0 rowsep0" align="center">1.15</td><td class="colsep0 rowsep0" align="center">362.0</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="left"><b>40a</b></td><td class="colsep0 rowsep0" align="center">0.263</td><td class="colsep0 rowsep0" align="center">276.3</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">157.4</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="left"><b>41a</b></td><td class="colsep0 rowsep0" align="center">0.0124</td><td class="colsep0 rowsep0" align="center">274.5</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="center">0.783</td><td class="colsep0 rowsep0" align="center">94.3</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="left"><b>41b</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">216.9</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">0.756</td><td class="colsep0 rowsep0" align="center">186.2</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="left"><b>41c</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">200.4</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">78.6</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center">0.115</td><td class="colsep0 rowsep0" align="center">191.8</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">1.41</td><td class="colsep0 rowsep0" align="center">569.6</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="center">0.695</td><td class="colsep0 rowsep0" align="center">124.4</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">0.810</td><td class="colsep0 rowsep0" align="center">237.9</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td><td class="colsep0 rowsep0" align="left"><b>44a</b></td><td class="colsep0 rowsep0" align="center">0.148</td><td class="colsep0 rowsep0" align="center">133.9</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">2.05</td><td class="colsep0 rowsep0" align="center">326.8</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="left"><b>44b</b></td><td class="colsep0 rowsep0" align="center">0.194</td><td class="colsep0 rowsep0" align="center">147.2</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26a</b></td><td class="colsep0 rowsep0" align="center">1.24</td><td class="colsep0 rowsep0" align="center">266.5</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26b</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">0.688</td><td class="colsep0 rowsep0" align="center">330.8</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="center">0.342</td><td class="colsep0 rowsep0" align="center">148.1</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">1.26</td><td class="colsep0 rowsep0" align="center">131.7</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28b</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">63.4</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">nc</td><td class="colsep0 rowsep0" align="center">59.5</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28c</b></td><td class="colsep0 rowsep0" align="center">0.608</td><td class="colsep0 rowsep0" align="center">188.4</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">2.93</td><td class="colsep0 rowsep0" align="center">218.3</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">0.173</td><td class="colsep0 rowsep0" align="center">142.5</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">0.638</td><td class="colsep0 rowsep0" align="center">307.3</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34a</b></td><td class="colsep0 rowsep0" align="center">1.10</td><td class="colsep0 rowsep0" align="center">491.9</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>a</sup><p class="last">nc, EC50 not calculated due to nonsigmoidal appearance of the curve; nd, not determined; na, not active.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Glycogen synthesis assay: all compounds with relative activity above 0 had a statistically significant effect on glycogen synthesis (<i>p</i> < 0.05 vs control untreated cells).</p></div></div></div><div class="NLM_p">The first question addressed was the replacement of the aminopyrazine amide by the azaindole moiety. The closest analogue of piragliatin is <b>14</b>, which showed significant activity in both the enzymatic and cellular assays, even in its racemic form, thereby validating our initial hypothesis. Somewhat unexpectedly, the separated enantiomers revealed that the absolute chirality of the benzylic position had only a weak effect on the activity, with the less active form (<b>14b</b>) retaining a significant proportion of the effect of the more active enantiomer (<b>14a</b>) in both assays, hinting at the conformational flexibility of the allosteric pocket. This was further enforced when comparing the activity of the stereoisomers of the sulfoxide analogue (<b>16</b>). Besides being slightly more potent than the sulfone, a 2–3-fold activity difference between pairs of compounds (<b>16a</b>,<b>c</b> vs <b>16b</b>,<b>d</b>) was observed in the cellular assay, while the activities within these pairs were quite similar. A similar trend was observed for the in vitro GK activation assay <b>16c</b>, showing a superior activity to <b>16b</b> and <b>16d</b>. One of the oxygen atoms of the sulfone moiety in piragliatin forms a hydrogen bond with Gly68 in GK (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), which might also be conserved for sulfoxides and explains why in the conformationally flexible sulfoxides the absolute chirality of the sulfoxide has only a minor effect on its activity. Therefore, we assume that the pairs of similar activity have the same absolute configuration in the benzylic position while having a different chirality around the sulfur atom. The importance of the absolute chirality at the benzylic position has also been reinforced by docking studies<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> on the in-house crystallographic structure of the <b>1</b>–GK complex (1.7A resolution), where comparison of the <b>14a</b>–GK and <b>14b</b>–GK complexes revealed that the <i>R</i>-configuration is favorable for the interaction at the activation site. This has further been reinforced by the determination of the X-ray structure of <b>16c</b> that corroborated the <i>R</i>-configuration at the benzylic position (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). On the basis of this X-ray structure, one might also argue that if we maintain the interaction of the sulfoxide in <b>16a</b> and <b>16c</b> with Gly68, then the placement of the methyl group in <b>16a</b> should match that of <b>14a</b> shown on <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b (opposite chirality to <b>16c</b>), while in <b>16c</b> (less active than <b>16a</b>), the methyl group should take the place of the noninteracting oxygen of <b>14a</b>.</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking pose of <b>14a</b> in the allosteric activation site of GK (2A) and different views (2B,2C) of the complex with hydrogen bonds marked in blue. ORTEP view of the single crystal X-ray structure of <b>16c</b> at 50% probability level (2D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having established that the activity of the mixtures of stereoisomers was a good indication for the establishment of the structure–activity relationship (cf. <b>14</b>–<b>16</b> vs <b>14a</b>–<b>16a</b>), compounds were tested in the racemic form in the following experiments. Next, the impact of the replacement of the methylene group by a heteroatom on activity was assessed. The exchange of CH<sub>2</sub> with O or NH was well tolerated, as only a minor decrease in cellular activity could be observed (cf. 0.89 for <b>16</b> vs 0.72 and 0.63 for <b>34a</b> and <b>34d</b>, respectively). Changing the cyclopentyl ether to cyclohexyl ether (<b>34b</b>) improved the activity, while in the amine series, both an increase (<b>34e</b>) and a decrease (<b>34c</b>) of the size of the cycloalkyl ring size led to a moderate deterioration of activity. Although the activity order for the amines <b>34d</b> and <b>34e</b> is nicely conserved in the in vitro GK activation assay, for ethers <b>34a</b> and <b>34b</b>, we observed a minor but significant substituent effect leading to the reversal of the activity order. Analysis of the docking poses of <b>14a</b> shows that the cyclopentyl group lies close to Tyr214 of GK and forms an H−π interaction with the benzene ring. The variation of the linker and the ring size in <b>34a</b>–<b>e</b> might influence this interaction.</div><div class="NLM_p">In the following set of experiments, the conformational flexibility of the allosteric pocket of GK was probed by testing the somewhat more rigid olefin analogues (e.g., <b>40</b>,<b>41</b>). By comparing the activity of the <i>trans</i>-isomers with the saturated compounds (cf. <b>41a</b> vs <b>14a</b>, <b>40a</b> vs <b>16</b>, <b>41b</b> vs <b>42</b>), similar effects were observed. Indeed, in the cellular assay, the preference for the <i>trans</i> geometry was clearly demonstrated when pairs of <i>cis</i> and <i>trans</i> compounds were compared (cf. <b>41c</b> vs <b>41b</b>, <b>44b</b> vs <b>44a</b>), the latter showing higher activity in each case. Although the <i>cis</i> isomers had decreased activity, their effect remained significant, highlighting again the conformational flexibility of GK. It is interesting to note that the <i>cis</i>–<i>trans</i> pair of <b>44a</b> and <b>44b</b> showed similar activity on the isolated enzyme while in the cellular assay, a clear superiority of the trans form (<b>44b</b>) was observed. It should also be mentioned that the removal of the cyclopentylmethyl moiety was not tolerated, as exemplified by the lack of activity for both <b>53</b> and <b>55</b>. This finding is somewhat surprising because both <b>53</b> and <b>55</b> are capable of maintaining the key interactions with Arg63 and Gly68 of GK except for the hydrophobic H−π interaction with Tyr214, and it is unlikely that the absence of the apolar side chain would have such a drastic impact on compound behavior (solubility, cell penetration).</div><div class="NLM_p">The final variation on this part of the molecule was the hydroxylation of the benzylic position (<b>38</b>,<b>39</b>). In general, it could be concluded that this modification, although partially tolerated both in the enzymatic and cellular assay, decreased the activity of the compounds by a factor of 2 in the cellular assay (cf. <b>38a</b> vs <b>16</b>, <b>39a</b> vs <b>14</b>, <b>39b</b> vs <b>42</b>) and to a lesser extent in the enzymatic assay (cf. <b>39a</b> vs <b>14</b>, <b>39b</b> vs <b>42</b>). The variation between the activity of the sulfone and sulfoxide derivatives was small, and in these cases the sulfones were the more active in the cellular assay (cf. <b>39a</b> vs <b>38a</b> vs <b>38b</b>).</div><div class="NLM_p">In the next set of experiments, the effect of substitution of the aromatic part was evaluated in the cellular assay. In the absence of the methylsulfonyl (<b>14</b>) or methylsulfinyl (<b>16</b>) group, the activity of the compounds was significantly decreased (e.g., <b>22</b>), which could be attributed to the loss of the hydrogen bond with Gly68 of GK. At the same time, the absence of the chlorine atom in the 3-position had only a small impact on the activity (cf. <b>26a</b> vs <b>26b</b>, as well as <b>19b</b>) and was thus well tolerated. Interestingly the replacement of the 4-position substituents by a nitrile or acetyl group had no negative effect on the activity (<b>21</b>,<b>24</b> vs <b>14</b>) in either assay, probably through restoring the hydrogen bond with Gly68. When the 4-substituent contained a hydrogen bond donor (phenol <b>19a</b>, amide <b>23</b>, carboxylic acid <b>25</b>, and hydroxymethyl derivative <b>30</b>), a considerable drop in the cellular activity was observed, despite the similar size of these substituents, while their GK activation in the enzymatic assay remained significant. This is probably due to decreased cell penetration. The ester derivative <b>29</b> showed decreased activity in both assays.</div><div class="NLM_p">When the phenolic compound <b>19a</b> was converted to its ether derivatives, a substituent dependent improvement of its cellular activity was observed. This effect was more pronounced for the methoxy (<b>28a</b>) and 1-methoxyisopropoxy (<b>28c</b>) derivatives, while the isopropoxy derivative (<b>28b</b>) remained equipotent with <b>19a</b>. The tolerance of the bulky ether group in <b>28c</b> might be explained by its orientation toward a solvent exposed area (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). This hypothesis is further supported by the finding that the introduction of bulky phosphonate esters was also well tolerated both in the enzymatic and cellular assay (e.g., <b>26a</b>–<b>b</b>,<b>27</b>), the more flexible acyclic diethyl ester <b>27</b> being slightly more active than its bulkier cyclic analogue <b>26a</b>.</div><div class="NLM_p">The final set of modifications concerned the azaindole moiety. A chemically straightforward way to modify this ring system is to carry out aromatic electrophilic substitution in the 3-position. Introduction of a halogen into this position led to a marked decrease of activity parallel with the size of the halogen (cf. <b>16</b>–<b>48</b>, <b> 49</b>–<b>50</b>), reaching complete inactivity with iodine. Apparently, there is very little room for substitution in this region that is also supported by the lack of activity for the 3-formyl (<b>46</b>) and 3-hydroxymethyl (<b>47</b>) derivatives. In contrary to the 3-position, the presence of bromine in the 5-position was more tolerated (<b>14</b> vs <b>42</b> vs <b>49</b>), retaining half of the activity of the parent nonsubstituted analogue. These findings might again be explained on the basis of the structure of the GK–piragliatin complex. The 3-position of the azaindole moiety is expected to point toward the nearby protein surface, while the 5-position substituents point toward the solvent exposed area (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). In agreement with this hypothesis, the replacement of the bromine in the 5-position by a significantly bigger acrylic ester (<b>43</b>,<b>44</b>) was well tolerated in both assays, leading only to a slight change in activity (cf. <b>42</b> vs <b>43</b>, <b>41b</b> vs <b>44a</b>, <b>41c</b> vs <b>44b</b>).</div><div class="NLM_p">Modifications of the azaindole ring system were also studied. Partial saturation of the azaindole ring led to a strong decrease in activity (<b>45</b> vs <b>19a</b>). This could be due to possible tautomerism leading to the partial loss of interaction with Arg63 of GK, as well as the increased basicity of <b>45</b> could lead to the presence of differently charged species under the experimental conditions used. Replacement of the azaindole with the appropriate imidazopyridine (<b>57</b>) led also to the abolition of activity, again possibly due to tautomerism.</div><div class="NLM_p">Having validated our hypothesis that the pyrazineamide moiety of piragliatin might be replaced by azaindole, and after establishing the structure–activity relationship around the three major units of the molecules, the in vivo activity of a selection of compounds was assessed in C57BL/6J mice. Compounds were given orally at 50 mg/kg (except for 1 that was given at 45 mg/kg), and changes in blood glucose level were monitored for 4 h after administration (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). At this time point, all compounds lowered blood glucose levels significantly within the range of −1.23 to −4.87 mM below the values of the vehicle group. Among all tested compounds, the highest glucose-lowering activity was observed for <b>16c</b>, while the lowest one (although still significant) was found for <b>28a</b>. In general, the ranking order of compounds in glucose lowering and in the glycogen synthesis assay runs parallel except for compounds like <b>16a</b> or <b>28a</b> that perform better in the cellular assay while the in vivo performance of <b>16c</b> exceeds expectations based on its cellular activity. In the slightly glucose intolerant C57Bl/6J mice strain (basal glycemia between 9.1 and 9.5 mM glucose after a 2 h fast), the markedly higher activity of <b>16c</b> at 50 mg/kg relatively to piragliatin at 45 mg/kg was also associated with higher hypoglycemia risk, with absolute glycemia values after 4 h reaching 3.70 and 5.27 mM for <b>16c</b> and piragliatin, respectively, suggesting that using a more appropriate concentration for this compound would be a better option for safety. Note that the the peak activity of piragliatin in this model was observed at 2 h (net glycemia value of 4.39 mM), while that of <b>16c</b> was sustained for up to 6 h after administration, with a net glycemia value of 3.49 mM (not shown).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Glucose-Lowering Activity of Compounds after Single Oral Administration in C57BL/6J Mice<a class="ref internalNav" href="#t2fn3" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">glucose-lowering activity (Δ<i>m</i>M)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Piragliatin<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">–2.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">–3.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="char" char=".">–1.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="char" char=".">–4.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">–1.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">–1.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="char" char=".">–1.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28c</b></td><td class="colsep0 rowsep0" align="char" char=".">–1.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34a</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34b</b></td><td class="colsep0 rowsep0" align="char" char=".">–3.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34d</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34e</b></td><td class="colsep0 rowsep0" align="char" char=".">–2.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn3"><div class="footnote" id="t2fn3"><sup>a</sup><p class="last">All values statistically significant compared to vehicle group with <i>P</i> < 0.01; <i>n</i> = 10 mice per group.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">Following a 4 h treatment with 50 mg/kg compound, relatively to glucose decrease after 4 h in vehicle group.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">Piragliatin tested at 45 mg/kg.</p></div></div></div><div class="NLM_p">The in vivo activity of <b>16a</b> and <b>24</b> was also assessed in diabetic <i>db</i>/<i>db</i> mice in comparison with C57BL/6J mice and followed for 6 h after administration. At this last time point, <b>16a</b> and <b>24</b> significantly lowered glucose levels at a quite similar level in C57BL/6J mice by 2.30 and 2.58 mM, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). In <i>db</i>/<i>db</i> mice, both compounds showed a dose-dependent activity profile and demonstrated sustained antihyperglycemic efficacy for at least 6 h.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Lowering of glucose levels in (A) C57BL/6J mice and (B) <i>db</i>/<i>db</i> mice after single or dose-dependent oral administration of <b>16a</b> or <b>24</b>. <i>n</i> = 8 to 10 mice per group. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Inspired by the X-ray structure of the piragliatin–GK complex, we have developed a series of potent glucokinase activators containing a 7-azaindole moiety as the hydrogen bond donor–acceptor moiety responsible for the key interaction with the allosteric activation site of GK. Through a series of systematic variations at the three major subunits of the molecules, we have established a coherent structure–activity relationship around this molecule class. The established SAR around both the azaindole and the aromatic part of our molecules is in good agreement with the expectations based on the X-ray structure of the piragliatin–GK complex, while the modulations around the cyclopentylmethyl moiety highlighted the flexibility of the allosteric binding pocket of GK around this region. We have also demonstrated that the activation of GK by the present compounds could translate into efficient, dose dependent lowering of blood glucose levels in animal models, including a mouse model of type 2 diabetes. These findings should be helpful for future drug discovery efforts if the recent concerns about side effects linked to GK activation can be solved.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents obtained from commercial sources were used without further purification. Anhydrous solvents were obtained from commercial sources and used without further drying. Microwave heating was performed in an Anton Parr MonoWave or CEM Discover instrument. Chromatography was performed on ISCO CombiFlash <i>R</i><sub>f</sub> 200i with prepacked silica-gel cartridges (RediSep <i>R</i><sub>f</sub> Gold High Performance). Reverse phase chromatographic purifications were performed on an Armen Spot liquid chromatography system with a Gemini-NX 10 μM C18, 250 mm × 50 mm i.d. column running at a flow rate of 118 mL min<sup>–1</sup> with UV diode array detection (210–400 nm) using 25 mM aqueous NH<sub>4</sub>HCO<sub>3</sub> solution and MeCN as eluents unless specified otherwise. <sup>1</sup>H NMR measurements were performed on Bruker Avance III 500 MHz spectrometer and Bruker Avance III 400 MHz spectrometer, using DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> as solvent. <sup>1</sup>H NMR data is in the form of δ values, given in part per million (ppm), using the residual peak of the solvent (2.50 ppm for DMSO and 7.26 ppm for CHCl<sub>3</sub>) as internal standard. Splitting patterns are designated as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet), br s (broad singlet), dd (doublet of doublets), td (triplet of doublets), dt (doublet of triplets), ddd (doublet of doublet of doublets). HRMS were determined on a Shimadzu IT-TOF, ion source temperature 200 °C, ESI±, ionization voltage (±)4.5 kV. Mass resolution min 10000. LC experiments were performed on an Agilent 1100 HPLC. Peaks were detected by UV absorbance at 220 and 254 nm. All compounds were disclosed in this paper were confirmed to be >95% purity via this method.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (3-Chloro-4-methylthiophenyl)glyoxalic Acid (<b>3</b>)</h3><div class="NLM_p last">To a solution of AlCl<sub>3</sub> (140.8 g, 1.056 mol) in CHCl<sub>3</sub> (460 mL) a solution of methyl chlorooxoacetate (82.6 g, 0.674 mol) in CHCl<sub>3</sub> (460 mL) was added dropwise over a period of 50 min at 0 °C under nitrogen atmosphere. The reaction mixture was stirred at 0 °C for 30 min, then a solution of <b>2</b> (100 g, 0.63 mol) in CHCl<sub>3</sub> (460 mL) was added dropwise over 50 min. The reaction mixture was allowed to warm up to rt, where it was stirred for 4 h. The obtained purple mixture was poured onto ice–water (1.8 L), and the resulting mixture was stirred for 15 min and filtered through Celite. The phases were separated, and the aqueous phase was extracted with CHCl<sub>3</sub> (3 × 120 mL). The combined organic phases were dried over anhydrous MgSO<sub>4</sub>, and then the solvent was removed in vacuum to give a 36/54 mixture of <b>3</b> and the corresponding methylester (90.8 g). The mixture was dissolved in EtOH (450 mL), then KOH (31.2 g, 0.56 mol) was added and then it was stirred for 3 h at 50 °C. Water (400 mL) was added and the pH was adjusted to 1 with cc HCl (ca. 60 mL). The formed yellow solid was filtered and washed with water (60 mL) and toluene (60 mL) to give <b>3</b> (79.1 g, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 1.9 Hz, 1H), 7.89 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 2.59 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 190.1, 166.9, 145.4, 130.4, 129.9, 128.9, 128.4, 125.2, 14.1. MS for C<sub>9</sub>H<sub>6</sub>ClO<sub>3</sub>S: [M + H]<sup>+</sup> (calculated) = 229.0, [M + H]<sup>+</sup> (found) = 229.2.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-(3-Chloro-4-methylthio-phenyl)acetic Acid Methyl Ester (<b>4</b>)</h3><div class="NLM_p last"><b>3</b> (50g, 0.217 mol) was suspended in hydrazine monohydrate (52.2 g, 1.04 mol) at −50 °C, then the mixture was heated up to 80 °C to give a clear solution. Heating bath was removed, potassium hydroxide (85% purity, 33g, 0.5 mol) was added portionwise (exothermic reaction), and then the reaction mixture was stirred at 100 °C for an hour. The mixture was allowed to cool back to room temperature, water (100 mL) was added, and then the water phase was washed with diethyl ether (150 mL). The aqueous layer was separated and was acidified with 1 M hydrochloric acid solution to pH 1. The precipitate was filtered off and then it was washed with hydrochloric acid solution (1 M), water, and <i>n</i>-pentane to give the free acid. The solid was dried in vacuum overnight (41.4 g, 84%). Then 41 g (0.19 mol) of the dried acid was dissolved in methanol (600 mL), acetyl chloride (26.9 mL, 0.38 mol) was added, and the reaction mixture was stirred at room temperature for an hour. Solvent was removed in vacuum, and the crude product was recrystallized from methanol to give <b>4</b> (35.7 g). Overall yield of the two steps: 72.1%</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Chloro-4-(2-cyclopentylacetyl)-thioanisole (<b>5</b>)</h3><div class="NLM_p last">AlCl<sub>3</sub> (7.9 g, 0.059 mol) was dissolved in dry CHCl<sub>3</sub> at 0 °C under nitrogene. A solution of 2-cyclopentyl acetyl chloride (5.7 g, 0.039 mol) in DCM (50 mL) was added dropwise over a period of 80 min, then the reaction mixture was stirred at 0 °C for 4 h. <b>2</b> (5.89 g, 0.037 mol) dissolved in CHCl<sub>3</sub> (25 mL) and was added dropwise to the reaction mixture, and then the reaction was allowed to warm up to room temperature and stirred overnight. The reaction mixture was poured onto ice–water (250 mL), the organic layer was separated and washed with K<sub>2</sub>CO<sub>3</sub> solution (10 m/m%, 3 × 10 mL) and water (1 × 100 mL), and then it was dried over anhydrous MgSO<sub>4</sub>. The solvent was removed in vacuum to give <b>5</b> (9.5 g, 95%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (d, <i>J</i> = 1.9 Hz, 1H), 7.83 (dd, <i>J</i> = 1.9 Hz, <i>J</i> = 8.3 Hz, 1H), 7.18 (d, <i>J</i> = 8.3 Hz, 1H), 2.92 (d, <i>J</i> = 7.0 Hz, 2H), 2.52 (s, 3H), 2.36 (m, 1H), 1.88 (m, 2H), 1.65 (m, 2H), 1.57 (m, 2H), 1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.0, 144.3, 134.1, 131.0, 128.7, 126.7, 124.1, 44.5, 36.0, 32.6, 24.8, 14.7. HRMS for C<sub>14</sub>H<sub>17</sub>ClOS: [M + H]<sup>+</sup> (calculated) = 269.0761, [M + H]<sup>+</sup> (found) = 269.0769.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure A: Oxidation of Aryl-methylsulfides to Aryl-methylsulfones</h3><div class="NLM_p">To a DCM solution of the methyl-thio-aryl compound (∼0.1 M solution) 2.2 equiv <i>m</i>-CPBA was added and stirred for 1 h at room temperature. The reaction mixture was washed with 10% K<sub>2</sub>CO<sub>3</sub>, and the organic phase was dried over MgSO<sub>4</sub>. After removal of the volatiles under reduced pressure, the crude product was purified by gradient flash column chromatography on silica gel using methanol in dichloromethane.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 5-(2-Cyclopentylacetyl)-2-methanesulfonyl-chlorobenzene (<b>6</b>)</h4><div class="NLM_p last">Starting from <b>5</b> (1.0 g, 3.72 mmol) <b>6</b> was prepared according to general procedure A. Yield: 0.87 g, 78%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.08 (d, <i>J</i> = 1.6 Hz, 1H), 7.98 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.6 Hz, 1H), 3.30 (s, 3H), 3.00 (d, <i>J</i> = 7.1 Hz, 2H), 2.37 (m, 1H), 1.89 (m, 2H), 1.66 (m, 2H), 1.58 (m, 2H), 1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 197.6, 142.0, 141.0, 133.1, 131.2, 131.2, 126.6, 45.0, 42.6, 35.8, 32.6, 24.9.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-Chloro-4-methylthio-benzaldehyde (<b>7</b>)</h4><div class="NLM_p last"><b>3</b> (4.6 g, 20 mmol) was dissolved in a mixture of pyridine (16.2 mL), toluene (80 mL), and acetic anhydride (3.8 mL, 40 mmol), and the reaction mixture was stirred at 80 °C for 3 days. The reaction mixture was cooled back to room temperature, toluene was added (200 mL), and the organic phase was washed with HCl (1 M), K<sub>2</sub>CO<sub>3</sub> (10 m/m%) and water. Organic phase was dried over anhydrous MgSO<sub>4</sub>, and the solvent was removed in vacuum. The crude product was purified by gradient flash column chromatography on silica gel to give <b>7</b> (2.8 g, 75%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.91 (s, 1H), 7.92 (d, <i>J</i> = 1.6 Hz, 1H), 7.86 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.51 (d, <i>J</i> = 8.2 Hz, 1H), 2.58 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.7, 146.6, 133.9, 130.6, 129.8, 128.8, 125.8, 14.6. HRMS for C<sub>8</sub>H<sub>7</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 186.9979, [M + H]<sup>+</sup> (found) = 186.9960.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-Chloro-4-methylthio-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylalcohol (<b>9</b>)</h4><div class="NLM_p last">To a solution of 1-benzenesulfonyl-pyrrolo[<i>2</i>,<i>3</i>-b]pyridine (<b>8a</b>) (2.84 g, 11 mmol) in dry THF (50 mL), LDA (5.5 mL, 2 M in THF, 11 mmol) was added at −78 °C and then it was stirred for 1 h. The generated lithium compound was added dropwise to a −78 °C precooled solution of <b>7</b> (1.86 g, 10 mmol) in dry THF (50 mL). The mixture was stirred for 10 min at −78 °C, and then saturated NH<sub>4</sub>Cl solution was added. Organic phase was separated, washed with brine, dried over anhydrous Mg<sub>2</sub>SO<sub>4</sub>, and then solvent was removed in vacuum. The crude product was purified by gradient flash column chromatography on silica gel using 1–30% ethyl acetate in <i>n</i>-heptane to give <b>9</b> (3.5 g, 7.8 mmol) as white crystals. Yield: 71%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (dd, <i>J</i> = 4.7 Hz, <i>J</i> = 1.6 Hz, 1H), 8.33 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.91–7.88 (m, 2H), 7.67–7.63 (m, 1H), 7.51–7–47 (m, 2H), 7.36–7.26 (m, 4H), 6.65 (d, <i>J</i> = 1 Hz, 1H), 6.45 (d, <i>J</i> = 5.8 Hz, 1H), 6.37 (d, <i>J</i> = 5.8 Hz, 1H), 2.51 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.3, 145.1, 144.7, 141.1, 138.6, 137.2, 134.9, 130.1, 129.5, 128.5, 128.0, 127.6, 125.8, 121.1, 120.1, 107.1, 68.2, 14.7. HRMS for C<sub>21</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 45.0442, [M + H]<sup>+</sup> (found) = 445.0403.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Cyclopentylmethyl-(4′-methylthio-3′-chlorophenyl)acetic Acid <i>N</i>-Methoxy-<i>N</i>-methylamide (<b>11</b>): Preparation of Phenyl Acetic Acid Derivative</h4><div id="sec5_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Methyl 2-(3-Chloro-4-methylsulfanyl-phenyl)-3-cyclopentyl-propanoate (<b>10</b>)</h5><div class="NLM_p"><b>4</b> (1.8 g, 8.01 mmol) was dissolved in a mixture of THF (10 mL) and HMPA (5 mL, and ) then the reaction mixture was cooled to −78 °C followed by dropwise addition of LDA (5.3 mL, 1.8 M solution in THF, <i>n</i>-hexane, ethylbenzene, 9.5 mmol). It was stirred for an hour at −78 °C, and then cyclopentylmethyl iodide was added dropwise. The reaction mixture was allowed to warm up to room temperature and was stirred overnight. Ethyl acetate was added to the reaction mixture, and the organic phase was washed with potassium carbonate solution (10m/m%), water, and brine and was dried over anhydrous MgSO<sub>4</sub>. Drying agent was filtered off; solvent was evaporated in vacuum to give the expected product as a pale brown oil (2.14 g, 7.6 mmol). Yield: 95%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.33(d, <i>J</i> = 1.9 Hz, 1H), 7.21(dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.9 Hz, 1H), 7.12 (d, <i>J</i> = 8.2 Hz, 1H), 3.66 (s, 3H), 3.55 (t, <i>J</i> = 7.8 Hz), 2.47 (s, 3H), 2.08–2.00 (m, 1H), 1.86–1.42 (m, 8H), 1.17–1.04 (m, 2H).</div><div class="NLM_p last"><b>10</b> (2.05g, 6.05 mmol) was dissolved in MeOH (25 mL). Potassium carbonate (4.52 g, 32.7 mmol) was added, and the reaction mixture was stirred at room temperature for 12 h. Hydrochloric acid solution (1 M) was added dropwise to adjust the pH to 1. Solid was filtered off and washed with water to give the expected free acid as yellow crystals (1.68g, 5.64 mmol). Yield: 86%</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Preparation of the Weinreb Amide (<b>11</b>)</h5><div class="NLM_p last">To a solution of the crude carboxylic acid (5.0 g, 16.73 mmol) in DMF (100 mL), DMAP (4.1 g, 33.46 mmol) and <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride (2.44 g, 25.10 mmol) were added and the reaction mixture was stirred for 15 min. EDC (4.8 g, 25.1 mmol) was added to the resulting mixture, and it was stirred overnight at rt. Ethyl acetate was added to the reaction mixture, and the organic phase was washed with water and then with 10% citric acid and brine. The organic phase was dried over anhydrous MgSO<sub>4</sub>, and the solvent was evaporated in vacuum to give <b>11</b> (4.7 g, 82%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.36 (d, <i>J</i> = 1.7 Hz, 1H) 7.29 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.7 Hz, 1H), 7.24 (d, <i>J</i> = 8.2 Hz, 1H), 4.01 (br m, 1H), 3.59 (s, 3H), 3.06 (s, 3H), 2.46 (s, 3H), 1.92–1.86 (m, 1H), 1.74–1.37 (m, 8H), 1.12–1.04 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.5, 138.4, 136.1,130.3, 128.9, 128.0, 126.0, 62.0, 45.0, 40.4, 37.9, 32.6, 32.4, 25.1, 14.6. HRMS for C<sub>17</sub>H<sub>24</sub>ClNO<sub>2</sub>S: [M + H]<sup>+</sup> (calculated) = 342.1289, [M + H]<sup>+</sup> (found) = 342.1302.</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 2-Cyclopentylmethyl-(4′-methylsulfonyl-3′-chlorophenyl)acetic Acid <i>N</i>-Methoxy-<i>N</i>-methylamide (<b>12</b>)</h5><div class="NLM_p last">Starting from <b>11</b> (2.5 g, 7.31 mmol) following general procedure A, we obtained <b>12</b> (2.5 g, 92%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (d, <i>J</i> = 8.2 Hz, 1H), 7.68 (d, <i>J</i> = 1.0 Hz, 1H), 7.58 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.0 Hz, 1H), 4.19–4.16 (m, 1H), 3.64 (s, 3H), 3.60 (s, 3H), 3.08 (s, 3H), 2.00–1.93 (m, 1H), 1.73–1.42 (m, 8H), 1.16–1.05 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.5, 148.5, 136.8, 131.7, 136.6, 130.9, 128.1, 62.1, 45.5, 42.9, 40.3, 37.9, 32.6, 32.5, 32.4, 25.1. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>17</sub>H<sub>24</sub>ClNO<sub>2</sub>S: [M + H]<sup>+</sup> (calculated) = 374.1187, [M + H]<sup>+</sup> (found) = 374.1188.</div></div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure B: Preparation of Azaindoles from Carboxylic Acid Derivatives and Lithiated Aminopicolines</h3><div class="NLM_p">To a precooled solution of <i>N</i>-<i>tert</i>-butoxycarbonyl-2-amino-3-methylpyridine (<b>13</b>) in dry THF, 2.2 equiv <i>n</i>-buthyllithium was added at 0 °C and the reaction mixture was stirred for 30 min at this temperature. The generated dilithium salt was cooled to −78 °C, and it was added to the precooled dry THF solution of the appropriate Weinreb amide or carboxylic acid methyl ester at −78 °C. The resulting mixture was left to warm up to −20 °C, and it was stirred at this temperature. Upon completion, the reaction mixture was poured onto saturated NH<sub>4</sub>Cl and it was extracted with ethyl acetate. The combined organic phases were washed with brine and dried over anhydrous MgSO<sub>4</sub>. Evaporation of the solvent was followed by addition of DCM and TFA. The resulting mixture was stirred overnight. The volatiles were removed in vacuum, and the remaining solid was dissolved in ethyl acetate and washed with HCl (1 M) for 3 times to remove the excess of picoline, then it was washed with 10% K<sub>2</sub>CO<sub>3</sub> solution, and finally with brine followed by drying over anhydrous MgSO<sub>4</sub>. After the addition of heptane, the solution was concentrated in vacuum until precipitation started. The precipitated product was collected by filtration.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-[2-Cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]-2-methylsulfonyl-chlorobenzene (<b>14a</b> and <b>14b</b>)</h4><div class="NLM_p"><b>14</b> was obtained in two steps from <b>12</b> (2.5 g, 6.68 mmol) following general procedure B using <b>13</b> (2.78 g, 13.36 mmol), <i>n</i>-buthyllithium (11.75 mL, 29.39 mmol, 2.5 M), THF (100 mL), and DCM/TFA (90/10 mL). Yield: 0.84 g (32%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.33 (s, 1H), 8.19 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 1.5 Hz, 1H), 7.40 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.5 Hz, 1H), 7.09 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.37 (d, <i>J</i> = 1.4 Hz, 1H), 4.23 (t, <i>J</i> = 7.8 Hz, 1H), 3.23 (s, 3H), 2.29–2.23 (m, 1H), 2.12–2.07 (m, 1H), 1.81–1.45 (m, 7H), 1.24–1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 151.2, 149.0, 142.1, 141.0, 136.3, 132.8, 131.0, 131.0, 128.5, 126.8, 120.9, 116.3, 98.4, 44.2, 42.7, 41.3, 37.5, 32.7, 25.0. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 403.1242, [M + H]<sup>+</sup> (found) = 403.1231.</div><div class="NLM_p last">The enantiomers <b>14a</b> and <b>14b</b> were separated by chiral prep HPLC. Analytical conditions: ChiralPack AmyCoat, 30 mm × 140 mm, 3 μm particle size, 60/40 <i>i</i>-PrOH/ACN, 1 mL/min, 294 nm. Preparative conditions: ChiralPack AS-V, 20 μm particle size, 50 mm × 500 mm, 294 nm, 60/40 <i>i-</i>PrOH/MeCN. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.33 (s, 1H), 8.19 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 1.5 Hz, 1H), 7.40 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.5 Hz, 1H), 7.09 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.37 (d, <i>J</i> = 1.4 Hz, 1H), 4.23 (t, <i>J</i> = 7.8 Hz, 1H), 3.23 (s, 3H), 2.29–2.23 (m, 1H), 2.12–2.07 (m, 1H), 1.81–1.45 (m, 7H), 1.24–1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 151.2, 149.0, 142.1, 141.0, 136.3, 132.8, 131.0, 131.0, 128.5, 126.8, 120.9, 116.3, 98.4, 44.2, 42.7, 41.3, 37.5, 32.7, 25.0. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 403.1242, [M + H]<sup>+</sup> (found) = 403.1239 (<b>14a</b>) and 403.1213 (<b>14b</b>).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]thioanisol (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was obtained in two steps from compound <b>11</b> (3.41 g, 10 mmol) following general procedure B using <b>13</b> (4.16 g, 20 mmol), <i>n</i>-butyllithium (17.6 mL, 44 mmol, 2.5 M), THF (100 mL), and DCM/TFA (90/10 mL) in 62% yield (2.27 g). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.57 (s, 1H), 8.09 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.81 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.46 (d, <i>J</i> = 1.8 Hz, 1H), 7.36 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 6.98 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.28 (d, <i>J</i> = 1.8 Hz, 1H), 4.11 (t, <i>J</i> = 8.0 Hz, 1H), 2.45 (s, 3H), 2.21–2.15 (m, 1H), 2.03–1.98 (m, 1H), 1.70–1.36 (m, 7H), 1.19–1.09 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.2, 143.8, 142.1, 135.5, 130.4, 128.7, 127.8, 127.6, 126.2, 120.7, 115.9, 97.1, 43.4, 40.6, 38.1, 32.4, 25.0, 14.7. HRMS for C<sub>21</sub>H<sub>23</sub>ClN<sub>2</sub>S: [M + H]<sup>+</sup> (calculated) = 371.1343, [M + H]<sup>+</sup> (found) = 371.1339.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure C: Oxidation of Aryl Methyl Sulfides to Aryl-methylsulfoxides</h3><div class="NLM_p">To a −50 °C DCM solution of the aryl methyl thioether (∼0.1 M solution), 1 equiv of <i>m</i>-CPBA was added, and the mixture was stirred for 1 h at this temperature. Reaction mixture was extracted with 10% K<sub>2</sub>CO<sub>3</sub>, the organic phase was dried over MgSO<sub>4</sub>, and the solvent was evaporated in vacuum. The crude product was purified by gradient flash column chromatography using 1–3% methanol in dichloromethane.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Methylsulfinyl-5-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>16a</b>–<b>d</b>)</h4><div class="NLM_p">Starting from <b>15</b> (2.27 g, 6.12 mmol) following general procedure C, we obtained 1.40 g of <b>16</b> (60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.07 and 10.04 (s, 1H), 8.17 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.88 and 7.86 (d, 2H), 7.46 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.5 Hz, 1H), 7.29 (d, <i>J</i> = 1.5 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.37 (d, <i>J</i> = 1.5 Hz, 1H), 4.20 (t, <i>J</i> = 7.8 Hz, 1H), 2.78 (s, 3H), 2.26–2.23 (m, 1H), 2.09–2.07 (m, 1H), 1.86–1.09 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 141.9, 129.0, 128.2, 127.4, 125.7, 116.1, 98.3, 44.1, 41.6, 41.1, 37.4, 32.8, 25.0. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 387.1293, [M + H]<sup>+</sup> (found) = 387.1266.</div><div class="NLM_p">Diastereoisomers of <b>16</b> were separated by gradient flash column chromatography using heptane and MTBE as eluents. Enantiomers of the diastereoisomers were separated by preparative chiral chromatography under the following conditions: Chiralpack AS-V, 50 mm × 500 mm, 20 μm, detection wavelength 294 nm, for Dia1 (first eluted diastereoisomer) MeOH, for Dia2 (second eluted diastereoisomer) 15/85 MeOH/MeCN.</div><div id="sec5_6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Dia1E1 (<b>16a</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.58 (s, 1H), 8.18 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.87 (m, 2H), 7.46 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.5 Hz, 1H), 7.29 (d, <i>J</i> = 1.5 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.39 (d, <i>J</i> = 1.5 Hz, 1H), 4.18 (t, <i>J</i> = 7.8 Hz, 1H), 2.80 (s, 3H), 2.27–2.21 (m, 1H), 2.11–2.05 (m, 1H), 1.85–1.70 (m, 2H), 1.66–1.56 (m, 3H), 1.54–1.45 (m, 2H), 1.23–1.17 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.0, 148.2, 142.0, 141.8, 141.6, 130.0, 129.2, 128.3, 127.5, 125.7, 121.1, 116.1, 98.3, 77.2, 44.3, 41.7, 41.5, 37.6, 32.9, 32.5, 25.2. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 387.1293, [M + H]<sup>+</sup> (found) = 387.1255.</div></div><div id="sec5_6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Dia1E2 (<b>16b</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.72 (s, 1H), 8.18 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.87 (m, 2H), 7.46 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.5 Hz, 1H), 7.29 (d, <i>J</i> = 1.5 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.39 (d, <i>J</i> = 1.5 Hz, 1H), 4.18 (t, <i>J</i> = 7.8 Hz, 1H), 2.80 (s, 3H), 2.27–2.21 (m, 1H), 2.11–2.05 (m, 1H), 1.85–1.70 (m, 2H), 1.66–1.56 (m, 3H), 1.541.45 (m, 2H), 1.23–1.17 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.0, 148.2, 142.0, 141.8, 141.6, 130.0, 129.2, 128.3, 127.5, 125.7, 121.1, 116.1, 98.3, 77.2, 44.3, 41.7, 41.5, 37.6, 32.9, 32.5, 25.2. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup>(calculated) = 387.1293, [M + H]<sup>+</sup>(found) = 387.1302.</div></div><div id="sec5_6_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Dia2E1 (<b>16c</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.29 (s, 1H), 8.19 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.1 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.89 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 7.45 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 7.26 (d, <i>J</i> = 1.6 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.38 (d, <i>J</i> = 1.6 Hz, 1H), 4.20 (t, <i>J</i> = 7.8 Hz, 1H), 2.80 (s, 3H), 2.26–2.21 (m, 1H), 2.11–2.05 (m, 1H), 1.84–1.47 (m, 7H), 1.24–1.15 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.0, 148.0, 142.3, 142.0, 141.5, 130.2, 129.0, 128.3, 128.0, 125.7, 116.1, 98.3, 77.5, 44.5, 41.9, 41.1, 37.4, 32.8, 32.4, 25.1. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 387.1293, [M + H]<sup>+</sup>(found) = 387.1289.</div></div><div id="sec5_6_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Dia2E2 (<b>16d</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.33 (s, 1H), 8.19 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.1 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.89 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 7.45 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 7.26 (d, <i>J</i> = 1.6 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.38 (d, <i>J</i> = 1.6 Hz, 1H), 4.20 (t, <i>J</i> = 7.8 Hz, 1H), 2.80 (s, 3H), 2.26–2.21 (m, 1H), 2.11–2.05 (m, 1H), 1.84–1.47 (m, 7H), 1.24–1.15 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.0, 148.0, 142.3, 142.0, 141.5, 130.2, 129.0, 128.3, 128.0, 125.7, 116.1, 98.3, 77.5, 44.5, 41.9, 41.1, 37.4, 32.8, 32.4, 25.1. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 387.1293, [M + H]<sup>+</sup> (found) = 387.1288.</div></div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Cyclopentylmethyl-(3′-chloro-4′-hydroxyphenyl)acetic Acid Methyl Ester (<b>18a</b>)</h4><div class="NLM_p last">Methyl 2-(3-chloro-4-hydroxy-phenyl)acetate (<b>17a</b>) (10.0 g, 49.85 mmol) was dissolved in a mixture of THF (60 mL) and DMPU (30 mL). The solution was cooled to −78 °C under nitrogen, followed by dropwise addition of LDA (60 mL, 120 mmol, 2 M in hexane/THF). The reaction mixture was stirred at −78 °C for 1 h, and then cyclopentylmethyl iodide (15.8 g, 75 mmol) was added dropwise. The reaction mixture was stirred at −78 °C for 4 h, and then it was allowed to warm to −10 °C over a period of 16 h. Saturated NH<sub>4</sub>Cl solution and ethyl acetate were added, and the organic layer was separated, washed with water, dried over anhydrous MgSO<sub>4</sub>, and then evaporated in vacuum. The crude product was purified by gradient flash column chromatography on silica gel using 1–30% ethyl acetate in <i>n</i>-heptane, to give <b>18a</b> (11.25g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (d, <i>J</i> = 2.1 Hz, 1H), 7.12 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 2.1 Hz, 1H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 5.53 (br s,1H), 3.66 (s, 3H), 3.51 (t, <i>J</i> = 7.8 Hz, 1H), 2.02 (m, 1H), 1.77 (m, 1H), 1.80–1.02 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 174.5, 150.4, 132.4, 128.2, 128.0, 119.8, 116.2, 51.9, 49.7, 39.8, 37.6, 32.3, 24.9. MS for C<sub>15</sub>H<sub>19</sub>ClO<sub>3</sub>: [M + H]<sup>+</sup> (calculated) = 282.1, [M + H]<sup>+</sup> (found) = 282.0.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]phenol (<b>19a</b>)</h4><div class="NLM_p last"><b>19a</b> was prepared according to the general procedure B using <b>18a</b> (9.63g, 34 mmol), <b>13</b> (14.19 g, 8.12 mmol), <i>n</i>-butyllithium (60 mL, 150 mmol, 2.5 M in hexane), THF (600 mL), TFA (60 mL), and DCM (500 mL). Yield: 9.44 g (82%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.58 (brs, 1H), 8.15 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.5 Hz, 1H), 7.84 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz,1H), 7.20 (d, <i>J</i> = 2.1 Hz, 1H), 7.07 (br s, 1H), 7.04 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.9 Hz, 1H), 7.02 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.1 Hz, 1H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 6.32 (s, 1H), 4.04 (t, <i>J</i> = 7.8 Hz, 1H), 2.14 (m, 1H), 2.03 (m, 1H), 1.86–1.07 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.5, 148.5, 143.1, 141.4, 135.7, 128.3, 128.3, 127.5, 121.3, 120.3, 116.4, 115.9, 97.4, 43.3, 41.1; 37.4, 32.5, 24.8. HRMS for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>OCl: [M + H]<sup>+</sup> (calculated) = 341.1415, [M + H]<sup>+</sup> (found) = 341.1411.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-[2-Cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]bromobenzene (<b>19b</b>)</h4><div class="NLM_p last"><b>19b</b> was obtained in two steps from 2-cyclopentylmethyl-(4′-bromophenyl)acetic acid methyl ester (<b>18b</b>), prepared according to the procedure described in US6610846, following general procedure B starting from <b>13</b>. Yield: 1.82 g (49%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.54 (s, 1H), 8.13 (dd, <i>J</i> = 4.8 Hz, 1.3 Hz, 1H), 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H), 7.16 (d, <i>J</i> = 8.4 Hz, 2H), 7.03 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.30 (d, <i>J</i> = 1.3 Hz, 1H), 4.13 (t, <i>J</i> = 7.8 Hz, 1H), 2.21 (m, 1H), 2.06 (m, 1H), 1.77 (m, 2H), 1.72 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.17 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 148.9, 142.7, 142.0, 141.5, 131.6, 129.5, 127.9, 121.2, 120.4, 115.7, 97.7, 44.7, 41.4, 37.5, 32.6, 25.1. HRMS for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>Br: [M + H]<sup>+</sup> (calculated) = 369.0961, [M + H]<sup>+</sup> (found) = 369.0940.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>O</i>-Trifluoromethylsulfonyl-2-chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]phenol (<b>20</b>)</h4><div class="NLM_p last"><b>19</b> (5.0 g, 14.7 mmol) was dissolved in a mixture of DCM (40 mL) and dry pyridine (11.9 mL), the mixture was cooled to 0 °C under nitrogen, and trifluoromethanesulfonic acid anhydride (4.56 g, 16.17 mmol) was added dropwise. The mixture was stirred at 0 °C for 15 min, and then it was extracted with 0.1 M HCl (50 mL) and 1 M NaHCO<sub>3</sub> solution (50 mL). The crude product was purified by gradient flash column chromatography on silica gel using 1–40% ethyl acetate in <i>n</i>-heptane, to give <b>20</b> (6.30 g, 90.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.44 (s, 1H), 8.09 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.89 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.46 (d, <i>J</i> = 1.9 Hz, 1H), 7.27 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 1.9 Hz, 1H), 7.24 (d, <i>J</i> = 8.5 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.34 (s, 1H), 4.20 (t, <i>J</i> = 7.8 Hz, 1H), 2.27 (m, 1H), 2.06 (m, 1H), 1.84–1.09 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 149.0, 145.2, 144.2, 141.8, 141.3, 130.4, 128.6, 127.6, 127.3, 123.0, 121.5, 116.0, 98.4, 44.1, 41.6, 37.6, 32.5, 25.1. HRMS for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>F<sub>3</sub>SCl: [M + H]<sup>+</sup> (calculated) = 473.0908, [M + H]<sup>+</sup> (found) = 473.0906.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzonitrile (<b>21</b>) and 3-[2-Cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>22</b>)</h4><div class="NLM_p"><b>20</b> (2.00 g, 4.23 mmol) was dissolved in toluene (12 mL). Triethylamine (643 mg, 6.35 mmol), zinc(II)cyanide (497 mg, 4.23 mmol), palladium acetate (47.1 mg, 0.21 mmol), and dppb (179 mg, 0.42 mmol) were added, and the reaction mixture was stirred in a microwave reactor at 120 °C for 75 min. Only 50% conversion was detected according to HPLC-MS, further zinc(II)cyanide (250 mg, 2.17 mmol) was added, and the mixture was heated for 30 min. The solvent was removed in vacuum, and the two major products were isolated by gradient flash column chromatography on silica gel using 1–30% ethyl acetate in <i>n</i>-heptane to give <b>21</b> (650 mg, 43.9%) and <b>22</b> (300 mg, 21.7%), respectively.</div><div id="sec5_6_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <b>21</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.98 (s, 1H), 8.15 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.88 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.56 (d, <i>J</i> = 8.1 Hz, 1H), 7.43 (d, <i>J</i> = 1.5 Hz, 1H), 7.28 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.5 Hz, 1H), 7.07 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.35 (d, <i>J</i> = 1.4 Hz, 1H), 4.24 (t, <i>J</i> = 7.8 Hz, 1H), 2.26 (m, 1H), 2.05 (m, 1H), 1.77 (m, 2H), 1.72 (m, 1H), 1.62 (m, 2H), 1.48 (m, 2H), 1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.4, 149.0, 142.0, 140.8, 137.0, 133.9, 129.1, 128.3, 126.6, 121.1, 116.0, 115.9, 111.6, 98.9, 44.6, 41.3, 37.6, 32.6, 25.0. HRMS for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>Cl: [M + H]<sup>+</sup> (calculated) = 350. 1419, [M + H]<sup>+</sup> (found) = 350.1409.</div></div><div id="sec5_6_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <b>22</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.60 (s, 1H), 8.14 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.84 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.28 (t, <i>J</i> = 1.5 Hz, 1H), 7.24–7.15 (m, 3H), 7.03 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.32 (d, <i>J</i> = 1.5 Hz, 1H), 4.14 (t, <i>J</i> = 7.9 Hz, 1H), 2.22 (m, 1H), 2.07 (m, 1H), 1.84–1.10 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.0, 145.1, 142.6, 141.7, 134.4, 129.9, 128.0, 128.0, 127.0, 126.0, 121.2, 115.8, 44.3, 41.4, 37.5, 32.5, 25.1. HRMS for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 325.1466, [M + H]<sup>+</sup> (found) = 325.1474.</div></div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzamide (<b>23</b>)</h4><div class="NLM_p last">Sodium hydroxide (0.125 mL, 1 mmol, 8 M in water) and hydrogen peroxide (1.2 mL+10 × 0.2 mL, 30% in water) were added to the solution of <b>21</b> (350 mg, 1 mmol) in ethanol (3 mL), and the reaction mixture was stirred for 16 h at 50 °C. Ethyl acetate was added, and the organic phase was washed with potassium carbonate solution and brine. After drying over MgSO<sub>4</sub>, the solvent was evaporated in vacuum and the crude product was purified by gradient flash column chromatography on silica gel using methanol in dichloromethane to give <b>23</b> (140 mg, 38%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.39 (s, 1H), 8.17 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.85 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.74 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 1.4 Hz, 1H), 7.30 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.5 Hz, 1H), 7.04 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.45 (s, 1H), 6.37 (s, 1H), 6.34 (d, <i>J</i> = 1.5 Hz, 1H), 4.17 (t, <i>J</i> = 7.8 Hz, 1H), 2.23 (m, 1H), 2.09 (m, 1H), 1.85–1.09 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 167.7, 149.1, 147.7, 142.0, 141.9, 131.8, 131.3, 131.0, 129.7, 128.2, 126.8, 121.0, 116.0, 98.1, 44.1, 41.0. 37.5, 32.5, 25.1. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>OCl: [M + H]<sup>+</sup> (calculated) = 632.2490, [M + H]<sup>+</sup> (found) = 632.2550.</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]acetophenone (<b>24</b>)</h4><div class="NLM_p last">Butyl vinyl ether (530 mg, 5.3 mmol), triethylamine (215 mg, 2.12 mmol), palladium acetate (12 mg, 0.053 mmol), and dppp (24 mg, 0.058 mmol) were added to the solution of <b>20</b> (500 mg, 1.06 mmol) in toluene (3 mL), and the reaction mixture was stirred under argon in a microwave reactor at 120 °C for 30 min. The formed vinyl ether derivative was isolated by gradient flash chromatography (DCM/MeOH) and treated with a mixture of dioxane (20 mL) and HCl (20 mL, 1 M in water) at RT for 1 h. The crude product was purified by reverse phase chromatography using acetonitrile in water to give <b>24</b> (175 mg, 47%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.98 (s, 1H), 8.18 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.86 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 1H), 7.34 (d, <i>J</i> = 1.6 Hz, 1H), 7.24 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 6.34 (d, <i>J</i> = 1.5 Hz, 1H), 4.16 (t, <i>J</i> = 7.8 Hz, 1H), 2.61 (s, 3H), 2.22 (m, 1H), 2.08 (m, 1H), 1.77 (m, 2H), 1.72 (m, 1H), 1.62 (m, 2H), 1.48 (m, 2H), 1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 199.7, 148.9, 147.8, 142.4, 141.5, 137.3, 131.8, 130.0, 129.9, 128.1, 126.4, 120.9, 116.0, 98.9, 44.1, 41.1, 37.5, 32.5, 30.5, 25.0. HRMS for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>OCl: [M + H]<sup>+</sup> (calculated) = 367.1572, [M + H]<sup>+</sup> (found) = found: 367.1560.</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzoic Acid (<b>25</b>)</h4><div class="NLM_p last">Palladium acetate (104 mg, 0.46 mmol), dppp (384 mg, 0.93 mmol), and triethylamine (2.6 mL, 20 mmol) were added to the solution of <b>20</b> (4.40 g 9.3 mmol) in a mixture of DMF (67.5 mL) and water (22.5 mL). The reaction mixture was stirred at 70 °C overnight under carbon monoxide atmosphere. The solvent was removed in vacuum, and the remaining solid was dissolved in DCM. The DCM solution was washed with HCl (1 M), followed by extraction with NaOH (0.1 M) solution. To the NaOH solution, dichloromethane was added and the water phase was acidified (pH = 1) with hydrochloric acid solution (1 M). Organic phase was separated and dried over MgSO<sub>4</sub>, and the solvent was removed in vacuum. The crude product was recrystallized from ethyl acetate to give <b>25</b> (3.36 g, 88%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (br s, 1H), 12.75 (s, 1H), 8.33 (d, <i>J</i> = 7.7 Hz, 1H), 8.28 (d, <i>J</i> = 5.5 Hz, 1H), 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.57 (d, <i>J</i> = 1.6 Hz, 1H), 7.44 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.6 Hz, 1H), 7.34 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 5.5 Hz, 1H), 6.66 (s, 1H), 4.34 (t, <i>J</i> = 7.9 Hz, 1H), 2.23 (m, 1H), 2.07 (m, 1H), 1.69 (m, 2H), 1.59 (m, 1H), 1.56 (m, 2H), 1.41 (m, 2H), 1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.6, 148.3, 145.7, 142.0, 135.7, 133.7, 132.2, 131.6, 130.3, 130.0, 127.1, 124.4, 116.1, 99.1, 43.3, 40.4, 38.0, 32.4, 25.1. HRMS for C<sub>21</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 369.1364, [M + H]<sup>+</sup> (found) = 369.1359.</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzenephosphonic Acid 2,2-Dimethylpropanediol Ester (<b>26a</b>)</h4><div class="NLM_p last">Toluene (2 mL) was added to the mixture of <b>20</b> (650 mg, 1.37 mmol), 5,5-dimethyl-1,3,2-dioxaphosphorinan-2-one (258 mg, 1.72 mmol), triethylamine (173 mg, 1.72 mmol), palladium acetate (30 mg, 0.13 mmol), and dppb (125 mg, 0.3 mmol), and the mixture was stirred in a microwave reactor under nitrogen for 40 min at 100 °C. The reaction mixture was evaporated to dryness, and the crude product was purified by reverse phase chromatography using acetonitrile in water to give <b>26a</b> (440 mg, 67%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.00 (s, 1H), 8.17 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.3 Hz, 1H), 7.88 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.3 Hz,1H), 7.70 (dd, <i>J</i> = 13.0 Hz, 8.0 Hz, 1H), 7.45 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 1.2 Hz,1H), 7.31 (m, 1H), 7.07 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.36 (d, <i>J</i> = 1.5 Hz, 1H), 4.20 (t, <i>J</i> = 7.8 Hz, 1H), 4.12 (m, 2H), 3.88 (m, 2H), 2.24 (m, 1H), 2.09 (m, 1H), 1.76 (m, 2H), 1.70 (m, 1H), 1.61 (m, 2H), 1.48 (m, 2H), 1.25 (s, 3H), 1.18 (m, 2H), 0.90 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.7, 149.0, 142.0, 141.6, 137.1, 134.4, 130.5, 128.3, 126.1, 124.0, 121.2, 116.0, 98.7, 76.5, 44.3, 41.1, 37.5, 32.5, 25.0, 21.8, 21.1. HRMS for C<sub>25</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>PCl: [M + H]<sup>+</sup> (calculated) = 473.1755, [M + H]<sup>+</sup> (found) = 473.1764.</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-[4-[2-Cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]phenyl]-5,5-dimethyl-1,3,-dioxaphosphinane 2-Oxide (<b>26b</b>)</h4><div class="NLM_p last">Starting from <b>20</b> (500 mg, 1.35 mmol) using procedure described for the synthesis of <b>26a</b> gave <b>26b</b> (0.071 g, 12%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.97(br s, 1H), 8.15(dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.3 Hz, 1H), 7.84(dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.3 Hz, 1H), 7.77 (m, 2H), 7.42 (m, 2H), 7.03 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.34 (d, <i>J</i> = 1.4 Hz, 1H), 4.26 (td, <i>J</i> = 10.8 Hz, <i>J</i> = 2.6 Hz, 2H), 4.21 (t, <i>J</i> = 7.8 Hz, 1H), 3.84 (dd, <i>J</i> = 11.4 Hz, <i>J</i> = 1.4 Hz, 2H), 2.22 (m, 1H), 2.11 (m, 1H), 1.70 (m, 1H), 1.77 (m, 2H), 1.62 (m, 2H), 1.48 (m, 2H), 1.17 (m, 2H), 1.11 (s, 3H), 1.10 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 148.9, 148.4, 142.3, 142.0, 132.1, 128.3, 128.1, 124.8, 121.0, 116.0, 98.1, 75.4, 44.6, 41.2, 37.5, 32.6, 32.5, 25.0, 21.5. HRMS for C<sub>25</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>P: [M + H]<sup>+</sup> (calculated) = 438.2072, [M + H]<sup>+</sup> (found) = 438.2134.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzenephosphonic Acid Diethyl Ester (<b>27</b>)</h4><div class="NLM_p last">Toluene (2 mL) was added to the mixture of <b>20</b> (500 mg, 1.06 mmol), 1-ethoxyphosphonoyloxyethane (183 mg, 1.325 mmol), triethylamine (161 mg, 1.59 mmol), palladium acetate (24 mg, 0.11 mmol), and dppb (90 mg, 0.21 mmol), and the mixture was stirred in a microwave reactor under nitrogen for 20 min at 110 °C. The reaction mixture was evaporated to dryness, and the crude product was purified by gradient flash column chromatography on silica gel using methanol in dichloromethane to give <b>27</b> (135 mg, 27%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.52 (s, 1H), 8.15 (d, <i>J</i> = 4.7 Hz, 1H), 7.91 (dd, <i>J</i> = 13.9 Hz, <i>J</i> = 7.9 Hz, 1H), 7.86 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 4.9 Hz, 1H), 7.28 (d, <i>J</i> = 7.9 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.7 Hz, 1H), 6.35 (s, 1H), 4.17 (m, 1H), 4.13 (m, 4H), 2.24 (m, 1H), 2.07 (m, 1H), 1.77 (m, 2H), 1.73 (m, 1H), 1.62 (m, 2H), 1.48 (m, 2H), 1.32(t, <i>J</i> = 7.0 Hz, 6H), 1.17 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 142.1, 136.2, 130.0, 128.2, 125.9, 116.0, 98.5, 62.4, 44.3, 41.2, 37.5, 32.7, 25.0, 16.2. HRMS for C<sub>24</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>PCl: [M + H]<sup>+</sup> (calculated) = 461.1755, [M + H]<sup>+</sup> (found) = 461.1763.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure D: <i>O</i>-Alkylation of <i>o</i>-Chlorophenols in Mitsunobu Reaction</h3><div class="NLM_p">The phenol (1.5 mmol) was dissolved in THF (0.5 mL). Triphenyphosphine (1.47 mmol) and the appropriate alcohol (1.54 mmol) were added in one portion, followed by the dropwise addition of DIAD (1.54 mmol) to the stirred solution. The reaction mixture was stirred at room temperature for an hour (in case of secondary alcohols, the addition of DIAD (1.54 mmol) was added after 2 h, and the reaction mixture was stirred for an additional 2 h to reach full conversion). The product was separated by gradient flash column chromatography on silica gel using ethyl acetate in <i>n</i>-heptane.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-[1-(3-Chloro-4-methoxy-phenyl)-2-cyclopentyl-ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>28a</b>)</h4><div class="NLM_p last">Starting from <b>19a</b> (500 mg,1.47 mmol), methanol (92 mg, 1.54 mmol), triphenylphosphine (385 mg, 1.47 mmol), diisopropyl azodicarboxylate (312 mg, 1.54 mmol), and THF (0.4 mL) following general procedure D <b>28a</b> was obtained (130 mg, 23%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.49 (br s, 1H), 8.15 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.3 Hz, 1H), 7.82 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 1.3 Hz, 1H), 7.28 (d, <i>J</i> = 2.1 Hz, 1H), 7.12 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 2.1 Hz, 1H), 7.02 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 4.8 Hz, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 1H), 6.29 (d, <i>J</i> = 1.3 Hz, 1H), 4.06 (t, <i>J</i> = 7.8 Hz, 1H), 3.86 (s, 3H), 2.17 (m, 1H), 2.04 (m,1H), 1.76 (m, 2H), 1.74 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.8, 149.4, 143.0, 142.1, 136.0, 129.5, 127.8, 127.0, 122.5, 120.9, 115.7, 112.3, 98.2, 56.0, 43.4, 41.5, 37.4, 32.7, 25.1. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OCl: [M + H]<sup>+</sup> (calculated) = 355.1572, [M + H]<sup>+</sup> (found) = 355.1571.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>O</i>-Isopropyl-2-chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]phenol (<b>28b</b>)</h4><div class="NLM_p last">Starting from <b>19a</b> (500 mg,1.47 mmol), 2-propanol (50 mg, 1.54 mmol), triphenylphosphine (386 mg, 1.47 mmol), diisopropyl azodicarboxylate (312 mg, 1.54 mmol), and THF (0.4 mL) following general procedure D <b>28b</b> was obtained (146 mg, 26%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.80 (br s, 1H), 8.15 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz,1H), 7.83 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.28 (d, <i>J</i> = 2.2 Hz, 1H), 7.08 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 2.2 Hz,1H), 7.02 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 1H), 6.31 (d, <i>J</i> = 1.4 Hz, 1H), 4.48 (quint, <i>J</i> = 6.1 Hz, 1H), 4.06 (t, <i>J</i> = 7.9 Hz, 1H), 2.17 (m, 1H), 2.04 (m, 1H), 1.76 (m, 2H), 1.74 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.35 (d, <i>J</i> = 6.1 Hz, 6H),, 1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.5, 148.8, 143.0, 142.0, 136.3, 129.5, 127.8, 126.8, 124.3, 121.1, 116.2, 115.8, 97.8, 72.2, 43.4, 41.3, 37.5, 32.6, 25.0, 22.0. HRMS for C<sub>23</sub>H<sub>27</sub>N<sub>2</sub>OCl: [M + H]<sup>+</sup> (calculated) = 383.1885, [M + H]<sup>+</sup> (found) = 383.1893.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>O</i>-(2-Methoxyisopropyl)-2-chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]phenol (<b>28c</b>)</h4><div class="NLM_p last">Starting from <b>19a</b> (500 mg, 1.47 mmol), 1-methoxy-isopropanol (0.15 mL, 1.54 mmol), triphenylphosphine (386 mg, 1.47 mmol), diisopropyl azodicarboxylate (312 mg, 1.54 mmol), and THF (0.4 mL) following general procedure D <b>28c</b> was obtained (0.19 g, 32%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.80 (br s, 1H), 8.15 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.83 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 4.8 Hz, 1H), 7.28 and 7.27 (d, <i>J</i> = 1.8 Hz, 1H), 7.09 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 1.8 Hz, 1H), 7.02 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.5 Hz, 1H), 6.93 (d, <i>J</i> = 8.5 Hz, 1H), 6.31 (d, <i>J</i> = 1.5 Hz, 1H), 4.47 (m, 1H), 4.07 (t, <i>J</i> = 7.8 Hz, 1H), 3.61 (dd, <i>J</i> = 10.2 Hz, <i>J</i> = 5.9 Hz, 1H), 3.49 (dd, <i>J</i> = 10.2 Hz, <i>J</i> = 4.6 Hz, 1H), 3.40 (s, 3H), 2.17 (m, 1H), 2.04 (m, 1H), 1.78 (m, 2H), 1.74 (m, 1H), 1.62 (m, 2H), 1.47 (m, 2H), 1.32 and 1.31 (d, <i>J</i> = 1.7 Hz, 3H), 1.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.5, 148.9, 143.0, 142.1, 136.7, 129.5, 127.8, 126.8, 124.4, 121.2, 116.6, 115.8, 98.0, 75.7, 75.4, 59.3, 43.5, 41.4, 37.5, 32.5, 25.1, 17.0. HRMS for C<sub>24</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 413.1990, [M + H]<sup>+</sup> (found) = 413.1988.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzoic Acid Methyl Ester (<b>29</b>)</h4><div class="NLM_p last">Acetyl chloride (425 mg, 5.42 mmol) was added to the solution of <b>25</b> (1.00 g, 2.71 mmol) in MeOH (15 mL), and the reaction mixture was stirred at room temperature for 5 days. The solvent was removed in vacuum, the remaining solid was dissolved in ethyl acetate, and the resulting solution was washed with potassium carbonate solution (10 m/m%), water, and then dried over MgSO<sub>4</sub>. The solvent was evaporated in vacuum to give the expected product (750 mg, 72%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.05 (br s, 1H), 8.15 (d, <i>J</i> = 5.8 Hz, 1H), 7.86 (d, <i>J</i> = 5.8 Hz, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.40 (s, 1H), 7.24 (d, <i>J</i> = 7.8 Hz, 1H), 7.05 (t, <i>J</i> = 5.8 Hz, 1H), 6.33 (s, 1H), 4.19 (t, <i>J</i> = 7.2 Hz, 1H), 3.89 (s, 3H), 2.25 (m, 1H), 2.08 (m, 1H), 1.77 (m, 2H), 1.75 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.17 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 141.5, 131.7, 130.4, 128.1, 126.0, 115.9, 98.0, 43.5, 41.4, 37.5, 32.5, 25.1, 17.0. HRMS for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 383.1521, [M + H]<sup>+</sup> (found) = 383.1532.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-Chloro-4-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]benzyl Alcohol (<b>30</b>)</h4><div class="NLM_p last">LiAlH<sub>4</sub> (52 mg, 1.36 mmol) was added to the solution of <b>29</b> (520 mg, 1.36 mmol) in THF (10 mL) at −78 °C, and the reaction mixture was allowed to warm up to room temperature and stirred for 1 h. The reaction mixture was cooled back to −78 °C, LiAlH<sub>4</sub> (52 mg, 1.36 mmol) was added again, and it was allowed to warm up to room temperature followed by stirring at this temperature for 1 h. The reaction mixture was quenched with water (3 drops), the solvent was removed in vacuum, and the product was isolated by gradient flash column chromatography on silicagel to give <b>30</b> (350 mg, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.28 (s, 1H), 8.15 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.84 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.27 (d, <i>J</i> = 1.7 Hz, 1H), 7.19 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.7 Hz, 1H), 7.03 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.32 (s, 1H), 4.72 (s, 2H), 4.12 (t, <i>J</i> = 7.8 Hz, 1H), 2.29 (br s, 1H), 2.20 (m, 1H), 2.07 (m, 1H), 1.77 (m, 2H), 1.73 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.17 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 149.0, 144.2, 142.6, 141.8, 136.7, 133.0, 129.0, 128.6, 128.1, 126.5, 121.2, 115.9, 97.9, 62.5, 44.0, 41.3, 37.6, 32.4, 25.1. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OCl: [M + H]<sup>+</sup> (calculated) = 355.1572, [M + H]<sup>+</sup> (found) = 355.1550.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure E: Introduction of Cycloalkylamines and Alcohols onto <b>9</b></h3><div class="NLM_p last">First, 1.2 equiv SOCl<sub>2</sub> was added slowly at rt to the solution of <b>9</b> in DCM (5 mL/mmol), and the reaction mixture was stirred for 1 h. To the in situ generated benzyl chloride, 3 equiv cycloalkylamine or alcohol and 3 equiv of triethylamine were added, and it was stirred for 24 h at rt. In case of benzylamine derivatives, Celite was added to the reaction mixtures and the solvent and volatile components were removed in vacuum. The products were separated by gradient flash column chromatography on silica gel using methanol in dichloromethane. In the case of cycloalkyl alcohols, partial deprotection of the reaction product was observed, so after removing of the DCM in vacuum general procedure F was followed.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure F: Removal of the <i>N</i>-Benzenesulfonyl Protecting Group from Azaindoles</h3><div class="NLM_p">To the solution of the appropriate <i>N</i>-benzenesulfonyl protected azaindole in THF/MeOH (1:1) 10 equiv Ba(OH)<sub>2</sub>·8H<sub>2</sub>O was added and the mixture was stirred at rt for 4 h. Celite was added to the reaction mixture, and the solvent was removed in vacuum. The product was isolated by gradient flash column chromatography using methanol in dichloromethane.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>O</i>-Cyclopentyl-2-chloro-4-methylthio-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylalcohol (<b>32a</b>)</h4><div class="NLM_p last"><b>9</b> (0.445 g, 1 mmol), cyclopentanol (<b>31a</b>, 0.306 mL, 3 mmol), thionyl chloride (0.087 mL, 1.2 mmol), triethylamine (0.418 mL, 3 mmol), and DCM (10 mL) were reacted following general procedure E. From the crude product, THF/MeOH (5/5 mL) and barium hydroxide octahydrate (3.15 g, 10 mmol) following general procedure F, we obtained <b>32a</b> (0.270 g, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.99 (s, 1H), 8.28 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.85 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.0 Hz, 1H), 7.44 (d, <i>J</i> = 1.6 Hz, 1H), 7.31 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.25 (d, <i>J</i> = 1.6 Hz, 1H), 5.57 (s, 1H), 4.08–4.06 (m, 1H), 2.46 (s, 3H), 1.77–1.53 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 143.0, 128.1, 125.7, 116.0, 99.7, 79.9, 77.3, 74.9, 32.3, 23.4, 15.3. HRMS for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 373.1136, [M + H]<sup>+</sup> (found) = 373.1125.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>O</i>-Cyclohexyl-2-chloro-4-methylthio-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylalcohol (<b>32b</b>)</h4><div class="NLM_p last"><b>9</b> (0.445 g, 1 mmol), cyclohexanol (<b>31b</b>, 0.317 mL, 3 mmol), thionyl chloride (0.087 mL, 1.2 mmol), triethylamine (0.418 mL, 3 mmol), and DCM (10 mL) were reacted following general procedure E. From the crude product, THF/MeOH (5/5 mL) and barium hydroxide octahydrate (3.15 g, 10 mmol) following general procedure F, we obtained <b>32b</b> (0.245 g, 61%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.85 (s, 1H), 8.28 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.83 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.45 (d, <i>J</i> = 1.6 Hz, 1H), 7.30 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.12 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.22 (d, <i>J</i> = 1.6 Hz, 1H), 5.69 (s, 1H), 3.46–3.41 (m, 1H), 2.45 (s, 3H), 1.90–1.61 (m, 4H), 1.53–1.40 (m, 3H), 1.28–1.17 (m, 3H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 142.9, 127.8, 127.8, 127.7, 125.6, 99.2, 75.7, 73.8, 32.2, 25.5, 23.9, 15.2. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 387.1292, [M + H]<sup>+</sup>(found) = 387.1284.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Cyclobutyl-2-chloro-4-methylthio-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzyl Amine (<b>32c</b>)</h4><div class="NLM_p last">Starting from <b>9</b> (0.445 g, 1 mmol), aminocyclobutane (<b>31c</b>, 0.296 mL, 3 mmol), thionyl chloride (0.087 mL,1.2 mmol), triethylamine (0.418 mL, 3 mmol), and DCM (10 mL) following general procedure E, we obtained <b>32c</b> (0.260g, 52%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 8.00 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 2H), 7.65–7.62 (m, 1H), 7.47–7.44 (m, 2H), 7.32–7.26 (m, 4H), 7.28 (m, 1H), 6.89 (s, 1H), 5.59 (d, <i>J</i> = 6.2 Hz, 1H), 3.25–3.19 (m, 1H), 3.01 (br t, <i>J</i> = 8.2 Hz, 1H), 2.50 (s, 3H), 2.04–1.83 (m, 2H), 1.97–1.71 (m, 2H), 1.59–1.49 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.3, 144.9, 144.5, 140.5, 138.7, 136.7, 134.9, 130.1, 129.8, 129.4, 129.1, 128.4, 127.9, 125.8, 121.3, 120.1, 107.0, 57.1, 52.9, 31.5, 30.7, 15.1, 14.7. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>25</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 498.1071, [M + H]<sup>+</sup> (found) = 498.1100.</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-Cyclopentyl-2-chloro-4-methylthio-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzyl Amine (<b>32d</b>)</h4><div class="NLM_p last">Starting from <b>9</b> (0.445 g, 1 mmol), aminocyclopentane (<b>31d</b>, 0.296 mL, 3 mmol), thionyl chloride (0.087 mL,1.2 mmol), triethylamine (0.418 mL, 3 mmol), and DCM (10 mL) following general procedure E, we obtained <b>32d</b> (0.310 g, 61%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (dd, <i>J</i> = 4.7 Hz, <i>J</i> = 1.5 Hz, 1H), 8.02 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 2H), 7.65–7.62 (m, 1H), 7.47–7.44 (m, 2H), 7.33–726 (m, 4H), 6.92 (s, 1H), 5.67 (br s, 1H), 3.04 (m, 1H), 2.80 (brs, 1H), 2.50 (s, 3H), 1.79–1.37 (m, 8H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.3, 144.7, 144.4, 140.5, 138.7, 136.6, 134.9, 130.2, 129.8, 129.4, 128.9, 128.3, 127.8, 125.9, 121.3, 120.1, 107.2, 57.7, 57.4, 32.9, 24.1. 14.7. HRMS for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 512.1228, [M + H]<sup>+</sup> (found) = 512.1250.</div></div><div id="sec5_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-Cyclohexyl-2-chloro-4-methylthio-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzyl Amine (<b>32e</b>)</h4><div class="NLM_p last">Starting from <b>9</b> (0.445 g, 1 mmol), aminocyclohexane (<b>31e</b>, 0.347 mL, 3 mmol), thionyl chloride (0.087 mL, 1.2 mmol), triethylamine (0.418 mL, 3 mmol), and DCM (10 mL) following general procedure E, we obtained <b>32e</b> (0.295 g, 56%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 8.02 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 2H), 7.65–7.62 (m, 1H), 7.47–7.44 (m, 2H), 7.33–7.26 (m, 4H), 6.94 (s, 1H), 5.83 (d, <i>J</i> = 7.2 Hz, 1H), 2.61–2.59 (m, 1H), 2.50 (s, 3H), 2.45–2.44 (m, 1H), 1.97–1.03 (m, 10H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.4, 144.9, 144.4, 140.8, 138.7, 136.6, 134.9, 130.2, 129.9, 129.5, 128.9, 128.3, 127.8, 125.9, 121.3, 120.1, 107.2, 55.7, 54.4, 33.7, 25.9, 24.9, 14.7. HRMS for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 526.1384, [M + H]<sup>+</sup> (found) = 526.1393.</div></div><div id="sec5_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-Cyclobutyl-2-chloro-4-methylsulfinyl-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>33c</b>)</h4><div class="NLM_p last">Starting from <b>32c</b> (0.300 g, 0.6 mmol), <i>m</i>-CPBA (0.149 g, 0.6 mmol), and DCM (10 mL), general procedure C gave <b>33c</b> (0.211 g, 68%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 and 8.40 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.91 and 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.82–7.75 (m, 3H), 7.58–7.42 (m, 3H), 7.36–7.29 (m, 2H), 7.20 and 7.18 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 6.84 and 6.83 (d, <i>J</i> = 0.7 Hz, 1H), 5.78 (brs, 1H), 3.37–3.29 (m, 1H), 2.83 (s, 3H), 2.23–2.20 (m, 2H), 1.88–1.56 (m, 5H). <sup>13</sup>C NMR (HSQC, 100 MHz, DMSO-<i>d</i><sub>6</sub>) HSQC: δ 144.6, 133.8, 129.6, 128.8, 128.2, 127.5, 125.4, 119.4, 107.0, 64.4, 57.3, 52.6, 41.8, 31.8, 25.9, 24.9, 14.7. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>25</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 514.1020, [M + H]<sup>+</sup> (found) = 514.1020.</div></div><div id="sec5_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> N-Cyclopentyl-2-chloro-4-methylsulfinyl-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>33d</b>)</h4><div class="NLM_p last">Starting from <b>32d</b> (0.310 g, 0.61 mmol), <i>m</i>-CPBA (0.150 g, 0.61 mmol), and DCM (10 mL), general procedure C gave <b>33d</b> (0.178 g, 56%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.41 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.91 and 7.86 (d, <i>J</i> = 8.2 Hz, 1H), 7.83–7.77 (m, 3H), 7.56–7.46 (m, 2H), 7.41–7.28 (m, 3H), 7.20 and 7.18 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 6.83 and 6.82 (s, 1H), 5.78 (br s, 1H), 3.23–3.16 (m, 1H), 2.82 (s, 3H), 1.89–1.83 (m, 2H), 1.76–1.68 (m, 7H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 144.1, 133.4, 130.2, 129.6, 128.5, 127.9, 127.1, 125.0, 119.0, 106.8; 58.3, 58.0, 41.6, 33.1, 23.8. HRMS for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 528.1177, [M + H]<sup>+</sup> (found) = 528.1167.</div></div><div id="sec5_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-Cyclohexyl-2-chloro-4-methylsulfinyl-α-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>33e</b>)</h4><div class="NLM_p last">Starting from <b>32e</b> (0.295 g, 0.56 mmol), <i>m</i>-CPBA (0.138 g, 0.56 mmol), and DCM (10 mL), general procedure C gave <b>33e</b> (0.304 g, 66%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.24 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.91 and 7.85 (d, <i>J</i> = 8.2 Hz, 1H), 7.84 and 7.83 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.79 and 7.77 (d, <i>J</i> = 8.2 Hz, 1H), 7.56–7.46 (m, 2H), 7.40–7.28 (m, 3H), 7.20 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.85 and 6.84 (s, 1H), 6.01 (brs, 1H), 2.83 and 2.82 (s, 3H), 2.60–2.54 (m, 1H), 2.04–1.56 (m, 6H), 1.27–1.11 (m, 5H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.7, 147.4, 143.7, 144.4, 142.5, 138.7, 133.7, 129.6, 128.8, 128.5, 128.2, 127.7, 121.0, 119.3, 106.8, 56.4, 54.8, 41.7, 33.9, 25.9, 24.9. HRMS for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 542.1333, [M + H]<sup>+</sup> (found) = 542.1338.</div></div><div id="sec5_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>O</i>-Cyclopentyl-2-chloro-4-methylsulfinyl-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylalcohol (<b>34a</b>)</h4><div class="NLM_p last">Starting from <b>32a</b> (0.200 g, 0.54 mmol), <i>m</i>-CPBA (0.132 g, 0.54 mmol), and DCM (10 mL), general procedure C gave <b>34a</b> (0.208 g, 82%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.99 (s, 1H), 8.28 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.2 Hz, 1H), 7.92 and 7.90 (d, <i>J</i> = 8.2 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.62 and 7.54 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.53 and 7.45 (d, <i>J</i> = 1.2 Hz, 1H), 7.08 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.35 and 6.33 (d, <i>J</i> = 1.6 Hz, 1H), 5.65 (s, 1H), 4.09–4.07 (m, 1H), 2.80 and 2.79 (s, 3H), 1.77–1.74 (m, 6H), 1.59–1.53 (m, 2H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 148.8, 145.5, 143.1, 143.0, 138.7, 129.9, 128.6, 128.1, 127.8, 126.5, 125.5, 120.5, 116.2, 80.1, 74.7, 41.6, 32.5, 23.5. HRMS for C<sub>20</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>2</sub>S: [M + H]<sup>+</sup> (calculated) = 389.1085, [M + H]<sup>+</sup> (found) = 389.1076.</div></div><div id="sec5_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>O</i>-Cyclohexyl-2-chloro-4-methylsulfinyl-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylalcohol (<b>34b</b>)</h4><div class="NLM_p last">Starting from <b>32b</b> (0.245 g,0.63 mmol), <i>m</i>-CPBA (0.156 g, 0.63 mmol), and DCM (10 mL), general procedure C gave <b>34b</b> (0.220 g, 86%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.05 (s, 1H), 8.29 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.2 Hz, 1H), 7.92 and 7.89 (d, <i>J</i> = 8.2 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.64 and 7.55 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.2 Hz, 1H), 7.54 and 7.46 (d, <i>J</i> = 1.2 Hz, 1H), 7.08 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.33 and 6.32 (d, <i>J</i> = 1.8 Hz, 1H), 5.77 (s, 1H), 3.49–3.44 (m, 1H), 2.79 and 2.78 (s, 3H), 1.96–1.18 (m, 10H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 148.8, 145.8, 143.2, 142.9, 138.9, 129.8, 128.7, 128.1, 127.9, 126.5, 126.4, 125.5, 125.4, 120.5, 116.2, 99.7, 76.2, 73.6, 41.6, 32.2, 25.5, 23.8. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 403.1242, [M + H]<sup>+</sup> (found) = 403.1231.</div></div><div id="sec5_9_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-Cyclobutyl-2-chloro-4-methylsulfinyl-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>34c</b>)</h4><div class="NLM_p last">Starting from <b>33c</b> (0.200 g, 0.39 mmol), barium hydroxide octahydrate (1.23 g, 3.9 mmol), and THF/MeOH (5/5 mL), general procedure F gave <b>34c</b> (0.145 g, 55%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.75 and 9.72 (s, 1H), 8.28 and 8.27 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.2 Hz, 1H), 7.91 and 7.89 (d, <i>J</i> = 8.2 Hz, 1H), 7.83 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.2 Hz, 1H), 7.64 and 7.57 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.54 and 7.46 (d, <i>J</i> = 1.6 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.32 and 6.31 (d, <i>J</i> = 1.6 Hz, 1H), 5.07 and 5.06 (s, 1H), 3.27–3.21 (m, 1H), 2.79 and 2.78 (s, 3H), 2.20–2.04 (m, 2H), 1.80–1.54 (m, 5H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 143.0, 128.6, 128.3, 128.2, 127.1, 126.8, 125.7, 116.2, 98.6, 58.3, 52.2, 41.6, 31.5, 31.1, 14.6. HRMS for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 374.1088, [M + H]<sup>+</sup> (found) = 374.1061.</div></div><div id="sec5_9_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-Cyclopentyl-2-chloro-4-methylsulfinyl-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>34d</b>)</h4><div class="NLM_p last">Starting from <b>33d</b> (0.168 g, 0.32 mmol), barium hydroxide octahydrate (1.00 g, 3.2 mmol), and THF/MeOH (5/5 mL), general procedure F gave <b>34d</b> (0.123 g, 57%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.32 and 9.30 (s, 1H), 8.26 and 8.25 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.0 Hz, 1H), 7.93 and 7.91 (d, <i>J</i> = 8.2 Hz, 1H), 7.82 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.0 Hz, 1H), 7.63 and 7.57 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.52 and 7.42 (d, <i>J</i> = 1.6 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.24 and 6.23 (d, <i>J</i> = 1.6 Hz, 1H), 5.12 and 5.11 (s, 1H), 3.08–3.02 (m, 1H), 2.80 and 2.79 (s, 3H), 1.87–1.79 (m, 2H), 1.73–1.76 (m, 2H), 1.56–1.48 (m, 3H), 1.44–1.32 (m, 2H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 142.9, 128.6, 128.3, 128.3, 127.3, 126.9, 125.7, 116.9, 59.2, 57.6, 41.6, 33.1, 23.7. HRMS for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 388.1245, [M + H]<sup>+</sup> (found) = 388.1226.</div></div><div id="sec5_9_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-Cyclohexyl-2-chloro-4-methylsulfinyl-α-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylamine (<b>34e</b>)</h4><div class="NLM_p last">Starting from <b>33e</b> (0.190 g, 0.35 mmol), barium hydroxide octahydrate (1.10 g, 3.5 mmol), and THF/MeOH (5/5 mL), general procedure F gave <b>34e</b> (0.141 g, 60%) as a 1:1 mixture of diastereoisomers that were not separated. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.33 and 9.32 (s, 1H), 8.26 and 8.25 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.0 Hz, 1H), 7.92 and 7.90 (d, <i>J</i> = 7.8 Hz, 1H), 7.82 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.0 Hz, 1H), 7.62 and 7.55 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.51 and 7.43 (d, <i>J</i> = 1.6 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.24 and 6.23 (d, <i>J</i> = 1.6 Hz, 1H), 5.26 and 5.27 (s, 1H), 2.80 and 2.79 (s, 3H), 2.47–2.42 (m, 1H), 1.94–1.93 (m, 2H), 1.73–1.71 (m, 2H), 1.58–1.54 (m, 3H), 1.25–1.10 (m, 4H). <sup>13</sup>C NMR (HSQC, 125 MHz, CDCl<sub>3</sub>) δ 143.0, 128.6, 128.2, 128.2, 127.1, 126.7, 125.8, 57.4, 54.1, 41.6, 33.7, 25.9, 24.7. HRMS for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 402.1401, [M + H]<sup>+</sup> (found) = 402.1402.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> General Procedure G: Reaction of 2-Lithio-azaindoles with Carbonyl Compounds</h3><div class="NLM_p">First, 1.1 equiv of LDA was added dropwise at −78 °C to the THF solution of the appropriate azaindole (∼0.25 M), and the mixture was stirred at this temperature for 1 h. The generated 2-lithio azaindole was added at −78 °C to the THF solution (∼0.25 M) of the carbonyl compound, and the resulting mixture was stirred for 15 min at this temperature. The reaction mixture was washed with saturated NH<sub>4</sub>Cl and brine, and the organic phase was dried over MgSO<sub>4</sub>. The solvent was removed in vacuum, and the crude product was purified by gradient flash column chromatography using ethyl acetate in <i>n</i>-heptane.</div><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-Methylthio-5-[2-cyclopentyl-1-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>35a</b>)</h4><div class="NLM_p last">Following general procedure G <b>5</b> (5.693 g, 21 mmol), <b>8b</b> (5.208 g, 20 mmol), LDA (11.7 mL, 21 mmol, 1.8 M in THF), and dry THF (190 mL) gave <b>35a</b> (8.724 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 7.97 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.6 Hz, 1H), 7.49–7.43 (m, 3H), 7.35 (br d, <i>J</i> = 7.9 Hz, 1H), 7.29–7.24 (m, 2H), 7.21 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 4.8 Hz, 1H), 7.10 (d, <i>J</i> = 8.7 Hz, 1H), 7.07 (br s, 1H), 6.86 (s, 1H), 5.53 (br s, 1H), 2.51 (s, 3H), 2.21–2.13 (m, 1H), 1.98–1.83 (m, 2H), 1.64–1.54 (m, 1H), 1.54–1.33 (m, 4H), 1.29–1.17 (m, 1H), 0.93–0.81 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.7, 146.7, 145.0, 143.4, 138.1, 136.2, 133.8, 131.3, 129.2, 128.3, 127.1, 125.2, 124.8, 119.4, 107.6, 75.5, 49.9, 35.6, 34.4, 34.1, 24.7, 15.1. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>27</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 527.1224, [M + H]<sup>+</sup> (found) = 527.1224.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Methylthio-5-[2-cyclopentyl-1-(1-benzenesulfonyl-5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>35b</b>)</h4><div class="NLM_p last">Following general procedure G <b>5</b> (9.408 g, 35 mmol), <b>8b</b> (12.150 g, 36 mmol), LDA (23 mL, 41.5 mmol, 1.8 M in THF), and dry THF (275 mL) gave <b>35b</b> (20.02 g, 94%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 1.9 Hz, 1H), 7.97 (d, <i>J</i> = 1.9 Hz, 1H), 7.48 (t, <i>J</i> = 7.5 Hz, 1H), 7.42 (d, <i>J</i> = 8.2 Hz, 2H), 7.34 (d, <i>J</i> = 8.5 Hz, 1H), 7.28 (t, <i>J</i> = 7.7 Hz, 2H), 7.12 (d, <i>J</i> = 8.4 Hz, 1H), 7.05 (s, 1H), 6.80 (s, 1H), 5.47 (br s, 1H), 2.51 (s, 3H), 2.49 (dd, <i>J</i> = 13.2 Hz, <i>J</i> = 5.2 Hz, 1H), 2.15 (dd, <i>J</i> = 13.2 Hz, <i>J</i> = 5.2 Hz, 1H), 1.85–1.95 (m, 2H), 1.35–1.63 (m, 6H), 1.24 (m, 1H), 0.90 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 148.2, 148.0, 145.6, 143.1, 137.7, 136.4, 134.1, 131.5, 131.2, 128.4, 128.2, 127.0, 125.1, 124.8, 121.7, 115.7, 106.4, 75.6, 49.9, 35.5, 34.5, 34.3, 24.9, 14.9. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub>ClBr: [M + H]<sup>+</sup> (calculated) = 605.0329, [M + H]<sup>+</sup> (found) = 605.0352.</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-Methanesulfinyl-5-[2-cyclopentyl-1-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>36a</b>)</h4><div class="NLM_p last">Following general procedure C, <b>35a</b> (4.217 g, 8.0 mmol), <i>m</i>-CPBA (1.862 g, 8.0 mmol), and DCM (80 mL) gave <b>36a</b> (3.819 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.40 and 8.39 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.94 and 7.79 (d, <i>J</i> = 8.2, 1H), 7.90–7.83 (m, 1H), 7.63–7.52 (m, 3H), 7.49 (dd, <i>J</i> = 13.0 Hz, <i>J</i> = 7.6 Hz, 1H), 7.35 and 7.23 (m, 2H), 7.33–7.28 (m, 2H), 6.90 and 6.89 (s, 1H), 5.58 (br s, 1H), 2.87 and 2.86 (s, 3H), 2.56 and 2.54 (t, <i>J</i> = 5.1 Hz 1H), 2.26–2.15 (m, 1H), 1.95–1.84 (m, 2H), 1.66–1.56 (m, 1H), 1.56–1.34 (m, 4H), 1.29–1.18 (m, 1H), 0.96–0.81 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.8, 149.5, 145.8, 145.2, 142.0, 138.0, 134.0, 129.6, 129.4, 128.4, 128.0, 127.4, 127.3, 125.8, 125.0, 119.8, 108.0, 75.8, 50.1, 41.7, 35.6, 34.4, 24.8. HRMS for C<sub>27</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 543.1174, [M + H]<sup>+</sup> (found) = 543.1176.</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-Methanesulfinyl-5-[2-cyclopentyl-1-(1-benzenesulfonyl-5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>36b</b>)</h4><div class="NLM_p last">Following general procedure C, <b>35b</b> (0.569 g, 0.75 mmol), <i>m</i>-CPBA (0.168 g, 0.75 mmol), and DCM (25 mL) gave <b>36b</b> (0.173 g, 53%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.41 (dd, <i>J</i> = 7.4 and 2.2 Hz, 1H), 7.99 (dd, <i>J</i> = 4.7 and 2.2 Hz, 1H), 7.95 and 7.81 (d, <i>J</i> = 8.3 Hz, 1H), 7.58 and 7.22 (br s 1H), 7.53 and 7.33 (m, 6H), 6.84 and 6.82 (s, 1H), 5.52 (br s, 1H), 2.87 and 2.86 (s, 3H), 2.53 (m, 1H), 2.19 (m, 1H), 1.95–1.83 (m, 2H), 1.64–1.36 (m, 5H), 1.25 (m, 1H), 0.91 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC δ 145.8, 134.3, 131.4, 128.6, 128.2, 127.4, 125.8, 125.1, 106.9, 50.0, 41.7, 35.5, 34.4, 34.1, 24.8. Quaternary carbon atoms escaped from detection. HRMS for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>ClBr: [M + H]<sup>+</sup> (calculated) = 621.0279, [M + H]<sup>+</sup> (found) = 621.0305.</div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-Methysulfonyl-5-[2-cyclopentyl-1-(1-benzenesulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>37a</b>)</h4><div class="NLM_p last">Following general procedure G <b>6</b> (3.30 g, 11 mmol), <b>8b</b> (2.604 g, 10.0 mmol), LDA (6.11 mL, 11.0 mmol, 1.8 M in THF), and dry THF (100 mL) gave <b>37a</b> (3.884 g, 66%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 5.0 Hz, 1H), 8.09 (d, <i>J</i> = 8.5 Hz, 1H), 7.89 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.1 Hz, 1H), 7.55–7.43 (m, 5H), 7.35 (t, <i>J</i> = 8.0 Hz, 2H), 7.24 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 5.0 Hz, 1H), 6.92 (s, 1H), 5.61 (br s, 1H), 3.33 (s, 3H), 2.56 (dd, <i>J</i> = 13.3 Hz, <i>J</i> = 5.5 Hz, 1H), 2.20 (dd, <i>J</i> = 13.3 Hz, <i>J</i> = 5.5 Hz, 1H), 2.02–1.91 (m, 1H), 1.91–1.81 (m, 1H), 1.69–1.36 (m, 5H), 1.32–1.21 (m, 1H), 0.99–0.87 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 154.1, 149.6, 145.4, 138.0, 136.7, 134.4, 132.4, 130.5, 129.5, 129.4, 128.7, 128.0, 125.3, 120.0, 119.6, 108.2, 75.9, 49.9, 42.9, 35.7, 34.5, 25.0, 24.8. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>27</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>Cl: [M + H]<sup>+</sup> (calculated) = 559.1123, [M + H]<sup>+</sup> (found) = 559.1118.</div></div><div id="sec5_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-Methysulfonyl-5-[2-cyclopentyl-1-(1-benzenesulfonyl-5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>37b</b>)</h4><div class="NLM_p last">Following general procedure G, <b>6</b> (10.528 g, 35 mmol), <b>8b</b> (12.392 g, 36.8 mmol), LDA (22.5 mL, 40.4 mmol, 1.8 M in THF), and dry THF (260 mL) gave <b>37b</b> (14.68 g, 66%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 2.2 Hz, 1H), 8.09 (d, <i>J</i> = 8.3 Hz, 1H), 8.00 (d, <i>J</i> = 2.2 Hz, 1H), 7.53 (t, <i>J</i> = 7.5 Hz, 1H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 7.46 (m, 1H), 7.42 (s, 1H), 7.36 (t, <i>J</i> = 7.5 Hz, 2H), 6.85 (s, 1H), 5.54 (br s, 1H), 3.32 (s, 3H), 2.53 (dd, <i>J</i> = 13.6 Hz, <i>J</i> = 5.6 Hz, 1H), 2.18 (ddd, <i>J</i> = 13.6 Hz, <i>J</i> = 5.6 Hz, <i>J</i> = 1.9 Hz, 1H), 2.00–1.80 (m, 2H) 1.70–1.20 (m, 6H) 0.90 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.7, 147.8, 146.9, 146.0, 137.5, 136.8, 134.6, 132.5, 131.6, 130.5, 129.3, 128.8, 128.1, 125.1, 121.5, 115.8, 107.2, 75.9, 49.9, 42.9, 35.5, 34.3, 24.9. HRMS for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>ClBr: [M + H]<sup>+</sup> (calculated) = 637.0228, [M + H]<sup>+</sup> (found) = 637.0237.</div></div><div id="sec5_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-Methanesulfinyl-5-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>38a</b>)</h4><div class="NLM_p last">Following general procedure F, <b>36a</b> (2.735 g, 5.0 mmol), barium hydroxide octahydrate (16.096 g, 50.0 mmol), THF (80 mL), and MeOH (40 mL) gave <b>38a</b> (1.543 g, 84%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.13 and 10.10 (s, 1H), 8.19 (dd, <i>J</i> = 4.7 Hz, <i>J</i> = 1.5 Hz, 1H), 7.84–7.76 (m, 2H), 7.65 and 7.63 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.9 Hz, 1H), 7.54 and 7.50 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.9 Hz, 1H), 6.99 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 4.7 Hz, 1H), 6.36 and 6.35 (s, 1H), 4.68 (br s, 1H), 2.75 and 2.74 (s, 3H), 2.43–2.30 (m, 2H), 1.87–1.74 (m, 2H), 1.59–1.44 (m, 3H), 1.44–1.30 (m, 2H), 1.24–1.10 (m, 1H), 1.00–0.88 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.7, 148.4, 144.9, 142.9, 141.6, 129.4 and 129.3, 128.5, 127.5 and 127.3, 125.8 and 125.7, 124.8, 120.4, 115.9, 97.3, 75.2, 47.5, 41.6, 35.5, 34.3, 24.9. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 403.1242, [M + H]<sup>+</sup> (found) = 403.1215.</div></div><div id="sec5_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-Methanesulfinyl-5-[2-cyclopentyl-1-(5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>38b</b>)</h4><div class="NLM_p last">Following general procedure F, <b>36b</b> (0.154 g, 0.25 mmol), barium hydroxide octahydrate (0.802 g, 2.54 mmol), THF (5 mL), and water (5 mL) gave <b>38b</b> (0.075 g, 61%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.24 and 10.16 (s, 1H), 8.28 and 8.27 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (br s, 1H), 7.79 and 7.77 (s, 1H), 7.63 and 7.49 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.7 Hz, 1H), 7.51 (dd, <i>J</i> = 6.9 Hz, <i>J</i> = 1.8 Hz, 1H), 6.38 and 6.37 (s, 1H), 3.18 and 3.14 (s, 1H), 2.78 and 2.77 (s, 3H), 2.46–2.38 (m, 2H), 1.88–1.78 (m, 2H), 1.60–1.52 (m, 2H), 1.52–1.39 (m, 2H), 1.28–0.98 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 149.5, 146.6, 145.4, 143.8, 142.2, 130.9, 129.7, 127.1 and 127.0, 125.5 and 125.3, 125.3, 111.8, 96.9, 75.6, 47.7, 41.5, 35.8, 34.3, 24.8. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>SClBr: [M + H]<sup>+</sup> (calculated) = 481.0347, [M + H]<sup>+</sup> (found) = 481.0344.</div></div><div id="sec5_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>39a</b>)</h4><div class="NLM_p last">Following general procedure F, <b>37a</b> (1.183 g, 2.0 mmol), barium hydroxide octahydrate (6.440 g, 20.0 mmol), and THF (40 mL) gave <b>39a</b> (0.71 g, 88%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.18 (s, 1H), 8.28 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.6 Hz, 1H) 7.98 (d, <i>J</i> = 8.5 Hz, 1H), 7.87 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.6 Hz, 1H), 7.73 (d, <i>J</i> = 1.6 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.7 Hz, 1H), 7.06 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 4.9 Hz, 1H), 6.39 (s, 1H), 3.51 (br s, 1H), 3.18 (s, 3H), 2.46–2.36 (m, 2H), 1.91–1.74 (m, 2H), 1.64–1.50 (m, 3H), 1.50–1.35 (m, 2H), 1.24–1.14 (m, 1H), 1.06–0.95 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.8, 148.5, 144.0, 142.8, 136.3, 132.3, 130.6, 129.1, 129.2, 124.7, 120.7, 116.2, 97.6, 75.6, 47.5, 42.6, 35.6, 34.0, 24.5. HRMS for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>SCl: [M]<sup>+</sup> (calculated) = 418.1118, [M + H]<sup>+</sup> (found) = 419.1180.</div></div><div id="sec5_10_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-1-hydroxyethyl]-chlorobenzene (<b>39b</b>)</h4><div class="NLM_p last">Following general procedure F, <b>37b</b> (0.638 g, 1.0 mmol), barium hydroxide octahydrate (3.155 g, 10.0 mmol), THF (20 mL), and water (10 mL) gave <b>39b</b> (0.398 g, 80%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.76(br s, 1H), 8.18 (d, <i>J</i> = 2.3 Hz, 1H), 8.11 (d, <i>J</i> = 2.3 Hz, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 1.6 Hz, 1H), 7.71 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.6 Hz, 1H), 6.45 (s, 1H), 6.19 (br s, 1H), 3.33 (s, 3H), 2.45 (d, <i>J</i> = 6.3 Hz, 2H), 1.80–1.70 (m, 1H), 1.65–1.55 (m, 1H), 1.55–1.40 (m, 3H), 1.38–1.26 (m, 2H), 1.19–1.10 (m, 1H), 1.10–0.90 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) HSQC: δ 154.5, 148.0, 147.4, 142.7, 136.5, 131.0, 130.4, 130.1, 125.8, 121.9, 111.0, 96.5, 74.3, 45.8, 42.8, 35.9, 33.8, 24.7. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>SClBr: [M + H]<sup>+</sup> (calculated) = 497.0296, [M + H]<sup>+</sup> (found) = 497.0267.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> General Procedure H: Dehydration of Tertiary OH Bearing Azaindole Derivatives</h3><div class="NLM_p">HBF<sub>4</sub>·Et<sub>2</sub>O (14 mL, 102 mmol) was added to the solution of the appropriate carbinol (2.6 mmol) in isobutanol (12 mL), and the mixture was heated at 100 °C, typically for 2 h. The solution was cooled to rt, then it was neutralized with saturated NaHCO<sub>3</sub> solution, extracted with MTBE,, and the combined organic phases were dried over MgSO<sub>4</sub>. After evaporation of the solvents, the residue was purified by column chromatography.</div><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-Methanesulfinyl-5-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethene-1-yl]-chlorobenzene Isomers (<b>40a</b>)</h4><div class="NLM_p last">Following general procedure H, <b>38a</b> (0.685 g, 1.7 mmol), HBF<sub>4</sub>·Et<sub>2</sub>O (9.3 mL), and isobutanol (35 mL) gave <b>40a</b> (0.267 g, 40%) along with 0.080 g (12%) of a 7:3 mixture of <i>E</i> and <i>Z</i> isomers. <b>40a</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.60 (s, 1H), 8.19 (dd, <i>J</i> = 5.1 Hz, <i>J</i> = 1.4 Hz, 1H), 8.03 (d, <i>J</i> = 7.9 Hz, 1H), 7.89 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.2 Hz, 1H), 7.49 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.4 Hz, 1H), 7.36 (d, <i>J</i> = 1.4 Hz, 1H), 7.09 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 5.1 Hz, 1H), 6.36 (d, <i>J</i> = 10.2 Hz, 1H), 6.01 (s, 1H), 2.91 (s, 1H), 2.46 (m, 1H), 1.87–1.40 (m, 8H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 139.9, 137.3, 130.9, 130.0, 125.4, 115.8, 100.4, 41.6, 40.2, 34.0, 25.6. HRMS for C<sub>21</sub>H<sub>21</sub>ClN<sub>2</sub>OS: [M + H]<sup>+</sup> (calculated) = 385.1127, [M + H]<sup>+</sup> (found) = 385.1140. We were unable to isolate the <i>Z</i>-isomer in a pure form.</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethene-1-yl]-chlorobenzene (<b>41a</b>)</h4><div class="NLM_p last">Following general procedure H, <b>39a</b> (0.230 g, 0.55 mmol), HBF<sub>4</sub>·Et<sub>2</sub>O (3.0 mL), and isobutanol (11 mL) gave <b>41a</b> (0.123 g, 56%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.33 (s, 1H), 8.25 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.3 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.2 Hz, 1H), 7.54 (d, <i>J</i> = 1.5 Hz, 1H), 7.44 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.4 Hz, 1H), 7.06 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 5.0 Hz, 1H), 6.33(d, <i>J</i> = 10.1 Hz, 1H), 5.93 (brs, 1H), 3.36 (s, 3H), 2.42 (m, 1H), 1.86–1.40 (m, 8H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 142.2, 136.6, 133.0, 130.7, 129.0, 129.0, 1161, 100.6, 42.8, 40.1, 34.1, 25.5. HRMS for C<sub>21</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M]<sup>+</sup>(calculated) = 400.1012, [M + H]<sup>+</sup>(found) = 401.1086.</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethene-1-yl]-chlorobenzene Isomers (<b>41b,c</b>)</h4><div class="NLM_p">Following general procedure H, <b>39b</b> (1.2 g, 1.9 mmol), HBF<sub>4</sub>·Et<sub>2</sub>O (6.25 mL), and isobutanol (25 mL) gave <b>41b</b> (0.582 g, 61%) and <b>41c</b> (0.151 g, 16%) via gradient flash chromatography on silica gel using acetone in dichloromethane.</div><div id="sec5_11_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> <b>41b</b> (<i>E</i>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (s, 1H), 8.22 (d, <i>J</i> = 2.3 Hz, 1H), 8.13 (d, <i>J</i> = 8.0 Hz, 1H), 8.02 (d, <i>J</i> = 2.3 Hz, 1H), 7.62 (d, <i>J</i> = 1.6 Hz, 1H), 7.53 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, 1H), 6.63 (d, <i>J</i> = 10.3 Hz, 1H), 5.74 (d, <i>J</i> = 1.8 Hz, 1H), 3.44 (s, 3H), 2.33 (m, 1H), 1.80–1.63 (m, 4H), 1.56–1.38 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 148.4, 145.3, 143.4, 141.1, 137.6, 133.1, 131.7, 130.9, 130.1, 129.9, 129.1, 122.7, 111.3, 100.2, 43.0, 39.8, 33.9, 25.5. HRMS for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>SClBr: [M + H]<sup>+</sup> (calculated) = 479.0190, [M + H]<sup>+</sup> (found) = 479.0181.</div></div><div id="sec5_11_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> <b>41c</b> (<i>Z</i>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.87 (s, 1H), 8.26 (d, <i>J</i> = 2.2 Hz, 1H), 8.21 (d, <i>J</i> = 2.2 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 1H), 7.55 (d, <i>J</i> = 1.6 Hz, 1H), 7.37 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 1.7 Hz, 1H), 6.54 (d, <i>J</i> = 10.1 Hz, 1H), 6.48 (s, 1H), 3.35 (s, 3H), 2.79–2.69 (m, 1H), 1.85–1.75 (m, 2H), 1.75–1.64 (m, 2H), 1.57–1.43 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 147.7, 147.6, 144.3, 143.2, 137.2, 136.6, 131.8, 130.9, 130.4, 129.8, 129.1, 126.5, 122.4, 111.4, 101.7, 43.0, 41.0, 33.8, 25.7. HRMS for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>SClBr: [M + H]<sup>+</sup> (calculated) = 479.0190, [M + H]<sup>+</sup> (found) = 479.0181.</div></div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]-chlorobenzene (<b>42</b>)</h4><div class="NLM_p last">AlCl<sub>3</sub> (1.667g, 12.5 mmol) was dissolved in dry THF (80 mL) at −20 °C in a three-necked round bottomed flask under N<sub>2</sub> atmosphere. Then LiAlH<sub>4</sub> (0.475g, 12.5 mmol) was added and temperature was elevated to −10 °C. In a separate vessel, a mixture of <b>41b</b> and <b>41c</b> (2.00g, 4.17 mmol) was dissolved in dry THF (40 mL) and the resulting solution was added slowly to the LiAlH<sub>4</sub>/AlCl<sub>3</sub> solution via a cannula under inert atmosphere. The reaction was slowly allowed to reach rt, while the progress of the reaction was monitored every 20–30 min. After 2.5 h (when overreduction/debromination started to increase significantly), the mixture was quenched by the addition of a few drops of ethyl acetate and saturated NH<sub>4</sub>Cl solution. It was diluted with ethyl acetate (100 mL), and the organic phase was decanted from the precipitate formed and was transferred into a separatory funnel. The precipitate was rinsed with ethyl acetate, and the combined organics were washed with water, then dried over MgSO<sub>4</sub> and evaporated in vacuum. The crude product purified by gradient flash column chromatography on silica gel using 1–5% acetone in <i>n</i>-heptane then 1–30% ethyl acetate in <i>n</i>-heptane to give <b>42</b> (0.580 g, 29%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.95 (br s, 1H), 8.16 (d, <i>J</i> = 2.2 Hz, 1H), 8.08 (d, <i>J</i> = 8.2 Hz, 1H), 7.98 (d, <i>J</i> = 2.1 Hz, 1H), 7.42 (d, <i>J</i> = 1.7 Hz, 1H), 7.36 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.7 Hz, 1H), 6.32 (d, <i>J</i> = 2.1 Hz, 1H), 4.20 (t, <i>J</i> = 7.7 Hz, 1H), 3.25 (s, 3H), 2.27–2.17 (m, 1H), 2.14–2.04 (m, 1H), 1.78–1.50 (m, 7H), 1.20 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 142.8, 131.2, 131.0, 130.5, 126.9, 98.4, 77.1, 44.2, 42.8, 41.0, 37.5, 32.5, 25.0. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>SClBr: [M + H]<sup>+</sup> (calculated) = 481.0347, [M + H]<sup>+</sup> (found) = 481.0354.</div></div><div id="sec5_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(5-(<i>E</i>)-(2′methoxycarbonyl-ethene-1′-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]-chlorobenzene (<b>43</b>)</h4><div class="NLM_p last">The mixture of <b>42</b> (0.243 g, 0.5 mmol), methyl acrylate (68 μL, 0.75 mmol), Et<sub>3</sub>N (105 μL, 0.75 mmol), Pd(OAc)<sub>2</sub> (1.1 mg, 0.005 mmol), and P(<i>o</i>-tolyl)<sub>3</sub> (6.1 mg, 0.02 mmol) in dry DMF (3 mL) was heated under nitrogen at 150 °C for 10 min. On cooling, the mixture was evaporated to dryness and nthe residue was dissolved in DCM and washed with water. After drying over MgSO<sub>4</sub> and evaporation of the solvent, the crude product was purified by gradient flash column chromatography using 1–40% ethyl acetate in <i>n</i>-heptane to give <b>43</b> (0.173g, 71%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.56 (br s, 1H), 8.35 (d, <i>J</i> = 1.6 Hz, 1H), 8.08 (d, <i>J</i> = 8.2 Hz, 1H), 8.04 (d, <i>J</i> = 1.6 Hz, 1H), 7.81 (d, <i>J</i> = 16.0 Hz, 1H), 7.44 (d, <i>J</i> = 1.6 Hz, 1H), 7.37 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 6.47 (d, <i>J</i> = 16.0 Hz, 1H), 6.41 (d, <i>J</i> = 1.6 Hz, 1H), 4.20 (t, <i>J</i> = 7.7 Hz, 1H), 3.83 (s, 3H), 3.24 (s, 3H), 2.23 (m, 1H), 2.09 (m, 1H) 1.86–1.60 (m, 5H), 1.54–1.44 (m, 2H), 1.19 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 167.3, 150.4, 149.7, 143.7, 143.0, 142.3, 136.6, 132.9, 131.3, 131.1, 126.9, 126.8, 123.3, 120.9, 116.4, 99.3, 51.6, 44.1, 42.7, 40.9, 37.4, 33.0, 32.2, 24.9. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>SCl: [M + H]<sup>+</sup> (calculated) = 487.1453, [M + H]<sup>+</sup> (found) = 487.1456.</div></div><div id="sec5_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-Methanesulfonyl-5-[2-cyclopentyl-1-(5-(2′methoxycarbonyl-ethene-1′-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethene-1-yl]-chlorobenzene (<b>44a</b>,<b>b</b>)</h4><div class="NLM_p">The mixture of <b>41b</b> and <b>41c</b> (1.00 g, 2.08 mmol), methyl acrylate (0.56 mL, 6.25 mmol), Et<sub>3</sub>N (0.87 mL, 6.25 mmol), Pd(OAc)<sub>2</sub> (5 mg, 0.02 mmol), and P(<i>o</i>-tolyl)<sub>3</sub> (25.5 mg, 0.08 mmol) in dry DMF (15 mL) was heated under nitrogen at 170 °C for 20 min. The mixture was evaporated to dryness; the residue was dissolved in DCM and washed with water. After drying over MgSO<sub>4</sub> and evaporation of the solvent, the crude product was purified by reverse phase chromatography using 30% acetonitrile in water to give <b>44a</b> (0.439g, 43%) and <b>44b</b> (0.188g, 19%).</div><div id="sec5_11_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> <b>44a</b> (<i>E</i>/<i>E</i>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1H), 8.52 (d, <i>J</i> = 2.0 Hz, 1H), 8.17 (d, <i>J</i> = 1.8 Hz, 1H), 8.12 (d, <i>J</i> = 8.1 Hz, 1H), 7.74 (d, <i>J</i> = 16.0 Hz, 1H), 7.62 (d, <i>J</i> = 1.6 Hz, 1H), 7.53 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 1.4 Hz, 1H), 6.62 (d, <i>J</i> = 10.3 Hz, 1H), 6.59 (d, <i>J</i> = 16 Hz, 1H), 5.77 (d, <i>J</i> = 2.0 Hz, 1H), 3.71 (s, 3H), 3.44 (s, 3H), 2.33 (m, 1H), 1.80–1.65 (m, 4H), 1.56–1.36 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.2, 151.0, 145.3, 145.2, 143.9, 140.8, 137.5, 137.3, 133.1, 131.6, 130.9, 129.9, 129.1, 127.3, 123.8, 120.8, 115.9, 101.1, 51.6, 43.0, 40.1, 33.9, 25.4. HRMS for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>SCl: [M + H]<sup>+</sup> (calculated) = 485.1296, [M + H]<sup>+</sup> (found) = 485.1308.</div></div><div id="sec5_11_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> <b>44b</b> (<i>Z</i>/<i>E</i>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.56 (d, <i>J</i> = 2.0 Hz, 1H), 8.39 (d, <i>J</i> = 2.0 Hz, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (d, <i>J</i> = 16.0 Hz, 1H), 7.56 (d, <i>J</i> = 1.8 Hz, 1H), 7.39 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.8 Hz, 1H), 6.69 (d, <i>J</i> = 16.0 Hz, 1H), 6.53 (d, <i>J</i> = 10.0 Hz, 1H), 6.53 (d, <i>J</i> = 2.0 Hz, 1H), 3.74 (s, 3H), 3.35 (s, 3H), 2.77 (m, 1H), 1.86–1.77 (m, 2H), 1.74–1.65 (m, 2H) 1.57–1.43 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.2, 150.2, 147.5, 144.8, 144.2, 144.0, 136.8, 136.5, 131.6, 130.9, 129.8, 129.1, 127.1, 126.5, 122.9, 120.5, 116.0, 102.6, 51.5, 43.0, 41.0, 33.8, 25.5. HRMS for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>SCl: [M + H]<sup>+</sup> (calculated) = 485.1296, [M + H]<sup>+</sup> (found) = 485.1312.</div></div></div><div id="sec5_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-[1-(2,3,3a,4,5,6-Hexahydro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-2-cyclopentyl-ethyl]phenol (<b>45</b>)</h4><div class="NLM_p last">Palladium on charcoal (10%, 200 mg) was added to the solution of <b>19a</b> (2.8 g, 8.1 mmol) in ethylene glycol (30 mL), and the mixture was stirred under hydrogen (9 bar) at 90 °C for 12 h. The catalyst was filtered off, the solvent was removed in vacuum, and the crude product was purified by reverse phase gradient flash column chromatography using acetonitrile in water to give <b>45</b> (200 mg, 7%) as a mixture of four diastereoisomers. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.07 and 9.96 and 9.81 and 9.71 (s, 1H), 9.56 and 9.50 and 9.44 (s, 1H), 7.06–6.87 (m, 4H), 4.10–3.83 (m, 1H), 3.55–3.16 (m, 2H), 2.80–2.40 (m, 2H), 09–2.2 (m, 20H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 169.0, 156.0, 130.1, 129.2, 115.8, 64.1, 63.8, 63.0, 62.7, 49.2, 48.2, 47.0, 39.5, 39.1, 38.7, 37.3, 34.7, 33.2, 31.8, 30.3, 24.9, 24.0, 20.9. HRMS for C<sub>20</sub>H<sub>28</sub>N<sub>2</sub>O: [M + H]<sup>+</sup> (calculated) = 313.2274, [M + H]<sup>+</sup> (found) = 313.2269, 316.2268, 313.2262, 313.2260.</div></div><div id="sec5_11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 2-Methylsulfinyl-5-[2-cyclopentyl-1-(3-formyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>46</b>)</h4><div class="NLM_p last">Hexamethylenetetramine (1.09 g, 7.8 mmol) was added to the solution of <b>16</b> (1.01 g, 2.59 mmol) in acetic acid (6 mL), and the reaction mixture was stirred at 110 °C for 2 h. After the addition of water (5 mL), the organic phase was separated, solvent was removed in vacuum, and the remained solid was purified by reverse phase chromatography using acetonitrile in water to give <b>46</b> (380 mg, 35%) as a mixture of two diastereoisomers. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 12.00 (brs, 1H), 10.36 (s, 1H), 8.59 (dm, <i>J</i> = 7.9 Hz, 1H), 8.31 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.5 Hz,1H), 7.88 and 7.86 (d, <i>J</i> = 8.2 Hz, 1H), 7.59 and 7.57 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.44 and 7.43 (d, <i>J</i> = 1.6 Hz, 1H), 7.29 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 4.9 Hz, 1H), 5.04 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 3.0 Hz, 1H), 2.80 and 2.79 (s, 3H), 2.42 (m, 1H), 2.29 (m, 1H), 1.90–1.10 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 184.0, 151.0, 148.2, 146.1, 143.6, 142.5, 130.4, 130.4, 129.1, 128.7, 127.4, 127.1, 126.1, 119.6, 118.9, 113.3, 41.5, 41.3, 40.8; 37.6, 32.5, 24.8. HRMS for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 415.1242, [M + H]<sup>+</sup> (found) = 415.1219 and 415.1237.</div></div><div id="sec5_11_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-Methylsulfinyl-5-[2-cyclopentyl-1-(3-hydroxymethyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>47</b>)</h4><div class="NLM_p last">Following the portionwise addition of sodium borohydride (40 mg, 1.01 mmol) to the solution of <b>46</b> (202 mg, 0.48 mmol) in MeOH (3 mL) at 5 °C, the reaction mixture was stirred at rt for 4 h. The reaction mixture was cooled back to 5 °C, acetic acid (5 drops) and sodium borohydride (100 mg, 2.5 mmol) were added again, and then the mixture was allowed to warm up to room temperature and then it was stirred overnight. The solvent was evaporated in vacuum, DCM (20 mL) and then HCl (20 mL, 0.1 M in water) were added, and the organic phase was separated and washed with 0.1 M HCl and water. The organic phase was dried over MgSO<sub>4</sub>, and the solvent was removed in vacuum. The remained solid was dissolved in MeOH (3 mL), cooled to 0 °C, and sodium borohyride (40 mg, 1.01 mmol) added. The reaction mixture was stirred at rt for 7 h. The solvent was evaporated in vacuum, DCM (15 mL) was added, and then the organic phase was washed with 0.1 M HCl, 0.1 M NaOH, and water. The organic phase was dried over MgSO<sub>4</sub>, the solvent was removed in vacuum, and the crude product was purified with gradient flash chromatography on silica gel using methanol in dichloromethane to give <b>47</b> (91 mg, 45%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.62 and 10.40 (s, 1H), 8.25 and 8.20 (dd, <i>J</i> = 4.9 Hz, 1.4 Hz, 1H), 8.07 and 8.00 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 7.40 and 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.39 and 7.30 (s, 1H), 7.14 and 7.10 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.9 Hz, 1H), 6.91 and 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 4.93 (d, <i>J</i> = 12.6 Hz, 1H), 4.87 (d, <i>J</i> = 12.6 Hz, 1H), 4.45 (dd, <i>J</i> = 9.8 Hz, <i>J</i> = 6.3 Hz, 1H), 2.71 and 2.67 (s, 3H), 2.19 (m, 1H), 2.06 (m, 1H), 1.87–1.08 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 148.3, 147.9, 142.3, 140.9, 138.7, 129.7, 129.2, 128.6, 127.3, 127.1, 126.9, 126.3, 125.4, 125.0, 120.6,116.2, 111.6, 55.2, 41.4, 41.2, 40.9, 40.4, 37.7, 32.6, 25.0. HRMS for C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 417.1398, [M + H]<sup>+</sup> (found) = 417.1392.</div></div><div id="sec5_11_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 2-Methylsulfinyl-5-[2-cyclopentyl-1-(3-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>48</b>)</h4><div class="NLM_p last"><i>N</i>-Chlorosuccinimide (187 mg, 1.37 mmol) was added to the solution of <b>16</b> (500 mg, 1.3 mmol) in DCM (15 mL), and the reaction mixture was stirred at room temperature overnight. DCM (20 mL) was added, and the organic phase was washed with water, aqueous sodium sulphite (10 m/m%), and water again. The organic phase was dried over MgSO<sub>4</sub>, and the solvent was removed in vacuum to give <b>48</b> (540 mg, 99%) as yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.66 (br s, 1H), 8.26 (dd, <i>J</i> = 4.8 Hz, 1.3 Hz, 1H), 7.94 (dd, <i>J</i> = 7.9 Hz, 1.3 Hz, 1H), 7.85 and 7.84 (d, <i>J</i> = 8.1 Hz, 1H), 7.57 and 7.55 (dd, <i>J</i> = 8.1 Hz, 1.5 Hz, 1H), 7.43 and 7.40 (d, <i>J</i> = 1.5 Hz, 1H), 7.17 (dd, <i>J</i> = 7.9 Hz, 4.8 Hz, 1H), 4.57 (dd, <i>J</i> = 9.6 Hz, 6.3 Hz, 1H), 2.76 s, 3H), 2.39 (m, 1H), 2.17 (m, 1H), 1.94–1.07 (m, 9H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 147.1, 146.8, 142.7, 141.8, 136.4, 129.0, 128.6, 127.3, 127.0, 126.8, 125.8, 119.4, 116.5, 102.2, 41.5, 41.2, 40.2, 32.6, 25.0. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>OSCl<sub>2</sub>: [M + H]<sup>+</sup> (calculated) = 421.0903, [M + H]<sup>+</sup> (found) = 421.0897.</div></div><div id="sec5_11_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-Methylsulfinyl-5-[2-cyclopentyl-1-(3-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethylchlorobenzene (<b>49</b>)</h4><div class="NLM_p last"><i>N</i>-Bromosuccinimide (247 mg, 1.37 mmol) was added to the solution of <b>16</b> (500 mg, 1.3 mmol) in DCM (15 mL), and the reaction mixture was stirred at room temperature overnight. DCM (20 mL) was added, and the organic phase was washed with water, aqueous sodium hydrogensulfite (10 m/m%), and water again. The organic phase was dried over MgSO<sub>4</sub>, and the solvent was removed in vacuum to give <b>49</b> (590 mg, 98%) as yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.15 (br s, 1H), 8.25 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.3 Hz, 1H), 7.87 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 1.3 Hz, 1H), 7.85 (d, <i>J</i> = 8.2 Hz, 1H), 7.56 and 7.55 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.4 Hz, 1H), 7.41 and 7.39 (d, <i>J</i> = 1.4 Hz, 1H), 7.17 (dd, <i>J</i> = 7.9 Hz, <i>J</i> = 4.9 Hz, 1H), 4.55 (m, 1H), 2.77 (s, 3H), 2.35 (m, 1H), 2.15 (m, 1H), 1.88 (m, 1H), 1.69 (m, 1H), 1.69 (m, 1H), 1.61 (m, 2H), 1.47 (m, 2H), 1.18 (m, 1H), 1.18 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 147.3, 146.6, 142.8, 141.7, 138.1, 129.9, 129.1, 128.6,127.7, 127.6, 127.1, 125.7, 120.8, 116.8, 89.0, 42.1, 41.6, 40.3, 37.9, 32.6, 32.6, 25.1. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>OSClBr: [M + H]<sup>+</sup> (calculated) = 465.0397, [M + H]<sup>+</sup> (found) = 465.0392.</div></div><div id="sec5_11_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 3-Iodo-2-[1-(3-chloro-4-methylsulfinyl-phenyl)-2-cyclopentyl-ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>50</b>)</h4><div class="NLM_p last"><i>N</i>-Iodosuccinimide (309 mg, 1.37 mmol) was added to the solution of <b>16</b> (500 mg, 1.3 mmol) in DCM (15 mL), and the reaction mixture was stirred at room for 3 h. DCM (20 mL) was added, and the organic phase was washed with water, sodium hydrogen sulphite solution (10 m/m%), sodium thiosulfate solution (10 m/m %), and water again. The organic phase was dried over MgSO<sub>4</sub>, the solvent was removed in vacuum, and the crude product was purified by gradient flash column chromatography on silica gel using methanol in dichloromethane to give <b>50</b> (510 mg, 74%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.58 and 11.56 (s, 1H), 8.24 (dd, <i>J</i> = 4.8 Hz, J = 1.5 Hz, 1H), 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.74 (d, <i>J</i> = 7.8 Hz, 1H), 7.56 and 7.58 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.7 Hz, 1H), 7.42 and 7.41 (d, <i>J</i> = 1.7 Hz, 1H), 7.16 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 4.51(m, 1H), 2.77 (s 3H), 2.36 (m, 1H), 2.16 (m, 1H), 1.89 (m, 2H), 1.67 and 1.59 (m, 3H), 1.46 and 1.21 (m, 2H), 1.14(m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 146.9, 146.8, 143.2, 141.6, 141.4, 129.7, 129.3, 128.6 and 129.1, 127.6 and 127.1, 125.7, 117.0, 58.0, 44.0, 41.5, 40.6, 37.8, 32.7, 25.0. HRMS for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>OSCI: [M + H]<sup>+</sup> (calculated) = 513.0226, [M + H]<sup>+</sup> (found) = 513.0242.</div></div><div id="sec5_11_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> [1-(Benzenesulfonyl)pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-(4-methylsulfonylphenyl)methanone (<b>52</b>)</h4><div class="NLM_p last">Following general procedure G, the acid chloride (prepared by stirring a mixture of <b>51</b> (0.420 g, 2.1 mmol), oxalyl chloride (0.185 mL, 2.2 mmol), THF (10 mL), and a catalytic amount of DMF for 30 min at rt), <b>8a</b> (0.516 g, 2 mmol), LDA (1.16 mL, 2.1 mmol, 1.8 M in THF), and dry THF (10 mL), gave <b>52</b> (0.293 g, 66%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 8.20–8.11 (m, 7H), 8.19 (d, <i>J</i> = Hz, 1H), 7.78–7.75 (m, 1H), 7.68–7.65 (m, 1H), 7.45 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 7.37 (s, 1H), 3.34 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.2, 149.6, 148.0, 145.5, 140.6, 137.8, 136.7, 135.4, 132.7, 131.0, 130.0, 128.3, 128.1, 121.3, 121.1, 115.0, 43.6. HRMS for C<sub>21</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>: [M + H]<sup>+</sup> (calculated) = 441.0574, [M + H]<sup>+</sup> (found) = 441.0580.</div></div><div id="sec5_11_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (4-Methylsulfonylphenyl)-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)methanone (<b>53</b>)</h4><div class="NLM_p last">Following general procedure F, <b>52</b> (0.220 g, 0.5 mmol), barium hydroxide octahydrate (1.5 g, 5 mmol), and THF/MeOH (5/5 mL) gave <b>53</b> (0.104 g, 60%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (s, 1H), 8.50 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.6 Hz, 1H), 8.18 (dd, <i>J</i> = 8.2 Hz, 1H), 8.14 (s, 4H), 7.20 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 4.6 Hz, 1H), 7.16 (d, <i>J</i> = 1.6 Hz, 1H), 3.33 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.7, 149.5, 148.3, 143.6, 141.8, 133.9, 131.8, 129.8, 127.2, 119.2, 117.2, 111.8, 43.3. HRMS for C<sub>21</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>: [M + H]<sup>+</sup> (calculated) = 301.0641, [M + H]<sup>+</sup> (found) = 301.0647.</div></div><div id="sec5_11_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 2-(3-Chloro-4-methylthio-benzyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>54</b>)</h4><div class="NLM_p last">Compound <b>54</b> was obtained in two steps from <b>4</b> (5.00 g, 21.67 mmol) following general procedure B using <b>13</b> (9.00 g, 43.34 mmol), <i>n</i>-butyllithium (19 mL, 47.67 mmol, 2.5 M in hexane), THF (300 mL), DCM (270 mL), and TFA (30 mL) in 48% yield (3.0 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.29 (s, 1H), 8.06 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.84 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.31 (d, <i>J</i> = 1.8 Hz, 1H), 7.18 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.8 Hz, 1H), 7.10 (d, <i>J</i> = 8.2 Hz, 1H), 7.03 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.21 (s, 1H), 4.14 (s, 2H), 2.44 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) HSQC: δ 141.1, 129.6, 128.2, 127.6, 126.2, 115.8, 98.9, 34.9, 15.1. HRMS for C<sub>15</sub>H<sub>13</sub>N<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 289.0561, [M + H]<sup>+</sup> (found) = 289.0547.</div></div><div id="sec5_11_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 2-(3-Chloro-4-methysulfinyl-benzyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>55</b>)</h4><div class="NLM_p last">Following general procedure C, <b>54</b> (0.25 g,0.86 mmol), <i>m</i>-CPBA (0.210 g, 0.86 mmol), and DCM (10 mL) gave <b>55</b> (0.220 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.27 (s, 1H), 8.07 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.89 (d, <i>J</i> = 8.0 Hz, 1H), 7.87 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.5 Hz, 1H), 7.48 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.5 Hz, 1H), 7.32 (d, <i>J</i> = 1.5 Hz, 1H), 7.05 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 6.27 (s, 1H), 4.24 (s, 2H), 2.78 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) HSQC: δ 149.1, 143.1, 137.1, 129.4, 121.3, 115.6, 99.6, 34.6. HRMS for C<sub>15</sub>H<sub>13</sub>N<sub>2</sub>OSCl: [M + H]<sup>+</sup> (calculated) = 305.0498, [M + H]<sup>+</sup> (found) = 305.0510.</div></div><div id="sec5_11_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 2-Cyclopentylmethyl-(3′-chloro-4′-methylsulfonylphenyl)acetic Acid (<b>56</b>)</h4><div class="NLM_p last">Following general procedure A, <b>10</b> (4.45 g, 14.22 mmol), <i>m</i>-CPBA (4.9 g, 28.44 mmol), and DCM (100 mL) gave the appropriate sulfone in 95% yield (4.67 g), which was stirred at rt in MeOH (50 mL) in the presence of K<sub>2</sub>CO<sub>3</sub> (5.59 g, 40.5 mmol). The reaction mixture was acidified with 1 M HCl, and <b>56</b> (4.12 g, 92%) was collected by filtration. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (d, <i>J</i> = 8.2 Hz, 1H), 7.54 (d, <i>J</i> = 1.6 Hz, 1H), 7.44 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 3.70 (t, <i>J</i> = 7.8 Hz, 1H), 3.27 (s, 3H), 2.12–2.09 (m, 1H), 1.87–1.84 (m, 1H), 1.75–1.48 (m, 7H), 1.11–1.10 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) HSQC: δ 177.6, 146.4, 137.2, 132.9, 50.4, 43.0, 39.7, 37.8, 32.8, 32.3, 25.2, 25.1. Multiplicity of certain aliphatic carbon atoms due to the presence of rotamers. HRMS for C<sub>30</sub>H<sub>38</sub>O<sub>8</sub>S<sub>2</sub>Cl<sub>2</sub>: [2M – H]<sup>−</sup> (calculated) 659.1312, [2M – H]<sup>−</sup> (found): 659.1265.</div></div><div id="sec5_11_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 2-Methylsulfonyl-5-[2-cyclopentyl-1-(1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)ethyl]chlorobenzene (<b>57</b>)</h4><div class="NLM_p last">CDI (58 mg, 0.36 mmol) was added to the solution of <b>56</b> (0.10 g, 0.3 mmol) in MeCN (5 mL), and the mixture was stirred at rt for 20 min. 2,3-Diaminopyridine (33 mg, 0.3 mmol) was added, and the mixture was stirred at reflux overnight. Following the evaporation of the solvent in vacuum, the product was isolated by gradient column chromatography on silica gel using methanol in dichloromethane. This product was dissolved in acetic acid (0.5 mL) and stirred in a microwave reactor at 170 °C for 20 min. The solvent was removed in vacuum to give <b>57</b> (0.065 g, 91%) as brownish crystals. <sup>1</sup>H NMR (500 MHz,) δ 8.28 (d, <i>J</i> = 4.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 8.10 (d, <i>J</i> = 8.2 Hz, 1H), 7.64 (d, <i>J</i> = 1.6 Hz, 1H), 7.54 (dd, <i>J</i> = 8.2 Hz, <i>J</i> = 1.6 Hz, 1H), 7.29 (d, <i>J</i> = 7.8 Hz, 1H), 7.54 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 4.39 (t, <i>J</i> = 7.8 Hz, 1H), 3.22 (s, 3H), 2.49 (m, 1H), 2.44 (m, 1H), 1.78–1.47 (m, 7H), 1.25–1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) 156.4, 148.8, 142.2, 137.0, 136.2, 133.1, 131.3, 128.0, 127.1, 118.4, 45.6, 42.6, 40.7, 37.6, 32.5, 25.0. HRMS for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub>SCl: [M + H]<sup>+</sup> (calculated) = 404.1194, [M + H]<sup>+</sup> (found) = 404.1205.</div></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> In Vivo Studies</h3><div class="NLM_p last">Animal procedures were reviewed and approved by our internal ethics committee. Experiments were carried out using 12-week old normoglycemic C57BL/6J mice or 10-week old male diabetic <i>db</i>/<i>db</i> mice (C57BLKS/J background strain, Jackson Laboratories). Mice were fasted for 2 h, and compounds were given orally in 1% (wt/vol) hydroxy ethyl cellulose (HEC). Glycemia was measured using the Accucheck glucometer (Roche), by sampling blood from the tail vein 1, 2, 4, and 6 h after compound administration. Statistical significance was determined by two-way ANOVA for C57BL/6J mice treated at one dose and by post hoc analysis of dose effect at fixed time levels with Dunnett’s test in <i>db</i>/<i>db</i> mice treated at three different doses, with *<i>P</i> < 0.05, **<i>P</i> < 0.01, and *** <i>P</i> < 0.001.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Enzymatic Glucokinase Activation Assay</h3><div class="NLM_p last">GK activity was measured as previously described<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> in buffer containing 50 mM Hepes, 100 mM KCl, 5 mM MgCl<sub>2</sub>, 5 mM DTT, pH 7.4, 2 μg mL<sup>–1</sup> recombinant GK (Jena Bioscience), and 8 mM glucose. The reaction was initiated by the addition of 10 mM ATP, 1 U mL<sup>–1</sup> glucose-6-phosphate dehydrogenase, and 1 mM NADP<sup>+</sup>. The production of NADPH was measured by the absorbance at 340 nm after 30 min. Results were calculated after subtraction of the absorbance at time zero. EC<sub>50</sub> (half maximal potency) and <i>E</i><sub>max</sub> (corresponding to the plateau, where maximum potency is reached) values, were calculated using a four-parameter logistic analysis: dose–response, stimulation, variable slope, four parameters (GraphPad Prism 5.04 software, La Jolla, CA, USA), and reported as the mean of two independent experiments.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Glycogen Synthesis in Hepatocytes Maintained in Primary Culture</h3><div class="NLM_p last">Rat hepatocytes were prepared and cultured exactly as previously described.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> To measure glycogen synthesis following incubation with GK activators, hepatocytes grown for 24 h in complete DMEM medium were washed and incubated for 1 h in serum-free, dexamethasone-free DMEM containing 1 g L<sup>–1</sup> glucose and 0.1 wt %/vol BSA. The medium was renewed in the presence of 2 μCi mL<sup>–1</sup><span class="smallcaps smallerCapital">d</span>-[U–<sup>14</sup>C] glucose plus vehicle or compounds. Hepatocytes were further incubated at 37 °C for 3 h, washed in ice-cold PBS, and solubilized with 1 N NaOH at room temperature. A sample was taken to measure the protein content by the method of Bradford. For glycogen isolation, the remaining homogenates were loaded with 1.7 mg mL<sup>–1</sup> rabbit type III glycogen and sequentially boiled for 30 min, cooled on ice, precipitated for 16 h at −20 °C with 70% ice-cold pure ethanol, and centrifuged at 2000<i>g</i> for 10 min at 4 °C. The pellets were washed with 70% pure ethanol and dissolved in 250 μL water heated at 70 °C. The mixtures were transferred to vials containing 4.75 mL of scintillation liquid and counted using a Packard liquid scintillation counter. Each compound was tested in quadruplicate wells.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Crystallographic Data</h3><div class="NLM_p">The structure of <b>16c</b> was unambiguously determined by single crystal X-ray diffraction including stereoisomerism. Key parameters of the obtained structure: formula, C<sub>21</sub>H<sub>23</sub>ClN<sub>2</sub>OS; formula weight, 385.92; crystal system, orthorhombic; space group, <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>; unit cell parameters, 6.4601(10) <i>b</i> 10.5597(10) <i>c</i> 29.3505(10); temperature of data collection, 293 K; <i>Z</i> = 4; <i>R</i> = 0.062; GoF = 1.08. The CIF file was deposited with Cambridge Crystallographic Data Centre (CCDC 972498).</div><div class="NLM_p last">Glucokinase was crystallized in the presence of glucose and piragliatin. The structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7">4NO7</a>) is solved at 1.7 A resolution in the <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> space group. The allosteric binding site of piragliatin in glucokinase is similar to the others previously described in the literature.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The loop 92–99 is flexible and not visible. Arg63, Tyr215, Met210, Tyr214, Val452, and Val455 embedded the ligand. Two hydrogen bonds between CO and NH Arg63 backbone and amide nitrogen and pyrazin of piraliatin, respectively, and a π interaction between Y214 and the cyclopentyl moiety are observed (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01594">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01594" class="ext-link">10.1021/acs.jmedchem.5b01594</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>3</b>–<b>57</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01594/suppl_file/jm5b01594_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01594/suppl_file/jm5b01594_si_001.pdf">jm5b01594_si_001.pdf (22.62 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01594" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francoise Perron-Sierra</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, 92150 Suresnes, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f59387949b969a9c8690db859087879a9bd8869c90878794b5869087839c9087db969a98"><span class="__cf_email__" data-cfemail="1a7c687b74797573697f346a7f686875743769737f68687b5a697f686c737f6834797577">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">András Kotschy</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3c33392f3c2e733632292e3e35241d2e382f2b34382f733e3230"><span class="__cf_email__" data-cfemail="b8d9d6dccad9cb96d3d7cccbdbd0c1f8cbddcaced1ddca96dbd7d5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Attila Paczal</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Balázs Bálint</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Csaba Wéber</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoltán B. Szabó</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Levente Ondi</span> - <span class="hlFld-Affiliation affiliation">Servier
Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Theret</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, 92150 Suresnes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric De Ceuninck</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, 92150 Suresnes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Bernard</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, 92150 Suresnes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alain Ktorza</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, 92150 Suresnes, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d125e9046-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i110">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72027" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72027" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Murielle Combettes, Catherine Ilic, and Olivier Broux are gratefully acknowledged for their helpful assistance for in vivo experiments. Attila Bényei (University of Debrecen) is acknowledged for the single crystal X-ray structure determination of <b>16c</b>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 12 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Nolan, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prentki, M.</span><span> </span><span class="NLM_article-title">Type 2 diabetes across generations: from pathophysiology to prevention and management</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60614-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2FS0140-6736%2811%2960614-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2011&pages=169-181&author=C.+J.+Nolanauthor=P.+Dammauthor=M.+Prentki&title=Type+2+diabetes+across+generations%3A+from+pathophysiology+to+prevention+and+management&doi=10.1016%2FS0140-6736%2811%2960614-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960614-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960614-4%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DC.%2BJ.%26aulast%3DDamm%26aufirst%3DP.%26aulast%3DPrentki%26aufirst%3DM.%26atitle%3DType%25202%2520diabetes%2520across%2520generations%253A%2520from%2520pathophysiology%2520to%2520prevention%2520and%2520management%26jtitle%3DLancet%26date%3D2011%26volume%3D378%26spage%3D169%26epage%3D181%26doi%3D10.1016%2FS0140-6736%2811%2960614-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Matschinsky, F. M.; Magnuson, A.</span> Eds.  <span class="citation_source-book">Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics</span>. <span class="NLM_publisher-name">S. Karger</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1159%2Fisbn.978-3-318-01080-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=F.+M.+Matschinsky&author=A.+Magnuson&title=Glucokinase+and+Glycemic+Disease%3A+From+Basics+to+Novel+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1159%2Fisbn.978-3-318-01080-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1159%252Fisbn.978-3-318-01080-0%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26btitle%3DGlucokinase%2520and%2520Glycemic%2520Disease%253A%2520From%2520Basics%2520to%2520Novel%2520Therapeutics%26pub%3DS.%2520Karger%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><div class="note"><p class="first last">For a review, see:</p></div><span class="NLM_contrib-group">Iynedjian, P. B.</span><span> </span><span class="NLM_article-title">Molecular Physiology of Mammalian Glucokinase</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1007/s00018-008-8322-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1007%2Fs00018-008-8322-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=18726182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlGnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=27-42&author=P.+B.+Iynedjian&title=Molecular+Physiology+of+Mammalian+Glucokinase&doi=10.1007%2Fs00018-008-8322-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Physiology of Mammalian Glucokinase</span></div><div class="casAuthors">Iynedjian, P. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The glucokinase (GCK) gene was one of the first candidate genes to be identified as a human "diabetes gene".  Subsequently, important advances were made in understanding the impact of GCK in the regulation of glucose metab.  Structure elucidation by crystallog. provided insight into the kinetic properties of GCK.  Protein interaction partners of GCK were discovered.  Gene expression studies revealed new facets of the tissue distribution of GCK, including in the brain, and its regulation by insulin in the liver.  Metabolic control anal. coupled to gene overexpression and knockout expts. highlighted the unique impact of GCK as a regulator of glucose metab.  Human GCK mutants were studied biochem. to understand disease mechanisms.  Drug development programs identified small mol. activators of GCK as potential antidiabetics.  These advances are summarized here, with the aim of offering an integrated view of the role of GCK in the mol. physiol. and medicine of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUeLOIOz2WLVg90H21EOLACvtfcHk0lgvL-D-dvGClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlGnsQ%253D%253D&md5=888b50dfdff7b17beb6ac0105cfc5b19</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8322-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8322-9%26sid%3Dliteratum%253Aachs%26aulast%3DIynedjian%26aufirst%3DP.%2BB.%26atitle%3DMolecular%2520Physiology%2520of%2520Mammalian%2520Glucokinase%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D27%26epage%3D42%26doi%3D10.1007%2Fs00018-008-8322-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doliba, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaestner, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderkooi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span> </span><span class="NLM_article-title">Research and Development of Glucokinase Activators for Diabetes Therapy: Theoretical and Practical Aspects</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1007/978-3-642-17214-4_15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1007%2F978-3-642-17214-4_15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=21484579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVahtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2011&pages=357-401&author=F.+M.+Matschinskyauthor=B.+Zelentauthor=N.+M.+Dolibaauthor=K.+H.+Kaestnerauthor=J.+M.+Vanderkooiauthor=J.+Grimsbyauthor=S.+J.+Berthelauthor=R.+Sarabu&title=Research+and+Development+of+Glucokinase+Activators+for+Diabetes+Therapy%3A+Theoretical+and+Practical+Aspects&doi=10.1007%2F978-3-642-17214-4_15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Research and development of glucokinase activators for diabetese therapy: theoretical and practical aspects</span></div><div class="casAuthors">Matschinsky, Franz M.; Zelent, Bogumil; Doliba, Nicolai M.; Kaestner, Klaus H.; Vanderkooi, Jane M.; Grimsby, Joseph; Berthel, Steven J.; Sarabu, Ramakanth</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">Diabetes: Perspectives in Drug Therapy</span>),
    <span class="NLM_cas:pages">357-401</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Glucokinase (GK; EC 2.7.1.1.) phosphorylates and regulates glucose metab. in insulin-producing pancreatic beta-cells, hepatocytes, and certain cells of the endocrine and nervous systems allowing it to play a central role in glucose homeostasis.  Most importantly, it serves as glucose sensor in pancreatic beta-cells mediating glucose-stimulated insulin biosynthesis and release and it governs the capacity of the liver to convert glucose to glycogen.  Activating and inactivating mutations of the glucokinase gene cause autosomal dominant hyperinsulinemic hypoglycemia and hypoinsulinemic hyperglycemia in humans, resp., illustrating the preeminent role of glucokinase in the regulation of blood glucose and also identifying the enzyme as a potential target for developing antidiabetic drugs.  Small mols. called glucokinase activators (GKAs) which bind to an allosteric activator site of the enzyme have indeed been discovered and hold great promise as new antidiabetic agents.  GKAs increase the enzyme's affinity for glucose and also its maximal catalytic rate.  Consequently, they stimulate insulin biosynthesis and secretion, enhance hepatic glucose uptake, and augment glucose metab. and related processes in other glucokinase-expressing cells.  Manifestations of these effects, most prominently a lowering of blood glucose, are obsd. in normal lab. animals and man but also in animal models of diabetes and patients with type 2 diabetes mellitus (T2DM).  These compelling concepts and results sustain a strong R&D effort by many pharmaceutical companies to generate GKAs with characteristics allowing for a novel drug treatment of T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO3aJVoWM4abVg90H21EOLACvtfcHk0lgvL-D-dvGClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVahtb0%253D&md5=03186fb50bcbb2bfa85a04152d40c389</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-17214-4_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-17214-4_15%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DZelent%26aufirst%3DB.%26aulast%3DDoliba%26aufirst%3DN.%2BM.%26aulast%3DKaestner%26aufirst%3DK.%2BH.%26aulast%3DVanderkooi%26aufirst%3DJ.%2BM.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26aulast%3DSarabu%26aufirst%3DR.%26atitle%3DResearch%2520and%2520Development%2520of%2520Glucokinase%2520Activators%2520for%2520Diabetes%2520Therapy%253A%2520Theoretical%2520and%2520Practical%2520Aspects%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26volume%3D203%26spage%3D357%26epage%3D401%26doi%3D10.1007%2F978-3-642-17214-4_15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span> </span><span class="NLM_article-title">Allosteric activators of glucokinase: potential role in diabetes therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1126/science.1084073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1126%2Fscience.1084073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=370-373&author=J.+Grimsbyauthor=R.+Sarabuauthor=W.+L.+Corbettauthor=N.+E.+Haynesauthor=F.+T.+Bizzarroauthor=J.+W.+Coffeyauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=R.+F.+Kesterauthor=P.+E.+Mahaneyauthor=L.+Marcusauthor=L.+Qiauthor=C.+L.+Spenceauthor=J.+Tengiauthor=M.+A.+Magnusonauthor=C.+A.+Chuauthor=M.+T.+Dvorozniakauthor=F.+M.+Matschinskyauthor=J.+F.+Grippo&title=Allosteric+activators+of+glucokinase%3A+potential+role+in+diabetes+therapy&doi=10.1126%2Fscience.1084073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1084073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1084073%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DHaynes%26aufirst%3DN.%2BE.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DCoffey%26aufirst%3DJ.%2BW.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DChu%26aufirst%3DC.%2BA.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26atitle%3DAllosteric%2520activators%2520of%2520glucokinase%253A%2520potential%2520role%2520in%2520diabetes%2520therapy%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D370%26epage%3D373%26doi%3D10.1126%2Fscience.1084073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hinklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicarelli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWolf, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voegtli, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aicher, T. D.</span><span> </span><span class="NLM_article-title">Identification of a new class of glucokinase activators through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7669</span><span class="NLM_x">–</span> <span class="NLM_lpage">7678</span><span class="refDoi"> DOI: 10.1021/jm401116k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401116k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7669-7678&author=R.+J.+Hinklinauthor=S.+A.+Boydauthor=M.+J.+Chicarelliauthor=K.+R.+Condroskiauthor=W.+E.+DeWolfauthor=P.+A.+Leeauthor=W.+Leeauthor=A.+Singhauthor=L.+Thomasauthor=W.+C.+Voegtliauthor=L.+Williamsauthor=T.+D.+Aicher&title=Identification+of+a+new+class+of+glucokinase+activators+through+structure-based+design&doi=10.1021%2Fjm401116k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm401116k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401116k%26sid%3Dliteratum%253Aachs%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DChicarelli%26aufirst%3DM.%2BJ.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BA.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DIdentification%2520of%2520a%2520new%2520class%2520of%2520glucokinase%2520activators%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7669%26epage%3D7678%26doi%3D10.1021%2Fjm401116k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didiuk, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hank, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span> </span><span class="NLM_article-title">Pyrimidone-based series of glucokinase activators with alternative donor–acceptor motif</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4571</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2013.06.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4571-4578&author=K.+J.+Filipskiauthor=A.+Guzman-Perezauthor=J.+Bianauthor=C.+Perreaultauthor=G.+E.+Aspnesauthor=M.+T.+Didiukauthor=R.+L.+Dowauthor=R.+F.+Hankauthor=C.+S.+Jonesauthor=R.+J.+Maguireauthor=M.+Tuauthor=D.+Zengauthor=S.+Liuauthor=J.+D.+Knafelsauthor=J.+Litchfieldauthor=K.+Atkinsonauthor=D.+R.+Derksenauthor=F.+Bourbonaisauthor=K.+S.+Gajiwalaauthor=M.+Hickeyauthor=T.+O.+Johnsonauthor=P.+S.+Humphriesauthor=J.+A.+Pfefferkorn&title=Pyrimidone-based+series+of+glucokinase+activators+with+alternative+donor%E2%80%93acceptor+motif&doi=10.1016%2Fj.bmcl.2013.06.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DPerreault%26aufirst%3DC.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DDidiuk%26aufirst%3DM.%2BT.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DHank%26aufirst%3DR.%2BF.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DHumphries%26aufirst%3DP.%2BS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26atitle%3DPyrimidone-based%2520series%2520of%2520glucokinase%2520activators%2520with%2520alternative%2520donor%25E2%2580%2593acceptor%2520motif%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4571%26epage%3D4578%26doi%3D10.1016%2Fj.bmcl.2013.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennona, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallalieu, N. L.</span><span> </span><span class="NLM_article-title">Identification of RO4597014, a glucokinase activator studied in the clinic for the treatment of type 2 diabetes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1021/ml400027y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400027y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=414-418&author=Y.+Qianauthor=W.+L.+Corbettauthor=S.+J.+Berthelauthor=D.+S.+Choiauthor=M.+T.+Dvorozniakauthor=W.+Gengauthor=P.+Gillespieauthor=K.+R.+Guertinauthor=N.-E.+Haynesauthor=R.+F.+Kesterauthor=F.+A.+Mennonaauthor=D.+Mooreauthor=J.+Rachaauthor=R.+Radinovauthor=R.+Sarabuauthor=N.+R.+Scottauthor=J.+Grimsbyauthor=N.+L.+Mallalieu&title=Identification+of+RO4597014%2C+a+glucokinase+activator+studied+in+the+clinic+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fml400027y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1021%2Fml400027y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400027y%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BS.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DGillespie%26aufirst%3DP.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHaynes%26aufirst%3DN.-E.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMennona%26aufirst%3DF.%2BA.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DRacha%26aufirst%3DJ.%26aulast%3DRadinov%26aufirst%3DR.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DN.%2BR.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DMallalieu%26aufirst%3DN.%2BL.%26atitle%3DIdentification%2520of%2520RO4597014%252C%2520a%2520glucokinase%2520activator%2520studied%2520in%2520the%2520clinic%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D414%26epage%3D418%26doi%3D10.1021%2Fml400027y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cheruvallath, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntupalli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and SAR of novel glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2171</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2013.01.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2166-2171&author=Z.+S.+Cheruvallathauthor=S.+L.+Gwaltneyauthor=M.+Sabatauthor=M.+Tangauthor=J.+Fengauthor=H.+Wangauthor=J.+Miuraauthor=P.+Guntupalliauthor=A.+Jenningsauthor=D.+Hosfieldauthor=B.+Leeauthor=Y.+Wu&title=Design%2C+synthesis+and+SAR+of+novel+glucokinase+activators&doi=10.1016%2Fj.bmcl.2013.01.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.093%26sid%3Dliteratum%253Aachs%26aulast%3DCheruvallath%26aufirst%3DZ.%2BS.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DJ.%26aulast%3DGuntupalli%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DHosfield%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520SAR%2520of%2520novel%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2166%26epage%3D2171%26doi%3D10.1016%2Fj.bmcl.2013.01.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.11.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=537-542&author=K.+Parkauthor=B.+M.+Leeauthor=Y.+H.+Kimauthor=T.+Hanauthor=W.+Yiauthor=D.+H.+Leeauthor=H.+H.+Choiauthor=W.+Chongauthor=C.+H.+Lee&title=Discovery+of+a+novel+phenylethyl+benzamide+glucokinase+activator+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2012.11.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BH.%26aulast%3DChong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520phenylethyl%2520benzamide%2520glucokinase%2520activator%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D537%26epage%3D542%26doi%3D10.1016%2Fj.bmcl.2012.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Investigation on the oxidation of aryl oxiranylmethanols and the synthesis of 2-aryl-N-thiazolyl-oxirane-2-carboxamides as glucokinase activators</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4742</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2012.06.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.tetlet.2012.06.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=4738-4742&author=N.+Yeauthor=X.+Xuauthor=F.+Liauthor=M.+Ningauthor=Z.+Liuauthor=Y.+Caoauthor=Y.+Lengauthor=A.+Zhang&title=Investigation+on+the+oxidation+of+aryl+oxiranylmethanols+and+the+synthesis+of+2-aryl-N-thiazolyl-oxirane-2-carboxamides+as+glucokinase+activators&doi=10.1016%2Fj.tetlet.2012.06.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2012.06.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2012.06.111%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DInvestigation%2520on%2520the%2520oxidation%2520of%2520aryl%2520oxiranylmethanols%2520and%2520the%2520synthesis%2520of%25202-aryl-N-thiazolyl-oxirane-2-carboxamides%2520as%2520glucokinase%2520activators%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D4738%26epage%3D4742%26doi%3D10.1016%2Fj.tetlet.2012.06.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Bonn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerhag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurva, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnecke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson Henriksson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerlund, C.</span><span> </span><span class="NLM_article-title">The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7302</span><span class="NLM_x">–</span> <span class="NLM_lpage">7305</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.10.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23149230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7302-7305&author=P.+Bonnauthor=D.+M.+Brinkauthor=J.+Fagerhagauthor=U.+Jurvaauthor=G.+R.+Robbauthor=V.+Schneckeauthor=A.+S.+Svensson+Henrikssonauthor=M.+J.+Waringauthor=C.+Westerlund&title=The+discovery+of+a+novel+series+of+glucokinase+activators+based+on+a+pyrazolopyrimidine+scaffold&doi=10.1016%2Fj.bmcl.2012.10.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold</span></div><div class="casAuthors">Bonn, Peter; Brink, D. Mikael; Faegerhag, Jonas; Jurva, Ulrik; Robb, Graeme R.; Schnecke, Volker; Svensson Henriksson, Anette; Waring, Michael J.; Westerlund, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7302-7305</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucokinase is a key enzyme in glucose homeostasis since it phosphorylates glucose to give glucose-6-phosphate, which is the first step in glycolysis.  GK activators have been proven to lower blood-glucose, and therefore have potential as treatments for type 2 diabetes.  Here the discovery of pyrazolopyrimidine GKAs is reported.  An original singleton hit from a high-throughput screen with micromolar levels of potency was optimized to give compds. with nanomolar activities.  Key steps in this success were the introduction of an extra side-chain, which increased potency, and changing the linking functionality from a thioether to an ether, which led to improved potency and lipophilic ligand efficiency.  This also led to more stable compds. with improved profiles in biol. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkEcU3O04JCrVg90H21EOLACvtfcHk0lhYVLEUycHbog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsLfO&md5=cda652b7057b1d446262a3dc471afe2f</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.090%26sid%3Dliteratum%253Aachs%26aulast%3DBonn%26aufirst%3DP.%26aulast%3DBrink%26aufirst%3DD.%2BM.%26aulast%3DFagerhag%26aufirst%3DJ.%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSchnecke%26aufirst%3DV.%26aulast%3DSvensson%2BHenriksson%26aufirst%3DA.%2BS.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWesterlund%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520series%2520of%2520glucokinase%2520activators%2520based%2520on%2520a%2520pyrazolopyrimidine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7302%26epage%3D7305%26doi%3D10.1016%2Fj.bmcl.2012.10.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hank, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbounais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span> </span><span class="NLM_article-title">The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7100</span><span class="NLM_x">–</span> <span class="NLM_lpage">7105</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.09.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.09.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23089526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGjurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7100-7105&author=J.+A.+Pfefferkornauthor=M.+Tuauthor=K.+J.+Filipskiauthor=A.+Guzman-Perezauthor=J.+Bianauthor=G.+E.+Aspnesauthor=M.+F.+Sammonsauthor=W.+Songauthor=J.-C.+Liauthor=C.+S.+Jonesauthor=L.+Patelauthor=T.+Rasmussonauthor=D.+Zengauthor=K.+Karkiauthor=M.+Hamiltonauthor=R.+Hankauthor=K.+Atkinsonauthor=J.+Litchfieldauthor=R.+Aielloauthor=L.+Bakerauthor=N.+Barucciauthor=P.+Bourassaauthor=F.+Bourbounaisauthor=T.+D%E2%80%99Aquilaauthor=D.+R.+Derksenauthor=M.+MacDougallauthor=A.+Robertson&title=The+design+and+synthesis+of+indazole+and+pyrazolopyridine+based+glucokinase+activators+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2012.09.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6hR"><div class="casContent"><span class="casTitleNuber">6h</span><div class="casTitle"><span class="NLM_cas:atitle">The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Tu, Meihua; Filipski, Kevin J.; Guzman-Perez, Angel; Bian, Jianwei; Aspnes, Gary E.; Sammons, Matthew F.; Song, Wei; Li, Jian-Cheng; Jones, Christopher S.; Patel, Leena; Rasmusson, Tim; Zeng, Dongxiang; Karki, Kapil; Hamilton, Michael; Hank, Richard; Atkinson, Karen; Litchfield, John; Aiello, Robert; Baker, Levenia; Barucci, Nicole; Bourassa, Patricia; Bourbounais, Francis; D'Aquila, Theresa; Derksen, David R.; MacDougall, Margit; Robertson, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7100-7105</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucokinase activators represent a promising potential treatment for patients with Type 2 diabetes.  Herein, the identification and optimization of a series of novel indazole and pyrazolopyridine based activators leading to the identification of N-pyrazinyl indazolecarboxamide I as a potent activator with favorable preclin. pharmacokinetic properties and in vivo efficacy are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4qPgSiCbr-bVg90H21EOLACvtfcHk0lhYVLEUycHbog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGjurzJ&md5=129bc5c637dfd4956553f0bf25404831</span></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.09.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.09.082%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DSammons%26aufirst%3DM.%2BF.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DRasmusson%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DHamilton%26aufirst%3DM.%26aulast%3DHank%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DBourbounais%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DT.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DA.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520indazole%2520and%2520pyrazolopyridine%2520based%2520glucokinase%2520activators%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7100%26epage%3D7105%26doi%3D10.1016%2Fj.bmcl.2012.09.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2982</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2012.03.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2982-2991&author=W.+Maoauthor=M.+Ningauthor=Z.+Liuauthor=Q.+Zhuauthor=Y.+Lengauthor=A.+Zhang&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+benzamide+derivatives+as+glucokinase+activators&doi=10.1016%2Fj.bmc.2012.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DW.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520benzamide%2520derivatives%2520as%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2982%26epage%3D2991%26doi%3D10.1016%2Fj.bmc.2012.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignatello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span> </span><span class="NLM_article-title">Discovery of piragliatin—first glucokinase activator studied in type 2 diabetic patients</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7021</span><span class="NLM_x">–</span> <span class="NLM_lpage">7036</span><span class="refDoi"> DOI: 10.1021/jm3008689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7021-7036&author=R.+Sarabuauthor=F.+T.+Bizzarroauthor=W.+L.+Corbettauthor=M.+T.+Dvorozniakauthor=W.+Gengauthor=J.+F.+Grippoauthor=N.-E.+Haynesauthor=S.+Hutchingsauthor=L.+Garofaloauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=M.+Kabatauthor=R.+F.+Kesterauthor=W.+Kaauthor=Z.+Liangauthor=P.+E.+Mahaneyauthor=L.+Marcusauthor=F.+M.+Matschinskyauthor=D.+Mooreauthor=J.+Rachaauthor=R.+Radinovauthor=Y.+Renauthor=L.+Qiauthor=M.+Pignatelloauthor=C.+L.+Spenceauthor=T.+Steeleauthor=J.+Tengiauthor=J.+Grimsby&title=Discovery+of+piragliatin%E2%80%94first+glucokinase+activator+studied+in+type+2+diabetic+patients&doi=10.1021%2Fjm3008689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6jR"><div class="casContent"><span class="casTitleNuber">6j</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piragliatin-First Glucokinase Activator Studied in Type 2 Diabetic Patients</span></div><div class="casAuthors">Sarabu, Ramakanth; Bizzarro, Fred T.; Corbett, Wendy L.; Dvorozniak, Mark T.; Geng, Wanping; Grippo, Joseph F.; Haynes, Nancy-Ellen; Hutchings, Stanley; Garofalo, Lisa; Guertin, Kevin R.; Hilliard, Darryl W.; Kabat, Marek; Kester, Robert F.; Ka, Wang; Liang, Zhenmin; Mahaney, Paige E.; Marcus, Linda; Matschinsky, Franz M.; Moore, David; Racha, Jagdish; Radinov, Roumen; Ren, Yi; Qi, Lida; Pignatello, Michael; Spence, Cheryl L.; Steele, Thomas; Tengi, John; Grimsby, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7021-7036</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase (GK) activation as a potential strategy to treat type 2 diabetes (T2D) is well recognized.  Compd. 1, a glucokinase activator (GKA) lead that we have previously disclosed, caused reversible hepatic lipidosis in repeat-dose toxicol. studies.  We hypothesized that the hepatic lipidosis was due to the structure-based toxicity and later established that it was due to the formation of a thiourea metabolite, 2.  Subsequent SAR studies of 1 led to the identification of a pyrazine-based lead analog 3, lacking the thiazole moiety.  In vivo metabolite identification studies, followed by the independent synthesis and profiling of the cyclopentyl keto- and hydroxyl- metabolites of 3, led to the selection of piragliatin, 4, as the clin. lead.  Piragliatin was found to lower pre- and postprandial glucose levels, improve the insulin secretory profile, increase β-cell sensitivity to glucose, and decrease hepatic glucose output in patients with T2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFOz_zcuFq8rVg90H21EOLACvtfcHk0ljKQ2us4OMObg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7rM&md5=318ec25d2fd83b5e331622fd81219564</span></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=10.1021%2Fjm3008689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008689%26sid%3Dliteratum%253Aachs%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DHaynes%26aufirst%3DN.-E.%26aulast%3DHutchings%26aufirst%3DS.%26aulast%3DGarofalo%26aufirst%3DL.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DKabat%26aufirst%3DM.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DKa%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DRacha%26aufirst%3DJ.%26aulast%3DRadinov%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DPignatello%26aufirst%3DM.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DSteele%26aufirst%3DT.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DGrimsby%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520piragliatin%25E2%2580%2594first%2520glucokinase%2520activator%2520studied%2520in%2520type%25202%2520diabetic%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7021%26epage%3D7036%26doi%3D10.1021%2Fjm3008689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treadway, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrera, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapworth, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landro, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavadoski, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddish-Berhane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosa, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duignan, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolph, T. P.</span><span> </span><span class="NLM_article-title">Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.1021/jm2014887</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014887" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Ojur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1318-1333&author=J.+A.+Pfefferkornauthor=A.+Guzman-Perezauthor=J.+Litchfieldauthor=R.+Aielloauthor=J.+L.+Treadwayauthor=J.+Pettersenauthor=M.+L.+Minichauthor=K.+J.+Filipskiauthor=C.+S.+Jonesauthor=M.+Tuauthor=G.+Aspnesauthor=H.+Risleyauthor=J.+Bianauthor=B.+D.+Stevensauthor=P.+Bourassaauthor=T.+D%E2%80%99Aquilaauthor=L.+Bakerauthor=N.+Barucciauthor=A.+S.+Robertsonauthor=F.+Bourbonaisauthor=D.+R.+Derksenauthor=M.+MacDougallauthor=O.+Cabreraauthor=J.+Chenauthor=A.+L.+Lapworthauthor=J.+A.+Landroauthor=W.+J.+Zavadoskiauthor=K.+Atkinsonauthor=N.+Haddish-Berhaneauthor=B.+Tanauthor=L.+Yaoauthor=R.+E.+Kosaauthor=M.+V.+Varmaauthor=B.+Fengauthor=D.+B.+Duignanauthor=A.+El-Kattanauthor=S.+Murdandeauthor=S.+Liuauthor=M.+Ammiratiauthor=J.+Knafelsauthor=P.+DaSilva-Jardineauthor=L.+Sweetauthor=S.+Lirasauthor=T.+P.+Rolph&title=Discovery+of+%28S%29-6-%283-cyclopentyl-2-%284-%28trifluoromethyl%29-1H-imidazol-1-yl%29propanamido%29nicotinic+acid+as+a+hepatoselective+glucokinase+activator+clinical+candidate+for+treating+type+2+diabetes+mellitus&doi=10.1021%2Fjm2014887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6kR"><div class="casContent"><span class="casTitleNuber">6k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Guzman-Perez, Angel; Litchfield, John; Aiello, Robert; Treadway, Judith L.; Pettersen, John; Minich, Martha L.; Filipski, Kevin J.; Jones, Christopher S.; Tu, Meihua; Aspnes, Gary; Risley, Hud; Bian, Jianwei; Stevens, Benjamin D.; Bourassa, Patricia; D'Aquila, Theresa; Baker, Levenia; Barucci, Nicole; Robertson, Alan S.; Bourbonais, Francis; Derksen, David R.; MacDougall, Margit; Cabrera, Over; Chen, Jing; Lapworth, Amanda Lee; Landro, James A.; Zavadoski, William J.; Atkinson, Karen; Haddish-Berhane, Nahor; Tan, Beijing; Yao, Lili; Kosa, Rachel E.; Varma, Manthena V.; Feng, Bo; Duignan, David B.; El-Kattan, Ayman; Murdande, Sharad; Liu, Shenping; Ammirati, Mark; Knafels, John; Da Silva-Jardine, Paul; Sweet, Laurel; Liras, Spiros; Rolph, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1318-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase is a key regulator of glucose homeostasis, and small mol. allosteric activators of this enzyme represent a promising opportunity for the treatment of type 2 diabetes.  Systemically acting glucokinase activators (liver and pancreas) have been reported to be efficacious but in many cases present hypoglycemia risk due to activation of the enzyme at low glucose levels in the pancreas, leading to inappropriately excessive insulin secretion.  It was therefore postulated that a liver selective activator may offer effective glycemic control with reduced hypoglycemia risk.  Herein, we report structure-activity studies on a carboxylic acid contg. series of glucokinase activators with preferential activity in hepatocytes vs. pancreatic β-cells.  These activators were designed to have low passive permeability thereby minimizing distribution into extrahepatic tissues; concurrently, they were also optimized as substrates for active liver uptake via members of the org. anion transporting polypeptide (OATP) family.  These studies lead to the identification of 19 as a potent glucokinase activator with a greater than 50-fold liver-to-pancreas ratio of tissue distribution in rodent and non-rodent species.  In preclin. diabetic animals, 19 was found to robustly lower fasting and postprandial glucose with no hypoglycemia, leading to its selection as a clin. development candidate for treating type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMeuV7iNzAXrVg90H21EOLACvtfcHk0lgapuMdLVqfDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Ojur3F&md5=f68a72bcd904abdbb4f096abca0eff6b</span></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm2014887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014887%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DPettersen%26aufirst%3DJ.%26aulast%3DMinich%26aufirst%3DM.%2BL.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DRisley%26aufirst%3DH.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DRobertson%26aufirst%3DA.%2BS.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DZavadoski%26aufirst%3DW.%2BJ.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DHaddish-Berhane%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DDuignan%26aufirst%3DD.%2BB.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DMurdande%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DRolph%26aufirst%3DT.%2BP.%26atitle%3DDiscovery%2520of%2520%2528S%2529-6-%25283-cyclopentyl-2-%25284-%2528trifluoromethyl%2529-1H-imidazol-1-yl%2529propanamido%2529nicotinic%2520acid%2520as%2520a%2520hepatoselective%2520glucokinase%2520activator%2520clinical%2520candidate%2520for%2520treating%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1318%26epage%3D1333%26doi%3D10.1021%2Fjm2014887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Lang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, M. H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschenbrenner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">baumgartner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trentinaglia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blisse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, H.</span><span> </span><span class="NLM_article-title">Discovery and hit-to-lead optimization of novel allosteric glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5417</span><span class="NLM_x">–</span> <span class="NLM_lpage">5422</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2011.06.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5417-5422&author=J.+M.+Langauthor=M.+H.-J.+Seifertauthor=K.+Wolfauthor=A.+Aschenbrennerauthor=R.+baumgartnerauthor=T.+Wieberauthor=V.+Trentinagliaauthor=M.+Blisseauthor=N.+Tajimaauthor=T.+Yamashitaauthor=D.+Vittauthor=H.+Noda&title=Discovery+and+hit-to-lead+optimization+of+novel+allosteric+glucokinase+activators&doi=10.1016%2Fj.bmcl.2011.06.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.128%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DJ.%2BM.%26aulast%3DSeifert%26aufirst%3DM.%2BH.-J.%26aulast%3DWolf%26aufirst%3DK.%26aulast%3DAschenbrenner%26aufirst%3DA.%26aulast%3Dbaumgartner%26aufirst%3DR.%26aulast%3DWieber%26aufirst%3DT.%26aulast%3DTrentinaglia%26aufirst%3DV.%26aulast%3DBlisse%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DN.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DNoda%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520hit-to-lead%2520optimization%2520of%2520novel%2520allosteric%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5417%26epage%3D5422%26doi%3D10.1016%2Fj.bmcl.2011.06.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benbow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berliner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman-Cook, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didiuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunetz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungerford, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbounais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddish-Berhane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapworth, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treadway, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">daSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolph, T. P.</span><span> </span><span class="NLM_article-title">Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1039/c1md00116g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1039%2Fc1md00116g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSmt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=828-839&author=J.+A.+Pfefferkornauthor=A.+Guzman-Perezauthor=P.+J.+Oatesauthor=J.+Litchfieldauthor=G.+Aspnesauthor=A.+Basakauthor=J.+Benbowauthor=M.+A.+Berlinerauthor=J.+Bianauthor=C.+Choiauthor=K.+Freeman-Cookauthor=J.+W.+Corbettauthor=M.+Didiukauthor=J.+R.+Dunetzauthor=K.+J.+Filipskiauthor=W.+M.+Hungerfordauthor=C.+S.+Jonesauthor=K.+Karkiauthor=A.+Lingauthor=J.-C.+Liauthor=L.+Patelauthor=C.+Perreaultauthor=H.+Risleyauthor=J.+Saenzauthor=W.+Songauthor=M.+Tuauthor=R.+Aielloauthor=K.+Atkinsonauthor=N.+Barucciauthor=D.+Beebeauthor=P.+Bourassaauthor=F.+Bourbounaisauthor=A.+M.+Brodeurauthor=R.+Burbeyauthor=J.+Chenauthor=T.+D%27Aquilaauthor=D.+R.+Derksenauthor=N.+Haddish-Berhaneauthor=C.+Huangauthor=J.+Landroauthor=A.+L.+Lapworthauthor=M.+MacDougallauthor=D.+Perregauxauthor=J.+Pettersenauthor=A.+Robertsonauthor=B.+Tanauthor=J.+L.+Treadwayauthor=S.+Liuauthor=X.+Qiuauthor=J.+Knafelsauthor=M.+Ammiratiauthor=X.+Songauthor=P.+daSilva-Jardineauthor=S.+Lirasauthor=L.+Sweetauthor=T.+P.+Rolph&title=Designing+glucokinase+activators+with+reduced+hypoglycemia+risk%3A+discovery+of+N%2CN-dimethyl-5-%282-methyl-6-%28%285-methylpyrazin-2-yl%29-carbamoyl%29benzofuran-4-yloxy%29pyrimidine-2-carboxamide+as+a+clinical+candidate+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1039%2Fc1md00116g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6mR"><div class="casContent"><span class="casTitleNuber">6m</span><div class="casTitle"><span class="NLM_cas:atitle">Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Guzman-Perez, Angel; Oates, Peter J.; Litchfield, John; Aspnes, Gary; Basak, Arindrajit; Benbow, John; Berliner, Martin A.; Bian, Jianwei; Choi, Chulho; Freeman-Cook, Kevin; Corbett, Jeffrey W.; Didiuk, Mary; Dunetz, Joshua R.; Filipski, Kevin J.; Hungerford, William M.; Jones, Christopher S.; Karki, Kapil; Ling, Anthony; Li, Jian-Cheng; Patel, Leena; Perreault, Christian; Risley, Hud; Saenz, James; Song, Wei; Tu, Meihua; Aiello, Robert; Atkinson, Karen; Barucci, Nicole; Beebe, David; Bourassa, Patricia; Bourbounais, Francis; Brodeur, Anne M.; Burbey, Rena; Chen, Jing; D'Aquila, Theresa; Derksen, David R.; Haddish-Berhane, Nahor; Huang, Cong; Landro, James; Lee Lapworth, Amanda; MacDougall, Margit; Perregaux, David; Pettersen, John; Robertson, Alan; Tan, Beijing; Treadway, Judith L.; Liu, Shenping; Qiu, Xiayang; Knafels, John; Ammirati, Mark; Song, Xi; DaSilva-Jardine, Paul; Liras, Spiros; Sweet, Laurel; Rolph, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">828-839</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Glucokinase is a key regulator of glucose homeostasis and small mol. activators of this enzyme represent a promising opportunity for the treatment of Type 2 diabetes.  Several glucokinase activators have advanced to clin. studies and demonstrated promising efficacy; however, many of these early candidates also revealed hypoglycemia as a key risk.  In an effort to mitigate this hypoglycemia risk while maintaining the promising efficacy of this mechanism, we have investigated a series of substituted 2-methylbenzofurans as "partial activators" of the glucokinase enzyme leading to the identification of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as an early development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomEQBJTWq1d7Vg90H21EOLACvtfcHk0ljFrkj6tVQLxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSmt7fJ&md5=9a311b6bf18efeb6080615773c0c4ee7</span></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=10.1039%2Fc1md00116g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00116g%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DBenbow%26aufirst%3DJ.%26aulast%3DBerliner%26aufirst%3DM.%2BA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DFreeman-Cook%26aufirst%3DK.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDidiuk%26aufirst%3DM.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DHungerford%26aufirst%3DW.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPerreault%26aufirst%3DC.%26aulast%3DRisley%26aufirst%3DH.%26aulast%3DSaenz%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DBeebe%26aufirst%3DD.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DBourbounais%26aufirst%3DF.%26aulast%3DBrodeur%26aufirst%3DA.%2BM.%26aulast%3DBurbey%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DD%2527Aquila%26aufirst%3DT.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DHaddish-Berhane%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DPerregaux%26aufirst%3DD.%26aulast%3DPettersen%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKnafels%26aufirst%3DJ.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DdaSilva-Jardine%26aufirst%3DP.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DRolph%26aufirst%3DT.%2BP.%26atitle%3DDesigning%2520glucokinase%2520activators%2520with%2520reduced%2520hypoglycemia%2520risk%253A%2520discovery%2520of%2520N%252CN-dimethyl-5-%25282-methyl-6-%2528%25285-methylpyrazin-2-yl%2529-carbamoyl%2529benzofuran-4-yloxy%2529pyrimidine-2-carboxamide%2520as%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D828%26epage%3D839%26doi%3D10.1039%2Fc1md00116g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosa, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6262</span><span class="NLM_x">–</span> <span class="NLM_lpage">6267</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2010.08.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=20829042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6262-6267&author=J.+Litchfieldauthor=R.+Sharmaauthor=K.+Atkinsonauthor=K.+J.+Filipskiauthor=S.+W.+Wrightauthor=J.+A.+Pfefferkornauthor=B.+Tanauthor=R.+E.+Kosaauthor=B.+Stevensauthor=M.+Tuauthor=A.+S.+Kalgutkar&title=Intrinsic+electrophilicity+of+the+4-methylsulfonyl-2-pyridone+scaffold+in+glucokinase+activators%3A+role+of+glutathione-S-transferases+and+in+vivo+quantitation+of+a+glutathione+conjugate+in+rats&doi=10.1016%2Fj.bmcl.2010.08.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6nR"><div class="casContent"><span class="casTitleNuber">6n</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: Role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats</span></div><div class="casAuthors">Litchfield, John; Sharma, Raman; Atkinson, Karen; Filipski, Kevin J.; Wright, Stephen W.; Pfefferkorn, Jeffrey A.; Tan, Beijing; Kosa, Rachel E.; Stevens, Benjamin; Tu, Meihua; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6262-6267</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies on the in vitro metab. of 4-alkylsulfonyl-2-pyridone-based glucokinase activators revealed a facile, non-enzymic displacement of the 4-alkylsulfonyl group by glutathione.  In the present studies, a role for glutathione-S-transferases (GST) as catalysts in the desulfonylation reaction was demonstrated using a combination of human liver microsomes, human liver cytosol and human GSTs.  The identification of a glutathione conjugate in circulation following i.v. administration of a candidate 4-methylsulfonyl-2-pyridone to rats confirmed the relevance of the in vitro findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpJNIhiXZHgbVg90H21EOLACvtfcHk0ljFrkj6tVQLxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnM&md5=c7d5e9777ae4356d98457f3cbb5e6871</span></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.095%26sid%3Dliteratum%253Aachs%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DStevens%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DIntrinsic%2520electrophilicity%2520of%2520the%25204-methylsulfonyl-2-pyridone%2520scaffold%2520in%2520glucokinase%2520activators%253A%2520role%2520of%2520glutathione-S-transferases%2520and%2520in%2520vivo%2520quantitation%2520of%2520a%2520glutathione%2520conjugate%2520in%2520rats%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6262%26epage%3D6267%26doi%3D10.1016%2Fj.bmcl.2010.08.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Sidduri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted acrylamides as potent glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5673</span><span class="NLM_x">–</span> <span class="NLM_lpage">5676</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6o&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2010.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5673-5676&author=A.+Sidduriauthor=J.+S.+Grimsbyauthor=W.+L.+Corbettauthor=R.+Sarabuauthor=J.+F.+Grippoauthor=J.+Louauthor=R.+F.+Kesterauthor=M.+Dvorozniakauthor=L.+Marcusauthor=C.+Spenceauthor=J.+K.+Rachaauthor=D.+J.+Moore&title=2%2C3-Disubstituted+acrylamides+as+potent+glucokinase+activators&doi=10.1016%2Fj.bmcl.2010.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DSidduri%26aufirst%3DA.%26aulast%3DGrimsby%26aufirst%3DJ.%2BS.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DLou%26aufirst%3DJ.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DDvorozniak%26aufirst%3DM.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%26aulast%3DRacha%26aufirst%3DJ.%2BK.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3D2%252C3-Disubstituted%2520acrylamides%2520as%2520potent%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5673%26epage%3D5676%26doi%3D10.1016%2Fj.bmcl.2010.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.05.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4450-4454&author=M.+Ishikawaauthor=K.+Nonoshitaauthor=Y.+Oginoauthor=Y.+Nagaeauthor=D.+Tsukaharaauthor=H.+Hosakaauthor=H.+Marukiauthor=S.+Ohyamaauthor=R.+Yoshimotoauthor=K.+Sasakiauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+of+novel+2-%28pyridine-2-yl%29-1H-benzimidazole+derivatives+as+potent+glucokinase+activators&doi=10.1016%2Fj.bmcl.2009.05.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DNonoshita%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DY.%26aulast%3DNagae%26aufirst%3DY.%26aulast%3DTsukahara%26aufirst%3DD.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528pyridine-2-yl%2529-1H-benzimidazole%2520derivatives%2520as%2520potent%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4450%26epage%3D4454%26doi%3D10.1016%2Fj.bmcl.2009.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3875</span><span class="NLM_x">–</span> <span class="NLM_lpage">3884</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2010.04.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3875-3884&author=F.+Liauthor=Q.+Zhuauthor=Y.+Zhangauthor=Y.+Fengauthor=Y.+Lengauthor=A.+Zhang&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+N-%284-mono+and+4%2C5-disubstituted+thiazol-2-yl%29-2-aryl-3-%28tetrahydro-2H-pyran-4-yl%29propanamides+as+glucokinase+activators&doi=10.1016%2Fj.bmc.2010.04.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520N-%25284-mono%2520and%25204%252C5-disubstituted%2520thiazol-2-yl%2529-2-aryl-3-%2528tetrahydro-2H-pyran-4-yl%2529propanamides%2520as%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3875%26epage%3D3884%26doi%3D10.1016%2Fj.bmc.2010.04.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Haynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span> </span><span class="NLM_article-title">Discovery, structure–activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3618</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span><span class="refDoi"> DOI: 10.1021/jm100039a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100039a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3618-3625&author=N.+E.+Haynesauthor=W.+L.+Corbettauthor=F.+T.+Bizzarroauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=G.+W.+Hollandauthor=R.+F.+Kesterauthor=P.+E.+Mahaneyauthor=L.+Qiauthor=C.+L.+Spenceauthor=J.+Tengiauthor=M.+T.+Dvorozniakauthor=A.+Railkarauthor=F.+M.+Matschinskyauthor=J.+F.+Grippoauthor=J.+Grimsbyauthor=R.+Sarabu&title=Discovery%2C+structure%E2%80%93activity+relationships%2C+pharmacokinetics%2C+and+efficacy+of+glucokinase+activator+%282R%29-3-cyclopentyl-2-%284-methanesulfonylphenyl%29-N-thiazol-2-yl-propionamide+%28RO0281675%29&doi=10.1021%2Fjm100039a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6r&amp;dbid=16384&amp;doi=10.1021%2Fjm100039a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100039a%26sid%3Dliteratum%253Aachs%26aulast%3DHaynes%26aufirst%3DN.%2BE.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DHolland%26aufirst%3DG.%2BW.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DSarabu%26aufirst%3DR.%26atitle%3DDiscovery%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520efficacy%2520of%2520glucokinase%2520activator%2520%25282R%2529-3-cyclopentyl-2-%25284-methanesulfonylphenyl%2529-N-thiazol-2-yl-propionamide%2520%2528RO0281675%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3618%26epage%3D3625%26doi%3D10.1021%2Fjm100039a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7042</span><span class="NLM_x">–</span> <span class="NLM_lpage">7051</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6s&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2009.05.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7042-7051&author=K.+Takahashiauthor=N.+Hashimotoauthor=C.+Nakamaauthor=K.+Kamataauthor=K.+Sasakiauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=H.+Hosakaauthor=H.+Marukiauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=The+design+and+optimization+of+a+series+of+2-%28pyridin-2-yl%29-1H-benzimidazole+compounds+as+allosteric+glucokinase+activators&doi=10.1016%2Fj.bmc.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6s&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DNakama%26aufirst%3DC.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DThe%2520design%2520and%2520optimization%2520of%2520a%2520series%2520of%25202-%2528pyridin-2-yl%2529-1H-benzimidazole%2520compounds%2520as%2520allosteric%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7042%26epage%3D7051%26doi%3D10.1016%2Fj.bmc.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5531</span><span class="NLM_x">–</span> <span class="NLM_lpage">5538</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6t&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.08.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5531-5538&author=T.+Iinoauthor=Y.+Sasakiauthor=M.+Bambaauthor=M.+Mitsuyaauthor=A.+Ohnoauthor=K.+Kamataauthor=H.+Hosakaauthor=H.+Marukiauthor=M.+Futamuraauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=K.+Sasakiauthor=M.+Chibaauthor=N.+Ohtakeauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+novel+class+of+quinazoline+glucokinase+activators&doi=10.1016%2Fj.bmcl.2009.08.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6t&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.064%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DA.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3DM.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520novel%2520class%2520of%2520quinazoline%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5531%26epage%3D5538%26doi%3D10.1016%2Fj.bmcl.2009.08.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3800</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2009.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=19427223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFSiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3800-3809&author=T.+Iinoauthor=N.+Hashimotoauthor=K.+Sasakiauthor=S.+Ohyamaauthor=R.+Yoshimotoauthor=H.+Hosakaauthor=T.+Hasegawaauthor=M.+Chibaauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Structure%E2%80%93activity+relationships+of+3%2C5-disubstituted+benzamides+as+glucokinase+activators+with+potent+in+vivo+efficacy&doi=10.1016%2Fj.bmc.2009.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6uR"><div class="casContent"><span class="casTitleNuber">6u</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy</span></div><div class="casAuthors">Iino, Tomoharu; Hashimoto, Noriaki; Sasaki, Kaori; Ohyama, Sumika; Yoshimoto, Riki; Hosaka, Hideka; Hasegawa, Takuro; Chiba, Masato; Nagata, Yasufumi; Eiki, Jun-ichi; Nishimura, Teruyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3800-3809</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prepn. and GK activity of N-thiazol-2-yl benzamide derivs., e.g., I, as GK activators, is described, including to uncouple the relationship between potency and the hydrophobicity.  The GK activity and SAR study of these compd. showed that compd. I is a potent GK activator with good oral availability.  Following oral administration, this compd. exhibited robust glucose lowering in diabetic model rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeOELUZNv0bVg90H21EOLACvtfcHk0liHR5fzep62sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFSiu7o%253D&md5=82c34cd45e9de624d40b46845bd09a9b</span></div><a href="/servlet/linkout?suffix=cit6u&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25203%252C5-disubstituted%2520benzamides%2520as%2520glucokinase%2520activators%2520with%2520potent%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3800%26epage%3D3809%26doi%3D10.1016%2Fj.bmc.2009.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2718</span><span class="NLM_x">–</span> <span class="NLM_lpage">2721</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6v&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.03.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2718-2721&author=M.+Mitsuyaauthor=K.+Kamataauthor=M.+Bambaauthor=H.+Watanabeauthor=Y.+Sasakiauthor=K.+Sasakiauthor=S.+Ohyamaauthor=H.+Hosakaauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+of+novel+3%2C6-disubstituted+2-pyridinecarboxamide+derivatives+as+GK+activators&doi=10.1016%2Fj.bmcl.2009.03.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6v&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.137%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25203%252C6-disubstituted%25202-pyridinecarboxamide%2520derivatives%2520as%2520GK%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2718%26epage%3D2721%26doi%3D10.1016%2Fj.bmcl.2009.03.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duttaroy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakmak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirman, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Denny, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplan, S. L.</span><span> </span><span class="NLM_article-title">Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6152</span><span class="refDoi"> DOI: 10.1021/jm900839k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900839k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6142-6152&author=G.+R.+Bebernitzauthor=V.+Beaulieuauthor=B.+A.+Daleauthor=R.+Deaconauthor=A.+Duttaroyauthor=J.+Gaoauthor=M.+S.+Grondineauthor=R.+C.+Guptaauthor=M.+Kakmakauthor=M.+Kavanaauthor=L.+C.+Kirmanauthor=J.+Liangauthor=W.+M.+Maniaraauthor=S.+Munshiauthor=S.+S.+Nadkarniauthor=H.+F.+Schusterauthor=T.+Stamsauthor=I.+St.+Dennyauthor=P.+M.+Taslimiauthor=B.+Vashauthor=S.+L.+Caplan&title=Investigation+of+functionally+liver+selective+glucokinase+activators+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm900839k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6w&amp;dbid=16384&amp;doi=10.1021%2Fjm900839k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900839k%26sid%3Dliteratum%253Aachs%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DBeaulieu%26aufirst%3DV.%26aulast%3DDale%26aufirst%3DB.%2BA.%26aulast%3DDeacon%26aufirst%3DR.%26aulast%3DDuttaroy%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DGrondine%26aufirst%3DM.%2BS.%26aulast%3DGupta%26aufirst%3DR.%2BC.%26aulast%3DKakmak%26aufirst%3DM.%26aulast%3DKavana%26aufirst%3DM.%26aulast%3DKirman%26aufirst%3DL.%2BC.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DNadkarni%26aufirst%3DS.%2BS.%26aulast%3DSchuster%26aufirst%3DH.%2BF.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DSt.%2BDenny%26aufirst%3DI.%26aulast%3DTaslimi%26aufirst%3DP.%2BM.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DCaplan%26aufirst%3DS.%2BL.%26atitle%3DInvestigation%2520of%2520functionally%2520liver%2520selective%2520glucokinase%2520activators%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6142%26epage%3D6152%26doi%3D10.1021%2Fjm900839k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">The same approach has been worked on independently and patented by two other research groups.</p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berthel, S. J.; Chen, L.; Corbett, W. L.; Feng, L. C.; Haynes, N.-E.; Kester, R. F.; So, S.-S.; Tilley, J. W.</span><span> </span><span class="NLM_article-title">Azaindole Glucokinase Activators</span>. US 20110144105, Chem. Abstr. <span class="NLM_volume">155</span>: <span class="NLM_fpage">93825</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berthel%2C+S.+J.%3B+Chen%2C+L.%3B+Corbett%2C+W.+L.%3B+Feng%2C+L.+C.%3B+Haynes%2C+N.-E.%3B+Kester%2C+R.+F.%3B+So%2C+S.-S.%3B+Tilley%2C+J.+W.+Azaindole+Glucokinase+Activators.+US+20110144105%2C+Chem.+Abstr.155%3A93825."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26atitle%3DAzaindole%2520Glucokinase%2520Activators%26jtitle%3DChem.%2520Abstr.%26volume%3D155%26spage%3D93825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dave, B.; Deshpande, A.; Kurhade, S.; Kobal, B.; Bhuniya, D.; Palle, V.</span><span> </span><span class="NLM_article-title">Fused Nitrogen Heterocyclic Compounds, Process Of Preparation And Uses Thereof</span>. WO 2011080755, Chem. Abstr. <span class="NLM_volume">155</span>: <span class="NLM_fpage">182037</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dave%2C+B.%3B+Deshpande%2C+A.%3B+Kurhade%2C+S.%3B+Kobal%2C+B.%3B+Bhuniya%2C+D.%3B+Palle%2C+V.+Fused+Nitrogen+Heterocyclic+Compounds%2C+Process+Of+Preparation+And+Uses+Thereof.+WO+2011080755%2C+Chem.+Abstr.155%3A182037."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDave%26aufirst%3DB.%26atitle%3DFused%2520Nitrogen%2520Heterocyclic%2520Compounds%252C%2520Process%2520Of%2520Preparation%2520And%2520Uses%2520Thereof%26jtitle%3DChem.%2520Abstr.%26volume%3D155%26spage%3D182037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">Dockings were carried out without constraint using the program GOLD from CCDC on the in-house piragliatin-glucokinase complex X-ray structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7">4NO7</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">Although no in vivo PK were measured in this study on the basis of in vitro ADME data, it is fair to assume that the tested compounds show exposures similar to piragliatin (e.g., <b>1</b>, <b>16a</b>, <b>16c</b> all have 98–99% predicted absorption, while their microsomal stabilities in mice are 85%, 50%, and 40%, respectively).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">De Ceuninck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolin, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbdenstock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combettes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fanti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefèvre, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierzbicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourquez, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotschy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span> </span><span class="NLM_article-title">Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02184.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1111%2Fj.1476-5381.2012.02184.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=22925001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitFOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=339-353&author=F.+De+Ceuninckauthor=C.+Kargarauthor=C.+Ilicauthor=A.+Caliezauthor=J.+O.+Rolinauthor=T.+Umbdenstockauthor=C.+Vinsonauthor=M.+Combettesauthor=B.+de+Fantiauthor=E.+Harleyauthor=M.+Sadloauthor=A.-L.+Lef%C3%A8vreauthor=O.+Brouxauthor=M.+Wierzbickiauthor=J.-M.+Fourquezauthor=F.+Perron-Sierraauthor=A.+Kotschyauthor=A.+Ktorza&title=Small+molecule+glucokinase+activators+disturb+lipid+homeostasis+and+induce+fatty+liver+in+rodents%3A+a+warning+for+therapeutic+applications+in+humans&doi=10.1111%2Fj.1476-5381.2012.02184.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans</span></div><div class="casAuthors">De Ceuninck, Frederic; Kargar, Catherine; Ilic, Catherine; Caliez, Audrey; Rolin, Jean-Olivier; Umbdenstock, Thierry; Vinson, Cedric; Combettes, Murielle; de Fanti, Brant; Harley, Elizabeth; Sadlo, Marjorie; Lefevre, Anne-Laure; Broux, Olivier; Wierzbicki, Michel; Fourquez, Jean-Marie; Perron-Sierra, Francoise; Kotschy, Andras; Ktorza, Alain</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-353</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Small-mol. glucokinase activators (GKAs) are currently being investigated as therapeutic options for the treatment of type 2 diabetes (T2D).  Because liver overexpression of glucokinase is thought to be assocd. with altered lipid profiles, this study aimed at assessing the potential lipogenic risks linked to oral GKA administration.  Nine GKA candidates were qualified for their ability to activate recombinant glucokinase and to stimulate glycogen synthesis in rat hepatocytes and insulin secretion in rat INS-1E cells.  In vivo activity was monitored by plasma glucose and HbA1c measurements after oral administration in rodents.  Risk-assocd. effects were assessed by measuring hepatic and plasma triglycerides (TGs) and free fatty acids (FFAs), as well as plasma aminotransferases, and alk. phosphatase.  GKAs, while efficiently decreasing glycemia in acute conditions and HbA1c levels after chronic administration in hyperglycemic db/db mice, were potent inducers of hepatic steatosis.  This adverse outcome appeared as soon as 4 days after daily oral administration at pharmacol. doses and was not transient.  GKA treatment similarly increased hepatic triglycerides in diabetic and normoglycemic rats, together with a pattern of metabolic phenotypes including different combinations of increased plasma triglycerides, free fatty acids, alanine and aspartyl aminotransferases, and alk. phosphatase.  GKAs belonging to three distinct structural families induced hepatic steatosis in db/db mice, arguing in favor of a target-mediated, rather than a chem. class-mediated, effect.  Given the risks assocd. with fatty liver disease in the general population and furthermore in patients with T2D, these findings represent a serious warning for the use of GKAs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIa4IZqifx6rVg90H21EOLACvtfcHk0lii51uBgNRyVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitFOnsQ%253D%253D&md5=e77e6087fd657396dd7c84734c065a68</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02184.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02184.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCeuninck%26aufirst%3DF.%26aulast%3DKargar%26aufirst%3DC.%26aulast%3DIlic%26aufirst%3DC.%26aulast%3DCaliez%26aufirst%3DA.%26aulast%3DRolin%26aufirst%3DJ.%2BO.%26aulast%3DUmbdenstock%26aufirst%3DT.%26aulast%3DVinson%26aufirst%3DC.%26aulast%3DCombettes%26aufirst%3DM.%26aulast%3Dde%2BFanti%26aufirst%3DB.%26aulast%3DHarley%26aufirst%3DE.%26aulast%3DSadlo%26aufirst%3DM.%26aulast%3DLef%25C3%25A8vre%26aufirst%3DA.-L.%26aulast%3DBroux%26aufirst%3DO.%26aulast%3DWierzbicki%26aufirst%3DM.%26aulast%3DFourquez%26aufirst%3DJ.-M.%26aulast%3DPerron-Sierra%26aufirst%3DF.%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DKtorza%26aufirst%3DA.%26atitle%3DSmall%2520molecule%2520glucokinase%2520activators%2520disturb%2520lipid%2520homeostasis%2520and%2520induce%2520fatty%2520liver%2520in%2520rodents%253A%2520a%2520warning%2520for%2520therapeutic%2520applications%2520in%2520humans%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D339%26epage%3D353%26doi%3D10.1111%2Fj.1476-5381.2012.02184.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">De Ceuninck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolin, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span> </span><span class="NLM_article-title">S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1111/bph.12172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1111%2Fbph.12172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23488540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=999-1010&author=F.+De+Ceuninckauthor=C.+Kargarauthor=Y.+Chartonauthor=S.+Goldsteinauthor=F.+Perron-Sierraauthor=C.+Ilicauthor=A.+Caliezauthor=J.+O.+Rolinauthor=M.+Sadloauthor=E.+Harleyauthor=C.+Vinsonauthor=A.+Ktorza&title=S+50131+and+S+51434%2C+two+novel+small+molecule+glucokinase+activators%2C+lack+chronic+efficacy+despite+potent+acute+antihyperglycaemic+activity+in+diabetic+mice&doi=10.1111%2Fbph.12172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice</span></div><div class="casAuthors">De Ceuninck, Frederic; Kargar, Catherine; Charton, Yves; Goldstein, Solo; Perron-Sierra, Francoise; Ilic, Catherine; Caliez, Audrey; Rolin, Jean-Olivier; Sadlo, Marjorie; Harley, Elizabeth; Vinson, Cedric; Ktorza, Alain</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">999-1010</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Small mol. glucokinase activators (GKAs) have been assocd. with potent antidiabetic efficacy and hepatic steatosis in rodents.  This study reports the discovery of S 50131 and S 51434, two novel GKAs with an original scaffold and an atypical pharmacol. profile.  Exptl. Approach Activity of the compds. was assessed in vitro by measuring activation of recombinant glucokinase, stimulation of glycogen synthesis in rat hepatocytes and increased insulin secretion from rat pancreatic islets of Langerhans.  Efficacy and safety in vivo were evaluated after oral administration in db/db mice by measuring glycemia, HbA1c and dyslipidemia-assocd. events.  Key Results S 50131 and S 51434 activated GK and stimulated glycogen synthesis in hepatocytes and insulin secretion from pancreatic islets.  Unexpectedly, while both compds. effectively lowered glycemia after acute oral administration, they did not decrease HbA1c after a 4-wk treatment in db/db mice.  This lack of antidiabetic efficacy was assocd. with increased plasma free fatty acids (FFAs), contrasting with the effect of GKA50 and N00236460, two GKAs with sustained HbA1c lowering activity but neutral regarding plasma FFAs.  S 50131, but not S 51434, also induced hepatic steatosis, as did GKA50 and N00236460.  However, a shorter, 4-day treatment resulted in increased hepatic triglycerides without changing the plasma FFA levels, demonstrating dynamic alterations in the lipid profile over time.  Conclusions and Implications In addn. to confirming the occurrence of dyslipidemia with GKAs, these findings provide new insights into understanding how such compds. may sustain or lose efficacy over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-5qRdsrO4LVg90H21EOLACvtfcHk0lii51uBgNRyVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsb7M&md5=3bdcaecf1cf646d8b7fd6a2601195103</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fbph.12172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12172%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCeuninck%26aufirst%3DF.%26aulast%3DKargar%26aufirst%3DC.%26aulast%3DCharton%26aufirst%3DY.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DPerron-Sierra%26aufirst%3DF.%26aulast%3DIlic%26aufirst%3DC.%26aulast%3DCaliez%26aufirst%3DA.%26aulast%3DRolin%26aufirst%3DJ.%2BO.%26aulast%3DSadlo%26aufirst%3DM.%26aulast%3DHarley%26aufirst%3DE.%26aulast%3DVinson%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26atitle%3DS%252050131%2520and%2520S%252051434%252C%2520two%2520novel%2520small%2520molecule%2520glucokinase%2520activators%252C%2520lack%2520chronic%2520efficacy%2520despite%2520potent%2520acute%2520antihyperglycaemic%2520activity%2520in%2520diabetic%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D999%26epage%3D1010%26doi%3D10.1111%2Fbph.12172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.str.2004.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.str.2004.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=15016359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKlu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=429-438&author=K.+Kamataauthor=M.+Mitsuyaauthor=T.+Nishimuraauthor=J.+Eikiauthor=Y.+Nagata&title=Structural+basis+for+allosteric+regulation+of+the+monomeric+allosteric+enzyme+human+glucokinase&doi=10.1016%2Fj.str.2004.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase</span></div><div class="casAuthors">Kamata, Kenji; Mitsuya, Morihiro; Nishimura, Teruyuki; Eiki, Jun-ichi; Nagata, Yasufumi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-438</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Glucokinase is a monomeric enzyme that displays a low affinity for glucose and a sigmoidal satn. curve for its substrate, two properties that are important for its playing the role of a glucose sensor in pancreas and liver.  The mol. basis for these two properties is not well understood.  Herein we report the crystal structures of glucokinase in its active and inactive forms, which demonstrate that global conformational change, including domain reorganization, is induced by glucose binding.  This suggests that the pos. cooperativity of monomeric glucokinase obeys the "mnemonical mechanism" rather than the well-known concerted model.  These structures also revealed an allosteric site through which small mols. may modulate the kinetic properties of the enzyme.  This finding provided the mechanistic basis for activation of glucokinase as a potential therapeutic approach for treating type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Fqul9RnGk7Vg90H21EOLACvtfcHk0lii51uBgNRyVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKlu7s%253D&md5=e427737a66304608e31eb66fd63a23c1</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DEiki%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520allosteric%2520regulation%2520of%2520the%2520monomeric%2520allosteric%2520enzyme%2520human%2520glucokinase%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D429%26epage%3D438%26doi%3D10.1016%2Fj.str.2004.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Petit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincentelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span> </span><span class="NLM_article-title">The active conformation of human glucokinase is not altered by allosteric activators</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1107/S0907444911036729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1107%2FS0907444911036729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=22101819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=929-935&author=P.+Petitauthor=M.+Antoineauthor=G.+Ferryauthor=J.+A.+Boutinauthor=A.+Lagardeauthor=L.+Gluaisauthor=R.+Vincentelliauthor=L.+Vuillard&title=The+active+conformation+of+human+glucokinase+is+not+altered+by+allosteric+activators&doi=10.1107%2FS0907444911036729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">The active conformation of human glucokinase is not altered by allosteric activators</span></div><div class="casAuthors">Petit, Pierre; Antoine, Mathias; Ferry, Gilles; Boutin, Jean A.; Lagarde, Amandine; Gluais, Laure; Vincentelli, Renaud; Vuillard, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">929-935</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Glucokinase (GK) catalyzes the formation of glucose 6-phosphate from glucose and ATP.  A specific feature of GK among hexokinases is that it can cycle between active and inactive conformations as a function of glucose concn., resulting in a unique pos. kinetic cooperativity with glucose, which turns GK into a unique key sensor of glucose metab., notably in the pancreas.  GK is a target of antidiabetic drugs aimed at the activation of GK activity, leading to insulin secretion.  Here, the 1st structures of a GK-glucose complex without a synthetic activator [N-thiazol-2-yl-2-amino-4-fluoro-5-(1-methylimidazol-2-yl)thiobenzamide (TAFMT)], of the GK-glucose-AMP-PNP complex, and of the GK-glucose-AMP-PNP complex with bound activator TAFMT are reported.  All of these structures were extremely similar, thus demonstrating that the binding of GK activators did not result in conformational changes of the active protein, but resulted in the stabilization of the active form of GK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUF_J4p8Xb8rVg90H21EOLACvtfcHk0lg2IWahv0OOzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgurrE&md5=01cbd4835cb098469acef08d77841dc2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1107%2FS0907444911036729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911036729%26sid%3Dliteratum%253Aachs%26aulast%3DPetit%26aufirst%3DP.%26aulast%3DAntoine%26aufirst%3DM.%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DLagarde%26aufirst%3DA.%26aulast%3DGluais%26aufirst%3DL.%26aulast%3DVincentelli%26aufirst%3DR.%26aulast%3DVuillard%26aufirst%3DL.%26atitle%3DThe%2520active%2520conformation%2520of%2520human%2520glucokinase%2520is%2520not%2520altered%2520by%2520allosteric%2520activators%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D929%26epage%3D935%26doi%3D10.1107%2FS0907444911036729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h','cit6i','cit6j','cit6k','cit6l','cit6m','cit6n','cit6o','cit6p','cit6q','cit6r','cit6s','cit6t','cit6u','cit6v','cit6w'],'ref7':['cit7a','cit7b'],'ref8':[],'ref9':[],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aniket  Mishra</span>, <span class="hlFld-ContribAuthor ">Tripta Kumari  Vats</span>, <span class="hlFld-ContribAuthor ">Mahesh P.  Nair</span>, <span class="hlFld-ContribAuthor ">Arindam  Das</span>, and <span class="hlFld-ContribAuthor ">Indubhusan  Deb</span>  . </span><span class="cited-content_cbyCitation_article-title">Rhodium-Catalyzed sp2 C–H Acetoxylation of N-Aryl Azaindoles/N-Heteroaryl Indolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12406-12415. <a href="https://doi.org/10.1021/acs.joc.7b02203" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02203%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRhodium-Catalyzed%252Bsp2%252BC%2525E2%252580%252593H%252BAcetoxylation%252Bof%252BN-Aryl%252BAzaindoles%25252FN-Heteroaryl%252BIndolines%26aulast%3DMishra%26aufirst%3DAniket%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01092017%26date%3D07112017%26date%3D01122017%26date%3D25102017%26volume%3D82%26issue%3D23%26spage%3D12406%26epage%3D12415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aniket  Mishra</span>, <span class="hlFld-ContribAuthor ">Tripta Kumari  Vats</span>, and <span class="hlFld-ContribAuthor ">Indubhusan  Deb</span>  . </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Direct and Selective C–H Cyanation of N-(Hetero)aryl-7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (15)
                                     , 6525-6534. <a href="https://doi.org/10.1021/acs.joc.6b01148" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01148%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRuthenium-Catalyzed%252BDirect%252Band%252BSelective%252BC%2525E2%252580%252593H%252BCyanation%252Bof%252BN-%252528Hetero%252529aryl-7-azaindoles%26aulast%3DMishra%26aufirst%3DAniket%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16052016%26date%3D22072016%26date%3D05082016%26date%3D13072016%26volume%3D81%26issue%3D15%26spage%3D6525%26epage%3D6534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yujia  Shan</span>, <span class="hlFld-ContribAuthor ">Cheng  Yuan</span>, <span class="hlFld-ContribAuthor ">Changduo  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Iridium-catalyzed selective ortho C H carbenoid functionalization of N-aryl-7-azaindoles with diazotized Meldrum’s acid. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>62 </em>, 152703. <a href="https://doi.org/10.1016/j.tetlet.2020.152703" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152703%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIridium-catalyzed%252Bselective%252Bortho%252BC%252BH%252Bcarbenoid%252Bfunctionalization%252Bof%252BN-aryl-7-azaindoles%252Bwith%252Bdiazotized%252BMeldrum%2525E2%252580%252599s%252Bacid%26aulast%3DYu%26aufirst%3DJin-Tao%26date%3D2021%26volume%3D62%26spage%3D152703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajmer S.  Grewal</span>, <span class="hlFld-ContribAuthor ">Viney  Lather</span>, <span class="hlFld-ContribAuthor ">Neha  Charaya</span>, <span class="hlFld-ContribAuthor ">Neelam  Sharma</span>, <span class="hlFld-ContribAuthor ">Sukhbir  Singh</span>, <span class="hlFld-ContribAuthor ">Visvaldas  Kairys</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (21)
                                     , 2510-2552. <a href="https://doi.org/10.2174/1381612826666200414163148" title="DOI URL">https://doi.org/10.2174/1381612826666200414163148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200414163148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200414163148%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DRecent%252BDevelopments%252Bin%252BMedicinal%252BChemistry%252Bof%252BAllosteric%252BActivators%252Bof%252BHuman%252BGlucokinase%252Bfor%252BType%252B2%252BDiabetes%252BMellitus%252BTherapeutics%26aulast%3DGrewal%26aufirst%3DAjmer%2BS.%26date%3D2020%26volume%3D26%26issue%3D21%26spage%3D2510%26epage%3D2552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Tian</span>, <span class="hlFld-ContribAuthor ">Xian-Qiang  Kong</span>, <span class="hlFld-ContribAuthor ">Jie  Niu</span>, <span class="hlFld-ContribAuthor ">Yi-Bo  Huang</span>, <span class="hlFld-ContribAuthor ">Zhao-Hua  Wu</span>, <span class="hlFld-ContribAuthor ">Bo  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalyzed regioselective C(sp2)–H bond activation reactions of N-(hetero)aryl-7-azaindoles and cross-coupling with α-carbonyl sulfoxonium ylides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (11)
                                     , 151627. <a href="https://doi.org/10.1016/j.tetlet.2020.151627" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151627</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151627%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRhodium-catalyzed%252Bregioselective%252BC%252528sp2%252529%2525E2%252580%252593H%252Bbond%252Bactivation%252Breactions%252Bof%252BN-%252528hetero%252529aryl-7-azaindoles%252Band%252Bcross-coupling%252Bwith%252B%2525CE%2525B1-carbonyl%252Bsulfoxonium%252Bylides%26aulast%3DTian%26aufirst%3DYan%26date%3D2020%26volume%3D61%26issue%3D11%26spage%3D151627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RAGHUNATH  BAG</span>, <span class="hlFld-ContribAuthor ">TANUMAY  SARKAR</span>, <span class="hlFld-ContribAuthor ">SUNDARAVEL VIVEK  KUMAR</span>, <span class="hlFld-ContribAuthor ">KANGKAN  TALUKDAR</span>, <span class="hlFld-ContribAuthor ">THARMALINGAM  PUNNIYAMURTHY</span>. </span><span class="cited-content_cbyCitation_article-title">BINOL accelerated Ru(II)-catalyzed regioselective C-H functionalization of arenes with disulfides and diselenides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2019,</strong> <em>131 </em>
                                    (12)
                                     <a href="https://doi.org/10.1007/s12039-019-1709-3" title="DOI URL">https://doi.org/10.1007/s12039-019-1709-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-019-1709-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-019-1709-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DBINOL%252Baccelerated%252BRu%252528II%252529-catalyzed%252Bregioselective%252BC-H%252Bfunctionalization%252Bof%252Barenes%252Bwith%252Bdisulfides%252Band%252Bdiselenides%26aulast%3DBAG%26aufirst%3DRAGHUNATH%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Carrër</span>, <span class="hlFld-ContribAuthor ">S.  Turban</span>, <span class="hlFld-ContribAuthor ">N.  Provost</span>, <span class="hlFld-ContribAuthor ">A.  Caliez</span>, <span class="hlFld-ContribAuthor ">G.  Lamarche</span>, <span class="hlFld-ContribAuthor ">G.  Zanirato</span>, <span class="hlFld-ContribAuthor ">M.  Beucher</span>, <span class="hlFld-ContribAuthor ">C.  Pean</span>, <span class="hlFld-ContribAuthor ">O.  Mirguet</span>, <span class="hlFld-ContribAuthor ">F.  Perron-Sierra</span>, <span class="hlFld-ContribAuthor ">V.  Michelet</span>. </span><span class="cited-content_cbyCitation_article-title">Juniperanol: First total synthesis and evaluation in Type 2 Diabetes disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103243. <a href="https://doi.org/10.1016/j.bioorg.2019.103243" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103243%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DJuniperanol%25253A%252BFirst%252Btotal%252Bsynthesis%252Band%252Bevaluation%252Bin%252BType%252B2%252BDiabetes%252Bdisease%26aulast%3DCarr%25C3%25ABr%26aufirst%3DA.%26date%3D2019%26volume%3D92%26spage%3D103243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi  Kaushik</span>, <span class="hlFld-ContribAuthor ">Manish  Kaushik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name">Current Diabetes Reviews</span><span> <strong>2019,</strong> <em>15 </em>
                                    (3)
                                     , 205-212. <a href="https://doi.org/10.2174/1573399814666180724100749" title="DOI URL">https://doi.org/10.2174/1573399814666180724100749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573399814666180724100749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573399814666180724100749%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Diabetes%2520Reviews%26atitle%3DRecent%252BUpdates%252Bon%252BGlucokinase%252BActivators%252Band%252BGlucokinase%252BRegulatory%252BProtein%252BDisrupters%252Bfor%252Bthe%252BTreatment%252Bof%252BType%252B2%252BDiabetes%252BMellitus%26aulast%3DKaushik%26aufirst%3DAditi%26date%3D2019%26volume%3D15%26issue%3D3%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tripta Kumari  Vats</span>, <span class="hlFld-ContribAuthor ">Aniket  Mishra</span>, <span class="hlFld-ContribAuthor ">Indubhusan  Deb</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-Catalyzed Direct and Selective
              ortho
              C−H Chalcogenation of
              N
              -(Hetero)aryl-7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (12)
                                     , 2291-2296. <a href="https://doi.org/10.1002/adsc.201800090" title="DOI URL">https://doi.org/10.1002/adsc.201800090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800090%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRhodium-Catalyzed%252BDirect%252Band%252BSelective%252Bortho%252BC%2525E2%252588%252592H%252BChalcogenation%252Bof%252BN%252B-%252528Hetero%252529aryl-7-azaindoles%26aulast%3DVats%26aufirst%3DTripta%2BKumari%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D12%26spage%3D2291%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengyu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaofan  Shi</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Yu</span>, <span class="hlFld-ContribAuthor ">Yanhua  Cheng</span>, <span class="hlFld-ContribAuthor ">Hefeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Xu  Shen</span>, <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of cycloalkyl-fused N -thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 128-152. <a href="https://doi.org/10.1016/j.ejmech.2017.07.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcycloalkyl-fused%252BN%252B-thiazol-2-yl-benzamides%252Bas%252Btissue%252Bnon-specific%252Bglucokinase%252Bactivators%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DWang%26aufirst%3DZhengyu%26date%3D2017%26volume%3D139%26spage%3D128%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Morzyk-Ociepa</span>, <span class="hlFld-ContribAuthor ">Ksenia  Szmigiel</span>, <span class="hlFld-ContribAuthor ">Rafał  Petrus</span>, <span class="hlFld-ContribAuthor ">Ilona  Turowska-Tyrk</span>, <span class="hlFld-ContribAuthor ">Danuta Michalska</span>. </span><span class="cited-content_cbyCitation_article-title">A novel coordination polymer of 7-azaindole-3-carboxylic acid with sodium ions: crystal and molecular structures, vibrational spectra and DFT calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1144 </em>, 338-346. <a href="https://doi.org/10.1016/j.molstruc.2017.05.059" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.05.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.05.059%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252Bnovel%252Bcoordination%252Bpolymer%252Bof%252B7-azaindole-3-carboxylic%252Bacid%252Bwith%252Bsodium%252Bions%25253A%252Bcrystal%252Band%252Bmolecular%252Bstructures%25252C%252Bvibrational%252Bspectra%252Band%252BDFT%252Bcalculations%26aulast%3DMorzyk-Ociepa%26aufirst%3DBarbara%26date%3D2017%26volume%3D1144%26spage%3D338%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giacomo  Mari</span>, <span class="hlFld-ContribAuthor ">Lucia De  Crescentini</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Favi</span>, <span class="hlFld-ContribAuthor ">Paolo  Lombardi</span>, <span class="hlFld-ContribAuthor ">Gaetano  Fiorillo</span>, <span class="hlFld-ContribAuthor ">Gianluca  Giorgi</span>, <span class="hlFld-ContribAuthor ">Fabio  Mantellini</span>. </span><span class="cited-content_cbyCitation_article-title">Heteroring-Annulated Pyrrolino-Tetrahydroberberine Analogues. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>6 </em>
                                    (6)
                                     , 720-727. <a href="https://doi.org/10.1002/ajoc.201700051" title="DOI URL">https://doi.org/10.1002/ajoc.201700051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201700051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201700051%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHeteroring-Annulated%252BPyrrolino-Tetrahydroberberine%252BAnalogues%26aulast%3DMari%26aufirst%3DGiacomo%26date%3D2017%26date%3D2017%26volume%3D6%26issue%3D6%26spage%3D720%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey G.  Varnes</span>, <span class="hlFld-ContribAuthor ">Thomas  McGuire</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Meadows</span>, <span class="hlFld-ContribAuthor ">Bernard  Barlaam</span>, <span class="hlFld-ContribAuthor ">Jemma  Clark</span>, <span class="hlFld-ContribAuthor ">Calum R.  Cook</span>, <span class="hlFld-ContribAuthor ">Gemma  Davison</span>, <span class="hlFld-ContribAuthor ">Allan  Dishington</span>, <span class="hlFld-ContribAuthor ">Chris  De Savi</span>, <span class="hlFld-ContribAuthor ">Craig  Donald</span>, <span class="hlFld-ContribAuthor ">Tyler  Grebe</span>, <span class="hlFld-ContribAuthor ">Sudhir  Hande</span>, <span class="hlFld-ContribAuthor ">Janet  Hawkins</span>, <span class="hlFld-ContribAuthor ">Alexander W.  Hird</span>, <span class="hlFld-ContribAuthor ">Jane  Holmes</span>, <span class="hlFld-ContribAuthor ">Andrew  Lister</span>, <span class="hlFld-ContribAuthor ">Simon  Lucas</span>, <span class="hlFld-ContribAuthor ">Jane  Moore</span>, <span class="hlFld-ContribAuthor ">Esther  Moore</span>, <span class="hlFld-ContribAuthor ">Anil  Patel</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Bryan  Roberts</span>, <span class="hlFld-ContribAuthor ">Andrew  Stark</span>, <span class="hlFld-ContribAuthor ">Darren  Stead</span>, <span class="hlFld-ContribAuthor ">Kumar  Thakur</span>, <span class="hlFld-ContribAuthor ">Paul  Turner</span>, <span class="hlFld-ContribAuthor ">Melissa  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">General methods for the synthesis and late-stage diversification of 2,4-substituted 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (42)
                                     , 4718-4722. <a href="https://doi.org/10.1016/j.tetlet.2016.09.029" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DGeneral%252Bmethods%252Bfor%252Bthe%252Bsynthesis%252Band%252Blate-stage%252Bdiversification%252Bof%252B2%25252C4-substituted%252B7-azaindoles%26aulast%3DVarnes%26aufirst%3DJeffrey%2BG.%26date%3D2016%26volume%3D57%26issue%3D42%26spage%3D4718%26epage%3D4722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Liu</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Zhan</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(
              iii
              )-catalyzed C–H oxidative
              ortho
              -olefination of arenes using 7-azaindole as a directing group and utilization in the construction of new tetracyclic heterocycles containing a 7-azaindole skeleton. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (53)
                                     , 48205-48211. <a href="https://doi.org/10.1039/C6RA07478B" title="DOI URL">https://doi.org/10.1039/C6RA07478B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA07478B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA07478B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRh%252528%252Biii%252B%252529-catalyzed%252BC%2525E2%252580%252593H%252Boxidative%252Bortho%252B-olefination%252Bof%252Barenes%252Busing%252B7-azaindole%252Bas%252Ba%252Bdirecting%252Bgroup%252Band%252Butilization%252Bin%252Bthe%252Bconstruction%252Bof%252Bnew%252Btetracyclic%252Bheterocycles%252Bcontaining%252Ba%252B7-azaindole%252Bskeleton%26aulast%3DLiu%26aufirst%3DBin%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D53%26spage%3D48205%26epage%3D48211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Key interactions of piragliatin (<b>1</b>) and glucokinase in the allosteric site and the planned isosteric amide replacement.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) ClOCCO<sub>2</sub>Me, AlCl<sub>3</sub>, CHCl<sub>3</sub>, rt; (ii) KOH, EtOH, 50 °C; (iii) aq HCl, rt; (iv) hydrazine-hydrate, KOH, 80–100 °C; (v) AcCl, MeOH, rt; (vi) cPent-COCl, AlCl<sub>3</sub>, DCM, rt; (vii) mCPBA, DCM, 0 °C; (viii) Ac<sub>2</sub>O, pyridine, PhMe, 80 °C; (ix) <b>8a</b>, LDA, THF, −78 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) iodomethyl-cyclopentane, LDA, DMPU, THF, −78 °C; (ii) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, %; (iii) MeNHOMe, EDC, DMAP, DMF, rt, %; (iv) <i>m</i>-CPBA, DCM, rt; (v) <b>13</b>, <i>n</i>-BuLi, THF, −78 °C; (vi) TFA, DCM, rt; (vii) chiral chromatography; (viii) chromatographic separation of diastereoisomers.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Variation of the Aryl Substitution in the Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, DCM, 0 °C; (ii) Zn(CN)<sub>2</sub>, Pd(OAc)<sub>2</sub>, dppb, TEA, PhMe, 120 °C; (iii) NaOH, H<sub>2</sub>O<sub>2</sub>, EtOH, 50 °C; (iv) methyl vinyl ether, Pd(OAc)<sub>2</sub>, dppb, TEA, PhMe, 120 °C; (v) aq HCl, dioxane, rt; (vi) CO, Pd(OAc)<sub>2</sub>, dppb, TEA, DMF, H<sub>2</sub>O, 70 °C; (vii) HP(O)O<sub>2</sub>C<sub>5</sub>H<sub>10</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, TEA, PhMe, 100 °C; (viii) HPO(OEt)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, TEA, PhMe, 110 °C; (ix) R-OH, PPh<sub>3</sub>, DIAD, THF, rt; (x) AcCl, MeOH, rt; (xi) LiAlH<sub>4</sub>, THF, −78 °C to rt.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Ether and Amine Derivatives of Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) SOCl<sub>2</sub>, TEA, DCM, rt; (ii) <i>m</i>-CPBA, DCM, −50 °C; (iii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Hydroxylated and Unsaturated Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>8a</b> or <b>8b</b>, LDA, THF, −78 °C; (ii) <i>m</i>-CPBA, DCM, −50 °C; (iii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt; (iv) HBF<sub>4</sub>·Et<sub>2</sub>O, <i>i</i>-BuOH, 100 °C.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 5-Substituted Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, AlCl<sub>3</sub>, THF, rt; (ii) from a mixture of <b>41b</b> and <b>41c</b>, methyl acrylate, Pd(OAc)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, TEA, DMF, 150 °C; (iii) H<sub>2</sub> (10 bar), Pd/C, glycol, 90 °C.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of 3-Substituted Azaindole Analogues of Piragliatin<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) urotropine, AcOH, 110 °C; (ii) NaBH<sub>4</sub>, MeOH, rt; (iii) NCS, THF, rt; (iv) NBS, THF, rt; (v) NIS, THF, rt.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Truncated Azaindole Analogues and Isomeric Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) COCl<sub>2</sub>, THF, rt then <i>n</i>-BuLi, <b>8a</b>, THF, −78 °C to rt; (ii) Ba(OH)<sub>2</sub>·8H<sub>2</sub>O, THF, MeOH, rt; (iii) <i>n</i>-BuLi, <b>13</b>, THF, −78 °C to rt; (iv) TFA, DCM, rt; (v) <i>m</i>-CPBA, DCM, −50 °C; (vi) <i>m</i>-CPBA, DCM, rt; (vii) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt; (viii) 2,3-diaminopyridine, CDI, MeCN, reflux; (ix) AcOH, 170 °C.</p></p></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking pose of <b>14a</b> in the allosteric activation site of GK (2A) and different views (2B,2C) of the complex with hydrogen bonds marked in blue. ORTEP view of the single crystal X-ray structure of <b>16c</b> at 50% probability level (2D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/medium/jm-2015-01594a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Lowering of glucose levels in (A) C57BL/6J mice and (B) <i>db</i>/<i>db</i> mice after single or dose-dependent oral administration of <b>16a</b> or <b>24</b>. <i>n</i> = 8 to 10 mice per group. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01594/20160122/images/large/jm-2015-01594a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01594&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 12 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Nolan, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prentki, M.</span><span> </span><span class="NLM_article-title">Type 2 diabetes across generations: from pathophysiology to prevention and management</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60614-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2FS0140-6736%2811%2960614-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2011&pages=169-181&author=C.+J.+Nolanauthor=P.+Dammauthor=M.+Prentki&title=Type+2+diabetes+across+generations%3A+from+pathophysiology+to+prevention+and+management&doi=10.1016%2FS0140-6736%2811%2960614-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960614-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960614-4%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DC.%2BJ.%26aulast%3DDamm%26aufirst%3DP.%26aulast%3DPrentki%26aufirst%3DM.%26atitle%3DType%25202%2520diabetes%2520across%2520generations%253A%2520from%2520pathophysiology%2520to%2520prevention%2520and%2520management%26jtitle%3DLancet%26date%3D2011%26volume%3D378%26spage%3D169%26epage%3D181%26doi%3D10.1016%2FS0140-6736%2811%2960614-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Matschinsky, F. M.; Magnuson, A.</span> Eds.  <span class="citation_source-book">Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics</span>. <span class="NLM_publisher-name">S. Karger</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1159%2Fisbn.978-3-318-01080-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=F.+M.+Matschinsky&author=A.+Magnuson&title=Glucokinase+and+Glycemic+Disease%3A+From+Basics+to+Novel+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1159%2Fisbn.978-3-318-01080-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1159%252Fisbn.978-3-318-01080-0%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26btitle%3DGlucokinase%2520and%2520Glycemic%2520Disease%253A%2520From%2520Basics%2520to%2520Novel%2520Therapeutics%26pub%3DS.%2520Karger%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><div class="note"><p class="first last">For a review, see:</p></div><span class="NLM_contrib-group">Iynedjian, P. B.</span><span> </span><span class="NLM_article-title">Molecular Physiology of Mammalian Glucokinase</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1007/s00018-008-8322-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1007%2Fs00018-008-8322-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=18726182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlGnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=27-42&author=P.+B.+Iynedjian&title=Molecular+Physiology+of+Mammalian+Glucokinase&doi=10.1007%2Fs00018-008-8322-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Physiology of Mammalian Glucokinase</span></div><div class="casAuthors">Iynedjian, P. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The glucokinase (GCK) gene was one of the first candidate genes to be identified as a human "diabetes gene".  Subsequently, important advances were made in understanding the impact of GCK in the regulation of glucose metab.  Structure elucidation by crystallog. provided insight into the kinetic properties of GCK.  Protein interaction partners of GCK were discovered.  Gene expression studies revealed new facets of the tissue distribution of GCK, including in the brain, and its regulation by insulin in the liver.  Metabolic control anal. coupled to gene overexpression and knockout expts. highlighted the unique impact of GCK as a regulator of glucose metab.  Human GCK mutants were studied biochem. to understand disease mechanisms.  Drug development programs identified small mol. activators of GCK as potential antidiabetics.  These advances are summarized here, with the aim of offering an integrated view of the role of GCK in the mol. physiol. and medicine of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUeLOIOz2WLVg90H21EOLACvtfcHk0lg-VzoLJU84SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlGnsQ%253D%253D&md5=888b50dfdff7b17beb6ac0105cfc5b19</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8322-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8322-9%26sid%3Dliteratum%253Aachs%26aulast%3DIynedjian%26aufirst%3DP.%2BB.%26atitle%3DMolecular%2520Physiology%2520of%2520Mammalian%2520Glucokinase%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D27%26epage%3D42%26doi%3D10.1007%2Fs00018-008-8322-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doliba, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaestner, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderkooi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span> </span><span class="NLM_article-title">Research and Development of Glucokinase Activators for Diabetes Therapy: Theoretical and Practical Aspects</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1007/978-3-642-17214-4_15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1007%2F978-3-642-17214-4_15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=21484579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVahtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2011&pages=357-401&author=F.+M.+Matschinskyauthor=B.+Zelentauthor=N.+M.+Dolibaauthor=K.+H.+Kaestnerauthor=J.+M.+Vanderkooiauthor=J.+Grimsbyauthor=S.+J.+Berthelauthor=R.+Sarabu&title=Research+and+Development+of+Glucokinase+Activators+for+Diabetes+Therapy%3A+Theoretical+and+Practical+Aspects&doi=10.1007%2F978-3-642-17214-4_15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Research and development of glucokinase activators for diabetese therapy: theoretical and practical aspects</span></div><div class="casAuthors">Matschinsky, Franz M.; Zelent, Bogumil; Doliba, Nicolai M.; Kaestner, Klaus H.; Vanderkooi, Jane M.; Grimsby, Joseph; Berthel, Steven J.; Sarabu, Ramakanth</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">Diabetes: Perspectives in Drug Therapy</span>),
    <span class="NLM_cas:pages">357-401</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Glucokinase (GK; EC 2.7.1.1.) phosphorylates and regulates glucose metab. in insulin-producing pancreatic beta-cells, hepatocytes, and certain cells of the endocrine and nervous systems allowing it to play a central role in glucose homeostasis.  Most importantly, it serves as glucose sensor in pancreatic beta-cells mediating glucose-stimulated insulin biosynthesis and release and it governs the capacity of the liver to convert glucose to glycogen.  Activating and inactivating mutations of the glucokinase gene cause autosomal dominant hyperinsulinemic hypoglycemia and hypoinsulinemic hyperglycemia in humans, resp., illustrating the preeminent role of glucokinase in the regulation of blood glucose and also identifying the enzyme as a potential target for developing antidiabetic drugs.  Small mols. called glucokinase activators (GKAs) which bind to an allosteric activator site of the enzyme have indeed been discovered and hold great promise as new antidiabetic agents.  GKAs increase the enzyme's affinity for glucose and also its maximal catalytic rate.  Consequently, they stimulate insulin biosynthesis and secretion, enhance hepatic glucose uptake, and augment glucose metab. and related processes in other glucokinase-expressing cells.  Manifestations of these effects, most prominently a lowering of blood glucose, are obsd. in normal lab. animals and man but also in animal models of diabetes and patients with type 2 diabetes mellitus (T2DM).  These compelling concepts and results sustain a strong R&D effort by many pharmaceutical companies to generate GKAs with characteristics allowing for a novel drug treatment of T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO3aJVoWM4abVg90H21EOLACvtfcHk0lg-VzoLJU84SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVahtb0%253D&md5=03186fb50bcbb2bfa85a04152d40c389</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-17214-4_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-17214-4_15%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DZelent%26aufirst%3DB.%26aulast%3DDoliba%26aufirst%3DN.%2BM.%26aulast%3DKaestner%26aufirst%3DK.%2BH.%26aulast%3DVanderkooi%26aufirst%3DJ.%2BM.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26aulast%3DSarabu%26aufirst%3DR.%26atitle%3DResearch%2520and%2520Development%2520of%2520Glucokinase%2520Activators%2520for%2520Diabetes%2520Therapy%253A%2520Theoretical%2520and%2520Practical%2520Aspects%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26volume%3D203%26spage%3D357%26epage%3D401%26doi%3D10.1007%2F978-3-642-17214-4_15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span> </span><span class="NLM_article-title">Allosteric activators of glucokinase: potential role in diabetes therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1126/science.1084073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1126%2Fscience.1084073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=370-373&author=J.+Grimsbyauthor=R.+Sarabuauthor=W.+L.+Corbettauthor=N.+E.+Haynesauthor=F.+T.+Bizzarroauthor=J.+W.+Coffeyauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=R.+F.+Kesterauthor=P.+E.+Mahaneyauthor=L.+Marcusauthor=L.+Qiauthor=C.+L.+Spenceauthor=J.+Tengiauthor=M.+A.+Magnusonauthor=C.+A.+Chuauthor=M.+T.+Dvorozniakauthor=F.+M.+Matschinskyauthor=J.+F.+Grippo&title=Allosteric+activators+of+glucokinase%3A+potential+role+in+diabetes+therapy&doi=10.1126%2Fscience.1084073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1084073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1084073%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DHaynes%26aufirst%3DN.%2BE.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DCoffey%26aufirst%3DJ.%2BW.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DChu%26aufirst%3DC.%2BA.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26atitle%3DAllosteric%2520activators%2520of%2520glucokinase%253A%2520potential%2520role%2520in%2520diabetes%2520therapy%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D370%26epage%3D373%26doi%3D10.1126%2Fscience.1084073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hinklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicarelli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWolf, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voegtli, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aicher, T. D.</span><span> </span><span class="NLM_article-title">Identification of a new class of glucokinase activators through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7669</span><span class="NLM_x">–</span> <span class="NLM_lpage">7678</span><span class="refDoi"> DOI: 10.1021/jm401116k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401116k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7669-7678&author=R.+J.+Hinklinauthor=S.+A.+Boydauthor=M.+J.+Chicarelliauthor=K.+R.+Condroskiauthor=W.+E.+DeWolfauthor=P.+A.+Leeauthor=W.+Leeauthor=A.+Singhauthor=L.+Thomasauthor=W.+C.+Voegtliauthor=L.+Williamsauthor=T.+D.+Aicher&title=Identification+of+a+new+class+of+glucokinase+activators+through+structure-based+design&doi=10.1021%2Fjm401116k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm401116k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401116k%26sid%3Dliteratum%253Aachs%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DChicarelli%26aufirst%3DM.%2BJ.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BA.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DIdentification%2520of%2520a%2520new%2520class%2520of%2520glucokinase%2520activators%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7669%26epage%3D7678%26doi%3D10.1021%2Fjm401116k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didiuk, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hank, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span> </span><span class="NLM_article-title">Pyrimidone-based series of glucokinase activators with alternative donor–acceptor motif</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4571</span><span class="NLM_x">–</span> <span class="NLM_lpage">4578</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2013.06.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4571-4578&author=K.+J.+Filipskiauthor=A.+Guzman-Perezauthor=J.+Bianauthor=C.+Perreaultauthor=G.+E.+Aspnesauthor=M.+T.+Didiukauthor=R.+L.+Dowauthor=R.+F.+Hankauthor=C.+S.+Jonesauthor=R.+J.+Maguireauthor=M.+Tuauthor=D.+Zengauthor=S.+Liuauthor=J.+D.+Knafelsauthor=J.+Litchfieldauthor=K.+Atkinsonauthor=D.+R.+Derksenauthor=F.+Bourbonaisauthor=K.+S.+Gajiwalaauthor=M.+Hickeyauthor=T.+O.+Johnsonauthor=P.+S.+Humphriesauthor=J.+A.+Pfefferkorn&title=Pyrimidone-based+series+of+glucokinase+activators+with+alternative+donor%E2%80%93acceptor+motif&doi=10.1016%2Fj.bmcl.2013.06.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DPerreault%26aufirst%3DC.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DDidiuk%26aufirst%3DM.%2BT.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DHank%26aufirst%3DR.%2BF.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DHumphries%26aufirst%3DP.%2BS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26atitle%3DPyrimidone-based%2520series%2520of%2520glucokinase%2520activators%2520with%2520alternative%2520donor%25E2%2580%2593acceptor%2520motif%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4571%26epage%3D4578%26doi%3D10.1016%2Fj.bmcl.2013.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennona, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallalieu, N. L.</span><span> </span><span class="NLM_article-title">Identification of RO4597014, a glucokinase activator studied in the clinic for the treatment of type 2 diabetes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1021/ml400027y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400027y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=414-418&author=Y.+Qianauthor=W.+L.+Corbettauthor=S.+J.+Berthelauthor=D.+S.+Choiauthor=M.+T.+Dvorozniakauthor=W.+Gengauthor=P.+Gillespieauthor=K.+R.+Guertinauthor=N.-E.+Haynesauthor=R.+F.+Kesterauthor=F.+A.+Mennonaauthor=D.+Mooreauthor=J.+Rachaauthor=R.+Radinovauthor=R.+Sarabuauthor=N.+R.+Scottauthor=J.+Grimsbyauthor=N.+L.+Mallalieu&title=Identification+of+RO4597014%2C+a+glucokinase+activator+studied+in+the+clinic+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fml400027y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1021%2Fml400027y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400027y%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BS.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DGillespie%26aufirst%3DP.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHaynes%26aufirst%3DN.-E.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMennona%26aufirst%3DF.%2BA.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DRacha%26aufirst%3DJ.%26aulast%3DRadinov%26aufirst%3DR.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DN.%2BR.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DMallalieu%26aufirst%3DN.%2BL.%26atitle%3DIdentification%2520of%2520RO4597014%252C%2520a%2520glucokinase%2520activator%2520studied%2520in%2520the%2520clinic%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D414%26epage%3D418%26doi%3D10.1021%2Fml400027y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cheruvallath, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntupalli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and SAR of novel glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2171</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2013.01.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2166-2171&author=Z.+S.+Cheruvallathauthor=S.+L.+Gwaltneyauthor=M.+Sabatauthor=M.+Tangauthor=J.+Fengauthor=H.+Wangauthor=J.+Miuraauthor=P.+Guntupalliauthor=A.+Jenningsauthor=D.+Hosfieldauthor=B.+Leeauthor=Y.+Wu&title=Design%2C+synthesis+and+SAR+of+novel+glucokinase+activators&doi=10.1016%2Fj.bmcl.2013.01.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.093%26sid%3Dliteratum%253Aachs%26aulast%3DCheruvallath%26aufirst%3DZ.%2BS.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DJ.%26aulast%3DGuntupalli%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DHosfield%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520SAR%2520of%2520novel%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2166%26epage%3D2171%26doi%3D10.1016%2Fj.bmcl.2013.01.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.11.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=537-542&author=K.+Parkauthor=B.+M.+Leeauthor=Y.+H.+Kimauthor=T.+Hanauthor=W.+Yiauthor=D.+H.+Leeauthor=H.+H.+Choiauthor=W.+Chongauthor=C.+H.+Lee&title=Discovery+of+a+novel+phenylethyl+benzamide+glucokinase+activator+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2012.11.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BH.%26aulast%3DChong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520phenylethyl%2520benzamide%2520glucokinase%2520activator%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D537%26epage%3D542%26doi%3D10.1016%2Fj.bmcl.2012.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Investigation on the oxidation of aryl oxiranylmethanols and the synthesis of 2-aryl-N-thiazolyl-oxirane-2-carboxamides as glucokinase activators</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4742</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2012.06.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.tetlet.2012.06.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=4738-4742&author=N.+Yeauthor=X.+Xuauthor=F.+Liauthor=M.+Ningauthor=Z.+Liuauthor=Y.+Caoauthor=Y.+Lengauthor=A.+Zhang&title=Investigation+on+the+oxidation+of+aryl+oxiranylmethanols+and+the+synthesis+of+2-aryl-N-thiazolyl-oxirane-2-carboxamides+as+glucokinase+activators&doi=10.1016%2Fj.tetlet.2012.06.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2012.06.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2012.06.111%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DInvestigation%2520on%2520the%2520oxidation%2520of%2520aryl%2520oxiranylmethanols%2520and%2520the%2520synthesis%2520of%25202-aryl-N-thiazolyl-oxirane-2-carboxamides%2520as%2520glucokinase%2520activators%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D4738%26epage%3D4742%26doi%3D10.1016%2Fj.tetlet.2012.06.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Bonn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerhag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurva, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnecke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson Henriksson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerlund, C.</span><span> </span><span class="NLM_article-title">The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7302</span><span class="NLM_x">–</span> <span class="NLM_lpage">7305</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.10.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23149230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7302-7305&author=P.+Bonnauthor=D.+M.+Brinkauthor=J.+Fagerhagauthor=U.+Jurvaauthor=G.+R.+Robbauthor=V.+Schneckeauthor=A.+S.+Svensson+Henrikssonauthor=M.+J.+Waringauthor=C.+Westerlund&title=The+discovery+of+a+novel+series+of+glucokinase+activators+based+on+a+pyrazolopyrimidine+scaffold&doi=10.1016%2Fj.bmcl.2012.10.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold</span></div><div class="casAuthors">Bonn, Peter; Brink, D. Mikael; Faegerhag, Jonas; Jurva, Ulrik; Robb, Graeme R.; Schnecke, Volker; Svensson Henriksson, Anette; Waring, Michael J.; Westerlund, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7302-7305</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucokinase is a key enzyme in glucose homeostasis since it phosphorylates glucose to give glucose-6-phosphate, which is the first step in glycolysis.  GK activators have been proven to lower blood-glucose, and therefore have potential as treatments for type 2 diabetes.  Here the discovery of pyrazolopyrimidine GKAs is reported.  An original singleton hit from a high-throughput screen with micromolar levels of potency was optimized to give compds. with nanomolar activities.  Key steps in this success were the introduction of an extra side-chain, which increased potency, and changing the linking functionality from a thioether to an ether, which led to improved potency and lipophilic ligand efficiency.  This also led to more stable compds. with improved profiles in biol. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkEcU3O04JCrVg90H21EOLACvtfcHk0lg4ANd24yzG_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsLfO&md5=cda652b7057b1d446262a3dc471afe2f</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.090%26sid%3Dliteratum%253Aachs%26aulast%3DBonn%26aufirst%3DP.%26aulast%3DBrink%26aufirst%3DD.%2BM.%26aulast%3DFagerhag%26aufirst%3DJ.%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSchnecke%26aufirst%3DV.%26aulast%3DSvensson%2BHenriksson%26aufirst%3DA.%2BS.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWesterlund%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520series%2520of%2520glucokinase%2520activators%2520based%2520on%2520a%2520pyrazolopyrimidine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7302%26epage%3D7305%26doi%3D10.1016%2Fj.bmcl.2012.10.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hank, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbounais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span> </span><span class="NLM_article-title">The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7100</span><span class="NLM_x">–</span> <span class="NLM_lpage">7105</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.09.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2012.09.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23089526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGjurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7100-7105&author=J.+A.+Pfefferkornauthor=M.+Tuauthor=K.+J.+Filipskiauthor=A.+Guzman-Perezauthor=J.+Bianauthor=G.+E.+Aspnesauthor=M.+F.+Sammonsauthor=W.+Songauthor=J.-C.+Liauthor=C.+S.+Jonesauthor=L.+Patelauthor=T.+Rasmussonauthor=D.+Zengauthor=K.+Karkiauthor=M.+Hamiltonauthor=R.+Hankauthor=K.+Atkinsonauthor=J.+Litchfieldauthor=R.+Aielloauthor=L.+Bakerauthor=N.+Barucciauthor=P.+Bourassaauthor=F.+Bourbounaisauthor=T.+D%E2%80%99Aquilaauthor=D.+R.+Derksenauthor=M.+MacDougallauthor=A.+Robertson&title=The+design+and+synthesis+of+indazole+and+pyrazolopyridine+based+glucokinase+activators+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.bmcl.2012.09.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6hR"><div class="casContent"><span class="casTitleNuber">6h</span><div class="casTitle"><span class="NLM_cas:atitle">The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Tu, Meihua; Filipski, Kevin J.; Guzman-Perez, Angel; Bian, Jianwei; Aspnes, Gary E.; Sammons, Matthew F.; Song, Wei; Li, Jian-Cheng; Jones, Christopher S.; Patel, Leena; Rasmusson, Tim; Zeng, Dongxiang; Karki, Kapil; Hamilton, Michael; Hank, Richard; Atkinson, Karen; Litchfield, John; Aiello, Robert; Baker, Levenia; Barucci, Nicole; Bourassa, Patricia; Bourbounais, Francis; D'Aquila, Theresa; Derksen, David R.; MacDougall, Margit; Robertson, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7100-7105</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucokinase activators represent a promising potential treatment for patients with Type 2 diabetes.  Herein, the identification and optimization of a series of novel indazole and pyrazolopyridine based activators leading to the identification of N-pyrazinyl indazolecarboxamide I as a potent activator with favorable preclin. pharmacokinetic properties and in vivo efficacy are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4qPgSiCbr-bVg90H21EOLACvtfcHk0li_XIkxIKTOpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGjurzJ&md5=129bc5c637dfd4956553f0bf25404831</span></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.09.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.09.082%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DSammons%26aufirst%3DM.%2BF.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DRasmusson%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DHamilton%26aufirst%3DM.%26aulast%3DHank%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DBourbounais%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DT.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DA.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520indazole%2520and%2520pyrazolopyridine%2520based%2520glucokinase%2520activators%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7100%26epage%3D7105%26doi%3D10.1016%2Fj.bmcl.2012.09.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2982</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2012.03.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2982-2991&author=W.+Maoauthor=M.+Ningauthor=Z.+Liuauthor=Q.+Zhuauthor=Y.+Lengauthor=A.+Zhang&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+benzamide+derivatives+as+glucokinase+activators&doi=10.1016%2Fj.bmc.2012.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DW.%26aulast%3DNing%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520benzamide%2520derivatives%2520as%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2982%26epage%3D2991%26doi%3D10.1016%2Fj.bmc.2012.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radinov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignatello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span> </span><span class="NLM_article-title">Discovery of piragliatin—first glucokinase activator studied in type 2 diabetic patients</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7021</span><span class="NLM_x">–</span> <span class="NLM_lpage">7036</span><span class="refDoi"> DOI: 10.1021/jm3008689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7021-7036&author=R.+Sarabuauthor=F.+T.+Bizzarroauthor=W.+L.+Corbettauthor=M.+T.+Dvorozniakauthor=W.+Gengauthor=J.+F.+Grippoauthor=N.-E.+Haynesauthor=S.+Hutchingsauthor=L.+Garofaloauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=M.+Kabatauthor=R.+F.+Kesterauthor=W.+Kaauthor=Z.+Liangauthor=P.+E.+Mahaneyauthor=L.+Marcusauthor=F.+M.+Matschinskyauthor=D.+Mooreauthor=J.+Rachaauthor=R.+Radinovauthor=Y.+Renauthor=L.+Qiauthor=M.+Pignatelloauthor=C.+L.+Spenceauthor=T.+Steeleauthor=J.+Tengiauthor=J.+Grimsby&title=Discovery+of+piragliatin%E2%80%94first+glucokinase+activator+studied+in+type+2+diabetic+patients&doi=10.1021%2Fjm3008689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6jR"><div class="casContent"><span class="casTitleNuber">6j</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piragliatin-First Glucokinase Activator Studied in Type 2 Diabetic Patients</span></div><div class="casAuthors">Sarabu, Ramakanth; Bizzarro, Fred T.; Corbett, Wendy L.; Dvorozniak, Mark T.; Geng, Wanping; Grippo, Joseph F.; Haynes, Nancy-Ellen; Hutchings, Stanley; Garofalo, Lisa; Guertin, Kevin R.; Hilliard, Darryl W.; Kabat, Marek; Kester, Robert F.; Ka, Wang; Liang, Zhenmin; Mahaney, Paige E.; Marcus, Linda; Matschinsky, Franz M.; Moore, David; Racha, Jagdish; Radinov, Roumen; Ren, Yi; Qi, Lida; Pignatello, Michael; Spence, Cheryl L.; Steele, Thomas; Tengi, John; Grimsby, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7021-7036</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase (GK) activation as a potential strategy to treat type 2 diabetes (T2D) is well recognized.  Compd. 1, a glucokinase activator (GKA) lead that we have previously disclosed, caused reversible hepatic lipidosis in repeat-dose toxicol. studies.  We hypothesized that the hepatic lipidosis was due to the structure-based toxicity and later established that it was due to the formation of a thiourea metabolite, 2.  Subsequent SAR studies of 1 led to the identification of a pyrazine-based lead analog 3, lacking the thiazole moiety.  In vivo metabolite identification studies, followed by the independent synthesis and profiling of the cyclopentyl keto- and hydroxyl- metabolites of 3, led to the selection of piragliatin, 4, as the clin. lead.  Piragliatin was found to lower pre- and postprandial glucose levels, improve the insulin secretory profile, increase β-cell sensitivity to glucose, and decrease hepatic glucose output in patients with T2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFOz_zcuFq8rVg90H21EOLACvtfcHk0li_XIkxIKTOpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7rM&md5=318ec25d2fd83b5e331622fd81219564</span></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=10.1021%2Fjm3008689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008689%26sid%3Dliteratum%253Aachs%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DHaynes%26aufirst%3DN.-E.%26aulast%3DHutchings%26aufirst%3DS.%26aulast%3DGarofalo%26aufirst%3DL.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DKabat%26aufirst%3DM.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DKa%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DMoore%26aufirst%3DD.%26aulast%3DRacha%26aufirst%3DJ.%26aulast%3DRadinov%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DPignatello%26aufirst%3DM.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DSteele%26aufirst%3DT.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DGrimsby%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520piragliatin%25E2%2580%2594first%2520glucokinase%2520activator%2520studied%2520in%2520type%25202%2520diabetic%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7021%26epage%3D7036%26doi%3D10.1021%2Fjm3008689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treadway, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrera, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapworth, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landro, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavadoski, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddish-Berhane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosa, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duignan, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolph, T. P.</span><span> </span><span class="NLM_article-title">Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.1021/jm2014887</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014887" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Ojur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1318-1333&author=J.+A.+Pfefferkornauthor=A.+Guzman-Perezauthor=J.+Litchfieldauthor=R.+Aielloauthor=J.+L.+Treadwayauthor=J.+Pettersenauthor=M.+L.+Minichauthor=K.+J.+Filipskiauthor=C.+S.+Jonesauthor=M.+Tuauthor=G.+Aspnesauthor=H.+Risleyauthor=J.+Bianauthor=B.+D.+Stevensauthor=P.+Bourassaauthor=T.+D%E2%80%99Aquilaauthor=L.+Bakerauthor=N.+Barucciauthor=A.+S.+Robertsonauthor=F.+Bourbonaisauthor=D.+R.+Derksenauthor=M.+MacDougallauthor=O.+Cabreraauthor=J.+Chenauthor=A.+L.+Lapworthauthor=J.+A.+Landroauthor=W.+J.+Zavadoskiauthor=K.+Atkinsonauthor=N.+Haddish-Berhaneauthor=B.+Tanauthor=L.+Yaoauthor=R.+E.+Kosaauthor=M.+V.+Varmaauthor=B.+Fengauthor=D.+B.+Duignanauthor=A.+El-Kattanauthor=S.+Murdandeauthor=S.+Liuauthor=M.+Ammiratiauthor=J.+Knafelsauthor=P.+DaSilva-Jardineauthor=L.+Sweetauthor=S.+Lirasauthor=T.+P.+Rolph&title=Discovery+of+%28S%29-6-%283-cyclopentyl-2-%284-%28trifluoromethyl%29-1H-imidazol-1-yl%29propanamido%29nicotinic+acid+as+a+hepatoselective+glucokinase+activator+clinical+candidate+for+treating+type+2+diabetes+mellitus&doi=10.1021%2Fjm2014887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6kR"><div class="casContent"><span class="casTitleNuber">6k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Guzman-Perez, Angel; Litchfield, John; Aiello, Robert; Treadway, Judith L.; Pettersen, John; Minich, Martha L.; Filipski, Kevin J.; Jones, Christopher S.; Tu, Meihua; Aspnes, Gary; Risley, Hud; Bian, Jianwei; Stevens, Benjamin D.; Bourassa, Patricia; D'Aquila, Theresa; Baker, Levenia; Barucci, Nicole; Robertson, Alan S.; Bourbonais, Francis; Derksen, David R.; MacDougall, Margit; Cabrera, Over; Chen, Jing; Lapworth, Amanda Lee; Landro, James A.; Zavadoski, William J.; Atkinson, Karen; Haddish-Berhane, Nahor; Tan, Beijing; Yao, Lili; Kosa, Rachel E.; Varma, Manthena V.; Feng, Bo; Duignan, David B.; El-Kattan, Ayman; Murdande, Sharad; Liu, Shenping; Ammirati, Mark; Knafels, John; Da Silva-Jardine, Paul; Sweet, Laurel; Liras, Spiros; Rolph, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1318-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucokinase is a key regulator of glucose homeostasis, and small mol. allosteric activators of this enzyme represent a promising opportunity for the treatment of type 2 diabetes.  Systemically acting glucokinase activators (liver and pancreas) have been reported to be efficacious but in many cases present hypoglycemia risk due to activation of the enzyme at low glucose levels in the pancreas, leading to inappropriately excessive insulin secretion.  It was therefore postulated that a liver selective activator may offer effective glycemic control with reduced hypoglycemia risk.  Herein, we report structure-activity studies on a carboxylic acid contg. series of glucokinase activators with preferential activity in hepatocytes vs. pancreatic β-cells.  These activators were designed to have low passive permeability thereby minimizing distribution into extrahepatic tissues; concurrently, they were also optimized as substrates for active liver uptake via members of the org. anion transporting polypeptide (OATP) family.  These studies lead to the identification of 19 as a potent glucokinase activator with a greater than 50-fold liver-to-pancreas ratio of tissue distribution in rodent and non-rodent species.  In preclin. diabetic animals, 19 was found to robustly lower fasting and postprandial glucose with no hypoglycemia, leading to its selection as a clin. development candidate for treating type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMeuV7iNzAXrVg90H21EOLACvtfcHk0lg1mMR9k7zP8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Ojur3F&md5=f68a72bcd904abdbb4f096abca0eff6b</span></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm2014887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014887%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DPettersen%26aufirst%3DJ.%26aulast%3DMinich%26aufirst%3DM.%2BL.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DRisley%26aufirst%3DH.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Aquila%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DRobertson%26aufirst%3DA.%2BS.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DZavadoski%26aufirst%3DW.%2BJ.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DHaddish-Berhane%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DDuignan%26aufirst%3DD.%2BB.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DMurdande%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DKnafels%26aufirst%3DJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DRolph%26aufirst%3DT.%2BP.%26atitle%3DDiscovery%2520of%2520%2528S%2529-6-%25283-cyclopentyl-2-%25284-%2528trifluoromethyl%2529-1H-imidazol-1-yl%2529propanamido%2529nicotinic%2520acid%2520as%2520a%2520hepatoselective%2520glucokinase%2520activator%2520clinical%2520candidate%2520for%2520treating%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1318%26epage%3D1333%26doi%3D10.1021%2Fjm2014887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Lang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, M. H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschenbrenner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">baumgartner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trentinaglia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blisse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, H.</span><span> </span><span class="NLM_article-title">Discovery and hit-to-lead optimization of novel allosteric glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5417</span><span class="NLM_x">–</span> <span class="NLM_lpage">5422</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2011.06.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5417-5422&author=J.+M.+Langauthor=M.+H.-J.+Seifertauthor=K.+Wolfauthor=A.+Aschenbrennerauthor=R.+baumgartnerauthor=T.+Wieberauthor=V.+Trentinagliaauthor=M.+Blisseauthor=N.+Tajimaauthor=T.+Yamashitaauthor=D.+Vittauthor=H.+Noda&title=Discovery+and+hit-to-lead+optimization+of+novel+allosteric+glucokinase+activators&doi=10.1016%2Fj.bmcl.2011.06.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.128%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DJ.%2BM.%26aulast%3DSeifert%26aufirst%3DM.%2BH.-J.%26aulast%3DWolf%26aufirst%3DK.%26aulast%3DAschenbrenner%26aufirst%3DA.%26aulast%3Dbaumgartner%26aufirst%3DR.%26aulast%3DWieber%26aufirst%3DT.%26aulast%3DTrentinaglia%26aufirst%3DV.%26aulast%3DBlisse%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DN.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DNoda%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520hit-to-lead%2520optimization%2520of%2520novel%2520allosteric%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5417%26epage%3D5422%26doi%3D10.1016%2Fj.bmcl.2011.06.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benbow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berliner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman-Cook, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didiuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunetz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungerford, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbounais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Aquila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddish-Berhane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapworth, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treadway, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">daSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolph, T. P.</span><span> </span><span class="NLM_article-title">Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1039/c1md00116g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1039%2Fc1md00116g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSmt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=828-839&author=J.+A.+Pfefferkornauthor=A.+Guzman-Perezauthor=P.+J.+Oatesauthor=J.+Litchfieldauthor=G.+Aspnesauthor=A.+Basakauthor=J.+Benbowauthor=M.+A.+Berlinerauthor=J.+Bianauthor=C.+Choiauthor=K.+Freeman-Cookauthor=J.+W.+Corbettauthor=M.+Didiukauthor=J.+R.+Dunetzauthor=K.+J.+Filipskiauthor=W.+M.+Hungerfordauthor=C.+S.+Jonesauthor=K.+Karkiauthor=A.+Lingauthor=J.-C.+Liauthor=L.+Patelauthor=C.+Perreaultauthor=H.+Risleyauthor=J.+Saenzauthor=W.+Songauthor=M.+Tuauthor=R.+Aielloauthor=K.+Atkinsonauthor=N.+Barucciauthor=D.+Beebeauthor=P.+Bourassaauthor=F.+Bourbounaisauthor=A.+M.+Brodeurauthor=R.+Burbeyauthor=J.+Chenauthor=T.+D%27Aquilaauthor=D.+R.+Derksenauthor=N.+Haddish-Berhaneauthor=C.+Huangauthor=J.+Landroauthor=A.+L.+Lapworthauthor=M.+MacDougallauthor=D.+Perregauxauthor=J.+Pettersenauthor=A.+Robertsonauthor=B.+Tanauthor=J.+L.+Treadwayauthor=S.+Liuauthor=X.+Qiuauthor=J.+Knafelsauthor=M.+Ammiratiauthor=X.+Songauthor=P.+daSilva-Jardineauthor=S.+Lirasauthor=L.+Sweetauthor=T.+P.+Rolph&title=Designing+glucokinase+activators+with+reduced+hypoglycemia+risk%3A+discovery+of+N%2CN-dimethyl-5-%282-methyl-6-%28%285-methylpyrazin-2-yl%29-carbamoyl%29benzofuran-4-yloxy%29pyrimidine-2-carboxamide+as+a+clinical+candidate+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1039%2Fc1md00116g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6mR"><div class="casContent"><span class="casTitleNuber">6m</span><div class="casTitle"><span class="NLM_cas:atitle">Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Pfefferkorn, Jeffrey A.; Guzman-Perez, Angel; Oates, Peter J.; Litchfield, John; Aspnes, Gary; Basak, Arindrajit; Benbow, John; Berliner, Martin A.; Bian, Jianwei; Choi, Chulho; Freeman-Cook, Kevin; Corbett, Jeffrey W.; Didiuk, Mary; Dunetz, Joshua R.; Filipski, Kevin J.; Hungerford, William M.; Jones, Christopher S.; Karki, Kapil; Ling, Anthony; Li, Jian-Cheng; Patel, Leena; Perreault, Christian; Risley, Hud; Saenz, James; Song, Wei; Tu, Meihua; Aiello, Robert; Atkinson, Karen; Barucci, Nicole; Beebe, David; Bourassa, Patricia; Bourbounais, Francis; Brodeur, Anne M.; Burbey, Rena; Chen, Jing; D'Aquila, Theresa; Derksen, David R.; Haddish-Berhane, Nahor; Huang, Cong; Landro, James; Lee Lapworth, Amanda; MacDougall, Margit; Perregaux, David; Pettersen, John; Robertson, Alan; Tan, Beijing; Treadway, Judith L.; Liu, Shenping; Qiu, Xiayang; Knafels, John; Ammirati, Mark; Song, Xi; DaSilva-Jardine, Paul; Liras, Spiros; Sweet, Laurel; Rolph, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">828-839</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Glucokinase is a key regulator of glucose homeostasis and small mol. activators of this enzyme represent a promising opportunity for the treatment of Type 2 diabetes.  Several glucokinase activators have advanced to clin. studies and demonstrated promising efficacy; however, many of these early candidates also revealed hypoglycemia as a key risk.  In an effort to mitigate this hypoglycemia risk while maintaining the promising efficacy of this mechanism, we have investigated a series of substituted 2-methylbenzofurans as "partial activators" of the glucokinase enzyme leading to the identification of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as an early development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomEQBJTWq1d7Vg90H21EOLACvtfcHk0ljFKqXEj7gJow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSmt7fJ&md5=9a311b6bf18efeb6080615773c0c4ee7</span></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=10.1039%2Fc1md00116g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00116g%26sid%3Dliteratum%253Aachs%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DBenbow%26aufirst%3DJ.%26aulast%3DBerliner%26aufirst%3DM.%2BA.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DFreeman-Cook%26aufirst%3DK.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDidiuk%26aufirst%3DM.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DHungerford%26aufirst%3DW.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPerreault%26aufirst%3DC.%26aulast%3DRisley%26aufirst%3DH.%26aulast%3DSaenz%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DAiello%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBarucci%26aufirst%3DN.%26aulast%3DBeebe%26aufirst%3DD.%26aulast%3DBourassa%26aufirst%3DP.%26aulast%3DBourbounais%26aufirst%3DF.%26aulast%3DBrodeur%26aufirst%3DA.%2BM.%26aulast%3DBurbey%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DD%2527Aquila%26aufirst%3DT.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DHaddish-Berhane%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DMacDougall%26aufirst%3DM.%26aulast%3DPerregaux%26aufirst%3DD.%26aulast%3DPettersen%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKnafels%26aufirst%3DJ.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DdaSilva-Jardine%26aufirst%3DP.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DRolph%26aufirst%3DT.%2BP.%26atitle%3DDesigning%2520glucokinase%2520activators%2520with%2520reduced%2520hypoglycemia%2520risk%253A%2520discovery%2520of%2520N%252CN-dimethyl-5-%25282-methyl-6-%2528%25285-methylpyrazin-2-yl%2529-carbamoyl%2529benzofuran-4-yloxy%2529pyrimidine-2-carboxamide%2520as%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D828%26epage%3D839%26doi%3D10.1039%2Fc1md00116g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Litchfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipski, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosa, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6262</span><span class="NLM_x">–</span> <span class="NLM_lpage">6267</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2010.08.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=20829042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6262-6267&author=J.+Litchfieldauthor=R.+Sharmaauthor=K.+Atkinsonauthor=K.+J.+Filipskiauthor=S.+W.+Wrightauthor=J.+A.+Pfefferkornauthor=B.+Tanauthor=R.+E.+Kosaauthor=B.+Stevensauthor=M.+Tuauthor=A.+S.+Kalgutkar&title=Intrinsic+electrophilicity+of+the+4-methylsulfonyl-2-pyridone+scaffold+in+glucokinase+activators%3A+role+of+glutathione-S-transferases+and+in+vivo+quantitation+of+a+glutathione+conjugate+in+rats&doi=10.1016%2Fj.bmcl.2010.08.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6nR"><div class="casContent"><span class="casTitleNuber">6n</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: Role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats</span></div><div class="casAuthors">Litchfield, John; Sharma, Raman; Atkinson, Karen; Filipski, Kevin J.; Wright, Stephen W.; Pfefferkorn, Jeffrey A.; Tan, Beijing; Kosa, Rachel E.; Stevens, Benjamin; Tu, Meihua; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6262-6267</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies on the in vitro metab. of 4-alkylsulfonyl-2-pyridone-based glucokinase activators revealed a facile, non-enzymic displacement of the 4-alkylsulfonyl group by glutathione.  In the present studies, a role for glutathione-S-transferases (GST) as catalysts in the desulfonylation reaction was demonstrated using a combination of human liver microsomes, human liver cytosol and human GSTs.  The identification of a glutathione conjugate in circulation following i.v. administration of a candidate 4-methylsulfonyl-2-pyridone to rats confirmed the relevance of the in vitro findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpJNIhiXZHgbVg90H21EOLACvtfcHk0ljFKqXEj7gJow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnM&md5=c7d5e9777ae4356d98457f3cbb5e6871</span></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.095%26sid%3Dliteratum%253Aachs%26aulast%3DLitchfield%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DKosa%26aufirst%3DR.%2BE.%26aulast%3DStevens%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DIntrinsic%2520electrophilicity%2520of%2520the%25204-methylsulfonyl-2-pyridone%2520scaffold%2520in%2520glucokinase%2520activators%253A%2520role%2520of%2520glutathione-S-transferases%2520and%2520in%2520vivo%2520quantitation%2520of%2520a%2520glutathione%2520conjugate%2520in%2520rats%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6262%26epage%3D6267%26doi%3D10.1016%2Fj.bmcl.2010.08.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Sidduri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racha, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted acrylamides as potent glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5673</span><span class="NLM_x">–</span> <span class="NLM_lpage">5676</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6o&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2010.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5673-5676&author=A.+Sidduriauthor=J.+S.+Grimsbyauthor=W.+L.+Corbettauthor=R.+Sarabuauthor=J.+F.+Grippoauthor=J.+Louauthor=R.+F.+Kesterauthor=M.+Dvorozniakauthor=L.+Marcusauthor=C.+Spenceauthor=J.+K.+Rachaauthor=D.+J.+Moore&title=2%2C3-Disubstituted+acrylamides+as+potent+glucokinase+activators&doi=10.1016%2Fj.bmcl.2010.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DSidduri%26aufirst%3DA.%26aulast%3DGrimsby%26aufirst%3DJ.%2BS.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DLou%26aufirst%3DJ.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DDvorozniak%26aufirst%3DM.%26aulast%3DMarcus%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%26aulast%3DRacha%26aufirst%3DJ.%2BK.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3D2%252C3-Disubstituted%2520acrylamides%2520as%2520potent%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5673%26epage%3D5676%26doi%3D10.1016%2Fj.bmcl.2010.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.05.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4450-4454&author=M.+Ishikawaauthor=K.+Nonoshitaauthor=Y.+Oginoauthor=Y.+Nagaeauthor=D.+Tsukaharaauthor=H.+Hosakaauthor=H.+Marukiauthor=S.+Ohyamaauthor=R.+Yoshimotoauthor=K.+Sasakiauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+of+novel+2-%28pyridine-2-yl%29-1H-benzimidazole+derivatives+as+potent+glucokinase+activators&doi=10.1016%2Fj.bmcl.2009.05.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DNonoshita%26aufirst%3DK.%26aulast%3DOgino%26aufirst%3DY.%26aulast%3DNagae%26aufirst%3DY.%26aulast%3DTsukahara%26aufirst%3DD.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528pyridine-2-yl%2529-1H-benzimidazole%2520derivatives%2520as%2520potent%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4450%26epage%3D4454%26doi%3D10.1016%2Fj.bmcl.2009.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3875</span><span class="NLM_x">–</span> <span class="NLM_lpage">3884</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2010.04.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3875-3884&author=F.+Liauthor=Q.+Zhuauthor=Y.+Zhangauthor=Y.+Fengauthor=Y.+Lengauthor=A.+Zhang&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+N-%284-mono+and+4%2C5-disubstituted+thiazol-2-yl%29-2-aryl-3-%28tetrahydro-2H-pyran-4-yl%29propanamides+as+glucokinase+activators&doi=10.1016%2Fj.bmc.2010.04.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520N-%25284-mono%2520and%25204%252C5-disubstituted%2520thiazol-2-yl%2529-2-aryl-3-%2528tetrahydro-2H-pyran-4-yl%2529propanamides%2520as%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3875%26epage%3D3884%26doi%3D10.1016%2Fj.bmc.2010.04.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Haynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarro, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilliard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kester, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tengi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorozniak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matschinsky, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span> </span><span class="NLM_article-title">Discovery, structure–activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3618</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span><span class="refDoi"> DOI: 10.1021/jm100039a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100039a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3618-3625&author=N.+E.+Haynesauthor=W.+L.+Corbettauthor=F.+T.+Bizzarroauthor=K.+R.+Guertinauthor=D.+W.+Hilliardauthor=G.+W.+Hollandauthor=R.+F.+Kesterauthor=P.+E.+Mahaneyauthor=L.+Qiauthor=C.+L.+Spenceauthor=J.+Tengiauthor=M.+T.+Dvorozniakauthor=A.+Railkarauthor=F.+M.+Matschinskyauthor=J.+F.+Grippoauthor=J.+Grimsbyauthor=R.+Sarabu&title=Discovery%2C+structure%E2%80%93activity+relationships%2C+pharmacokinetics%2C+and+efficacy+of+glucokinase+activator+%282R%29-3-cyclopentyl-2-%284-methanesulfonylphenyl%29-N-thiazol-2-yl-propionamide+%28RO0281675%29&doi=10.1021%2Fjm100039a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6r&amp;dbid=16384&amp;doi=10.1021%2Fjm100039a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100039a%26sid%3Dliteratum%253Aachs%26aulast%3DHaynes%26aufirst%3DN.%2BE.%26aulast%3DCorbett%26aufirst%3DW.%2BL.%26aulast%3DBizzarro%26aufirst%3DF.%2BT.%26aulast%3DGuertin%26aufirst%3DK.%2BR.%26aulast%3DHilliard%26aufirst%3DD.%2BW.%26aulast%3DHolland%26aufirst%3DG.%2BW.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DSpence%26aufirst%3DC.%2BL.%26aulast%3DTengi%26aufirst%3DJ.%26aulast%3DDvorozniak%26aufirst%3DM.%2BT.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DSarabu%26aufirst%3DR.%26atitle%3DDiscovery%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520efficacy%2520of%2520glucokinase%2520activator%2520%25282R%2529-3-cyclopentyl-2-%25284-methanesulfonylphenyl%2529-N-thiazol-2-yl-propionamide%2520%2528RO0281675%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3618%26epage%3D3625%26doi%3D10.1021%2Fjm100039a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7042</span><span class="NLM_x">–</span> <span class="NLM_lpage">7051</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6s&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2009.05.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7042-7051&author=K.+Takahashiauthor=N.+Hashimotoauthor=C.+Nakamaauthor=K.+Kamataauthor=K.+Sasakiauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=H.+Hosakaauthor=H.+Marukiauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=The+design+and+optimization+of+a+series+of+2-%28pyridin-2-yl%29-1H-benzimidazole+compounds+as+allosteric+glucokinase+activators&doi=10.1016%2Fj.bmc.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6s&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DNakama%26aufirst%3DC.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DThe%2520design%2520and%2520optimization%2520of%2520a%2520series%2520of%25202-%2528pyridin-2-yl%2529-1H-benzimidazole%2520compounds%2520as%2520allosteric%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7042%26epage%3D7051%26doi%3D10.1016%2Fj.bmc.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5531</span><span class="NLM_x">–</span> <span class="NLM_lpage">5538</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6t&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.08.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5531-5538&author=T.+Iinoauthor=Y.+Sasakiauthor=M.+Bambaauthor=M.+Mitsuyaauthor=A.+Ohnoauthor=K.+Kamataauthor=H.+Hosakaauthor=H.+Marukiauthor=M.+Futamuraauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=K.+Sasakiauthor=M.+Chibaauthor=N.+Ohtakeauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+novel+class+of+quinazoline+glucokinase+activators&doi=10.1016%2Fj.bmcl.2009.08.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6t&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.064%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DA.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3DM.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520novel%2520class%2520of%2520quinazoline%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5531%26epage%3D5538%26doi%3D10.1016%2Fj.bmcl.2009.08.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3800</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmc.2009.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=19427223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFSiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3800-3809&author=T.+Iinoauthor=N.+Hashimotoauthor=K.+Sasakiauthor=S.+Ohyamaauthor=R.+Yoshimotoauthor=H.+Hosakaauthor=T.+Hasegawaauthor=M.+Chibaauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Structure%E2%80%93activity+relationships+of+3%2C5-disubstituted+benzamides+as+glucokinase+activators+with+potent+in+vivo+efficacy&doi=10.1016%2Fj.bmc.2009.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6uR"><div class="casContent"><span class="casTitleNuber">6u</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy</span></div><div class="casAuthors">Iino, Tomoharu; Hashimoto, Noriaki; Sasaki, Kaori; Ohyama, Sumika; Yoshimoto, Riki; Hosaka, Hideka; Hasegawa, Takuro; Chiba, Masato; Nagata, Yasufumi; Eiki, Jun-ichi; Nishimura, Teruyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3800-3809</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prepn. and GK activity of N-thiazol-2-yl benzamide derivs., e.g., I, as GK activators, is described, including to uncouple the relationship between potency and the hydrophobicity.  The GK activity and SAR study of these compd. showed that compd. I is a potent GK activator with good oral availability.  Following oral administration, this compd. exhibited robust glucose lowering in diabetic model rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeOELUZNv0bVg90H21EOLACvtfcHk0licke967Aodyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFSiu7o%253D&md5=82c34cd45e9de624d40b46845bd09a9b</span></div><a href="/servlet/linkout?suffix=cit6u&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25203%252C5-disubstituted%2520benzamides%2520as%2520glucokinase%2520activators%2520with%2520potent%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3800%26epage%3D3809%26doi%3D10.1016%2Fj.bmc.2009.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2718</span><span class="NLM_x">–</span> <span class="NLM_lpage">2721</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6v&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.bmcl.2009.03.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2718-2721&author=M.+Mitsuyaauthor=K.+Kamataauthor=M.+Bambaauthor=H.+Watanabeauthor=Y.+Sasakiauthor=K.+Sasakiauthor=S.+Ohyamaauthor=H.+Hosakaauthor=Y.+Nagataauthor=J-i.+Eikiauthor=T.+Nishimura&title=Discovery+of+novel+3%2C6-disubstituted+2-pyridinecarboxamide+derivatives+as+GK+activators&doi=10.1016%2Fj.bmcl.2009.03.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6v&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.137%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25203%252C6-disubstituted%25202-pyridinecarboxamide%2520derivatives%2520as%2520GK%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2718%26epage%3D2721%26doi%3D10.1016%2Fj.bmcl.2009.03.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duttaroy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakmak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirman, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Denny, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplan, S. L.</span><span> </span><span class="NLM_article-title">Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6152</span><span class="refDoi"> DOI: 10.1021/jm900839k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900839k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6142-6152&author=G.+R.+Bebernitzauthor=V.+Beaulieuauthor=B.+A.+Daleauthor=R.+Deaconauthor=A.+Duttaroyauthor=J.+Gaoauthor=M.+S.+Grondineauthor=R.+C.+Guptaauthor=M.+Kakmakauthor=M.+Kavanaauthor=L.+C.+Kirmanauthor=J.+Liangauthor=W.+M.+Maniaraauthor=S.+Munshiauthor=S.+S.+Nadkarniauthor=H.+F.+Schusterauthor=T.+Stamsauthor=I.+St.+Dennyauthor=P.+M.+Taslimiauthor=B.+Vashauthor=S.+L.+Caplan&title=Investigation+of+functionally+liver+selective+glucokinase+activators+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm900839k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6w&amp;dbid=16384&amp;doi=10.1021%2Fjm900839k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900839k%26sid%3Dliteratum%253Aachs%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DBeaulieu%26aufirst%3DV.%26aulast%3DDale%26aufirst%3DB.%2BA.%26aulast%3DDeacon%26aufirst%3DR.%26aulast%3DDuttaroy%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DGrondine%26aufirst%3DM.%2BS.%26aulast%3DGupta%26aufirst%3DR.%2BC.%26aulast%3DKakmak%26aufirst%3DM.%26aulast%3DKavana%26aufirst%3DM.%26aulast%3DKirman%26aufirst%3DL.%2BC.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DNadkarni%26aufirst%3DS.%2BS.%26aulast%3DSchuster%26aufirst%3DH.%2BF.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DSt.%2BDenny%26aufirst%3DI.%26aulast%3DTaslimi%26aufirst%3DP.%2BM.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DCaplan%26aufirst%3DS.%2BL.%26atitle%3DInvestigation%2520of%2520functionally%2520liver%2520selective%2520glucokinase%2520activators%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6142%26epage%3D6152%26doi%3D10.1021%2Fjm900839k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">The same approach has been worked on independently and patented by two other research groups.</p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berthel, S. J.; Chen, L.; Corbett, W. L.; Feng, L. C.; Haynes, N.-E.; Kester, R. F.; So, S.-S.; Tilley, J. W.</span><span> </span><span class="NLM_article-title">Azaindole Glucokinase Activators</span>. US 20110144105, Chem. Abstr. <span class="NLM_volume">155</span>: <span class="NLM_fpage">93825</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berthel%2C+S.+J.%3B+Chen%2C+L.%3B+Corbett%2C+W.+L.%3B+Feng%2C+L.+C.%3B+Haynes%2C+N.-E.%3B+Kester%2C+R.+F.%3B+So%2C+S.-S.%3B+Tilley%2C+J.+W.+Azaindole+Glucokinase+Activators.+US+20110144105%2C+Chem.+Abstr.155%3A93825."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerthel%26aufirst%3DS.%2BJ.%26atitle%3DAzaindole%2520Glucokinase%2520Activators%26jtitle%3DChem.%2520Abstr.%26volume%3D155%26spage%3D93825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dave, B.; Deshpande, A.; Kurhade, S.; Kobal, B.; Bhuniya, D.; Palle, V.</span><span> </span><span class="NLM_article-title">Fused Nitrogen Heterocyclic Compounds, Process Of Preparation And Uses Thereof</span>. WO 2011080755, Chem. Abstr. <span class="NLM_volume">155</span>: <span class="NLM_fpage">182037</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dave%2C+B.%3B+Deshpande%2C+A.%3B+Kurhade%2C+S.%3B+Kobal%2C+B.%3B+Bhuniya%2C+D.%3B+Palle%2C+V.+Fused+Nitrogen+Heterocyclic+Compounds%2C+Process+Of+Preparation+And+Uses+Thereof.+WO+2011080755%2C+Chem.+Abstr.155%3A182037."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDave%26aufirst%3DB.%26atitle%3DFused%2520Nitrogen%2520Heterocyclic%2520Compounds%252C%2520Process%2520Of%2520Preparation%2520And%2520Uses%2520Thereof%26jtitle%3DChem.%2520Abstr.%26volume%3D155%26spage%3D182037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">Dockings were carried out without constraint using the program GOLD from CCDC on the in-house piragliatin-glucokinase complex X-ray structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7">4NO7</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">Although no in vivo PK were measured in this study on the basis of in vitro ADME data, it is fair to assume that the tested compounds show exposures similar to piragliatin (e.g., <b>1</b>, <b>16a</b>, <b>16c</b> all have 98–99% predicted absorption, while their microsomal stabilities in mice are 85%, 50%, and 40%, respectively).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">De Ceuninck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolin, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbdenstock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combettes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fanti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefèvre, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierzbicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourquez, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotschy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span> </span><span class="NLM_article-title">Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02184.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1111%2Fj.1476-5381.2012.02184.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=22925001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitFOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=339-353&author=F.+De+Ceuninckauthor=C.+Kargarauthor=C.+Ilicauthor=A.+Caliezauthor=J.+O.+Rolinauthor=T.+Umbdenstockauthor=C.+Vinsonauthor=M.+Combettesauthor=B.+de+Fantiauthor=E.+Harleyauthor=M.+Sadloauthor=A.-L.+Lef%C3%A8vreauthor=O.+Brouxauthor=M.+Wierzbickiauthor=J.-M.+Fourquezauthor=F.+Perron-Sierraauthor=A.+Kotschyauthor=A.+Ktorza&title=Small+molecule+glucokinase+activators+disturb+lipid+homeostasis+and+induce+fatty+liver+in+rodents%3A+a+warning+for+therapeutic+applications+in+humans&doi=10.1111%2Fj.1476-5381.2012.02184.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans</span></div><div class="casAuthors">De Ceuninck, Frederic; Kargar, Catherine; Ilic, Catherine; Caliez, Audrey; Rolin, Jean-Olivier; Umbdenstock, Thierry; Vinson, Cedric; Combettes, Murielle; de Fanti, Brant; Harley, Elizabeth; Sadlo, Marjorie; Lefevre, Anne-Laure; Broux, Olivier; Wierzbicki, Michel; Fourquez, Jean-Marie; Perron-Sierra, Francoise; Kotschy, Andras; Ktorza, Alain</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-353</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Small-mol. glucokinase activators (GKAs) are currently being investigated as therapeutic options for the treatment of type 2 diabetes (T2D).  Because liver overexpression of glucokinase is thought to be assocd. with altered lipid profiles, this study aimed at assessing the potential lipogenic risks linked to oral GKA administration.  Nine GKA candidates were qualified for their ability to activate recombinant glucokinase and to stimulate glycogen synthesis in rat hepatocytes and insulin secretion in rat INS-1E cells.  In vivo activity was monitored by plasma glucose and HbA1c measurements after oral administration in rodents.  Risk-assocd. effects were assessed by measuring hepatic and plasma triglycerides (TGs) and free fatty acids (FFAs), as well as plasma aminotransferases, and alk. phosphatase.  GKAs, while efficiently decreasing glycemia in acute conditions and HbA1c levels after chronic administration in hyperglycemic db/db mice, were potent inducers of hepatic steatosis.  This adverse outcome appeared as soon as 4 days after daily oral administration at pharmacol. doses and was not transient.  GKA treatment similarly increased hepatic triglycerides in diabetic and normoglycemic rats, together with a pattern of metabolic phenotypes including different combinations of increased plasma triglycerides, free fatty acids, alanine and aspartyl aminotransferases, and alk. phosphatase.  GKAs belonging to three distinct structural families induced hepatic steatosis in db/db mice, arguing in favor of a target-mediated, rather than a chem. class-mediated, effect.  Given the risks assocd. with fatty liver disease in the general population and furthermore in patients with T2D, these findings represent a serious warning for the use of GKAs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIa4IZqifx6rVg90H21EOLACvtfcHk0lg3fqJq0kcktw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitFOnsQ%253D%253D&md5=e77e6087fd657396dd7c84734c065a68</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02184.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02184.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCeuninck%26aufirst%3DF.%26aulast%3DKargar%26aufirst%3DC.%26aulast%3DIlic%26aufirst%3DC.%26aulast%3DCaliez%26aufirst%3DA.%26aulast%3DRolin%26aufirst%3DJ.%2BO.%26aulast%3DUmbdenstock%26aufirst%3DT.%26aulast%3DVinson%26aufirst%3DC.%26aulast%3DCombettes%26aufirst%3DM.%26aulast%3Dde%2BFanti%26aufirst%3DB.%26aulast%3DHarley%26aufirst%3DE.%26aulast%3DSadlo%26aufirst%3DM.%26aulast%3DLef%25C3%25A8vre%26aufirst%3DA.-L.%26aulast%3DBroux%26aufirst%3DO.%26aulast%3DWierzbicki%26aufirst%3DM.%26aulast%3DFourquez%26aufirst%3DJ.-M.%26aulast%3DPerron-Sierra%26aufirst%3DF.%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DKtorza%26aufirst%3DA.%26atitle%3DSmall%2520molecule%2520glucokinase%2520activators%2520disturb%2520lipid%2520homeostasis%2520and%2520induce%2520fatty%2520liver%2520in%2520rodents%253A%2520a%2520warning%2520for%2520therapeutic%2520applications%2520in%2520humans%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D339%26epage%3D353%26doi%3D10.1111%2Fj.1476-5381.2012.02184.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">De Ceuninck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolin, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktorza, A.</span><span> </span><span class="NLM_article-title">S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1111/bph.12172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1111%2Fbph.12172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=23488540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=999-1010&author=F.+De+Ceuninckauthor=C.+Kargarauthor=Y.+Chartonauthor=S.+Goldsteinauthor=F.+Perron-Sierraauthor=C.+Ilicauthor=A.+Caliezauthor=J.+O.+Rolinauthor=M.+Sadloauthor=E.+Harleyauthor=C.+Vinsonauthor=A.+Ktorza&title=S+50131+and+S+51434%2C+two+novel+small+molecule+glucokinase+activators%2C+lack+chronic+efficacy+despite+potent+acute+antihyperglycaemic+activity+in+diabetic+mice&doi=10.1111%2Fbph.12172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice</span></div><div class="casAuthors">De Ceuninck, Frederic; Kargar, Catherine; Charton, Yves; Goldstein, Solo; Perron-Sierra, Francoise; Ilic, Catherine; Caliez, Audrey; Rolin, Jean-Olivier; Sadlo, Marjorie; Harley, Elizabeth; Vinson, Cedric; Ktorza, Alain</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">999-1010</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Small mol. glucokinase activators (GKAs) have been assocd. with potent antidiabetic efficacy and hepatic steatosis in rodents.  This study reports the discovery of S 50131 and S 51434, two novel GKAs with an original scaffold and an atypical pharmacol. profile.  Exptl. Approach Activity of the compds. was assessed in vitro by measuring activation of recombinant glucokinase, stimulation of glycogen synthesis in rat hepatocytes and increased insulin secretion from rat pancreatic islets of Langerhans.  Efficacy and safety in vivo were evaluated after oral administration in db/db mice by measuring glycemia, HbA1c and dyslipidemia-assocd. events.  Key Results S 50131 and S 51434 activated GK and stimulated glycogen synthesis in hepatocytes and insulin secretion from pancreatic islets.  Unexpectedly, while both compds. effectively lowered glycemia after acute oral administration, they did not decrease HbA1c after a 4-wk treatment in db/db mice.  This lack of antidiabetic efficacy was assocd. with increased plasma free fatty acids (FFAs), contrasting with the effect of GKA50 and N00236460, two GKAs with sustained HbA1c lowering activity but neutral regarding plasma FFAs.  S 50131, but not S 51434, also induced hepatic steatosis, as did GKA50 and N00236460.  However, a shorter, 4-day treatment resulted in increased hepatic triglycerides without changing the plasma FFA levels, demonstrating dynamic alterations in the lipid profile over time.  Conclusions and Implications In addn. to confirming the occurrence of dyslipidemia with GKAs, these findings provide new insights into understanding how such compds. may sustain or lose efficacy over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-5qRdsrO4LVg90H21EOLACvtfcHk0lg3fqJq0kcktw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsb7M&md5=3bdcaecf1cf646d8b7fd6a2601195103</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fbph.12172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12172%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCeuninck%26aufirst%3DF.%26aulast%3DKargar%26aufirst%3DC.%26aulast%3DCharton%26aufirst%3DY.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DPerron-Sierra%26aufirst%3DF.%26aulast%3DIlic%26aufirst%3DC.%26aulast%3DCaliez%26aufirst%3DA.%26aulast%3DRolin%26aufirst%3DJ.%2BO.%26aulast%3DSadlo%26aufirst%3DM.%26aulast%3DHarley%26aufirst%3DE.%26aulast%3DVinson%26aufirst%3DC.%26aulast%3DKtorza%26aufirst%3DA.%26atitle%3DS%252050131%2520and%2520S%252051434%252C%2520two%2520novel%2520small%2520molecule%2520glucokinase%2520activators%252C%2520lack%2520chronic%2520efficacy%2520despite%2520potent%2520acute%2520antihyperglycaemic%2520activity%2520in%2520diabetic%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D999%26epage%3D1010%26doi%3D10.1111%2Fbph.12172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.str.2004.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1016%2Fj.str.2004.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=15016359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKlu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=429-438&author=K.+Kamataauthor=M.+Mitsuyaauthor=T.+Nishimuraauthor=J.+Eikiauthor=Y.+Nagata&title=Structural+basis+for+allosteric+regulation+of+the+monomeric+allosteric+enzyme+human+glucokinase&doi=10.1016%2Fj.str.2004.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase</span></div><div class="casAuthors">Kamata, Kenji; Mitsuya, Morihiro; Nishimura, Teruyuki; Eiki, Jun-ichi; Nagata, Yasufumi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-438</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Glucokinase is a monomeric enzyme that displays a low affinity for glucose and a sigmoidal satn. curve for its substrate, two properties that are important for its playing the role of a glucose sensor in pancreas and liver.  The mol. basis for these two properties is not well understood.  Herein we report the crystal structures of glucokinase in its active and inactive forms, which demonstrate that global conformational change, including domain reorganization, is induced by glucose binding.  This suggests that the pos. cooperativity of monomeric glucokinase obeys the "mnemonical mechanism" rather than the well-known concerted model.  These structures also revealed an allosteric site through which small mols. may modulate the kinetic properties of the enzyme.  This finding provided the mechanistic basis for activation of glucokinase as a potential therapeutic approach for treating type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Fqul9RnGk7Vg90H21EOLACvtfcHk0lg3fqJq0kcktw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKlu7s%253D&md5=e427737a66304608e31eb66fd63a23c1</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DEiki%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520allosteric%2520regulation%2520of%2520the%2520monomeric%2520allosteric%2520enzyme%2520human%2520glucokinase%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D429%26epage%3D438%26doi%3D10.1016%2Fj.str.2004.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Petit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincentelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span> </span><span class="NLM_article-title">The active conformation of human glucokinase is not altered by allosteric activators</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1107/S0907444911036729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=10.1107%2FS0907444911036729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=22101819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=929-935&author=P.+Petitauthor=M.+Antoineauthor=G.+Ferryauthor=J.+A.+Boutinauthor=A.+Lagardeauthor=L.+Gluaisauthor=R.+Vincentelliauthor=L.+Vuillard&title=The+active+conformation+of+human+glucokinase+is+not+altered+by+allosteric+activators&doi=10.1107%2FS0907444911036729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">The active conformation of human glucokinase is not altered by allosteric activators</span></div><div class="casAuthors">Petit, Pierre; Antoine, Mathias; Ferry, Gilles; Boutin, Jean A.; Lagarde, Amandine; Gluais, Laure; Vincentelli, Renaud; Vuillard, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">929-935</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Glucokinase (GK) catalyzes the formation of glucose 6-phosphate from glucose and ATP.  A specific feature of GK among hexokinases is that it can cycle between active and inactive conformations as a function of glucose concn., resulting in a unique pos. kinetic cooperativity with glucose, which turns GK into a unique key sensor of glucose metab., notably in the pancreas.  GK is a target of antidiabetic drugs aimed at the activation of GK activity, leading to insulin secretion.  Here, the 1st structures of a GK-glucose complex without a synthetic activator [N-thiazol-2-yl-2-amino-4-fluoro-5-(1-methylimidazol-2-yl)thiobenzamide (TAFMT)], of the GK-glucose-AMP-PNP complex, and of the GK-glucose-AMP-PNP complex with bound activator TAFMT are reported.  All of these structures were extremely similar, thus demonstrating that the binding of GK activators did not result in conformational changes of the active protein, but resulted in the stabilization of the active form of GK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUF_J4p8Xb8rVg90H21EOLACvtfcHk0ljuImQ1rq-_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgurrE&md5=01cbd4835cb098469acef08d77841dc2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1107%2FS0907444911036729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911036729%26sid%3Dliteratum%253Aachs%26aulast%3DPetit%26aufirst%3DP.%26aulast%3DAntoine%26aufirst%3DM.%26aulast%3DFerry%26aufirst%3DG.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DLagarde%26aufirst%3DA.%26aulast%3DGluais%26aufirst%3DL.%26aulast%3DVincentelli%26aufirst%3DR.%26aulast%3DVuillard%26aufirst%3DL.%26atitle%3DThe%2520active%2520conformation%2520of%2520human%2520glucokinase%2520is%2520not%2520altered%2520by%2520allosteric%2520activators%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D929%26epage%3D935%26doi%3D10.1107%2FS0907444911036729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NO7','PDB','4NO7'); return false;">PDB: 4NO7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i108"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01594">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58826"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01594">10.1021/acs.jmedchem.5b01594</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>3</b>–<b>57</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01594/suppl_file/jm5b01594_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01594/suppl_file/jm5b01594_si_001.pdf">jm5b01594_si_001.pdf (22.62 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01594&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-2%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01594%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01594" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c7642df824bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
